Psychiatry

• 

  Subject Areas on Research

  • "A Résumé for the Baby": Biosocial Precarity and Care of Substance-Using, Pregnant Women in San Francisco. 
  • "Flipping" the Academic Half-Day to Create an Opportunity for Faculty Development. 
  • "Go here-to there" performance after amphetamine: the importance of the response requirement in successive discrimination. 
  • "Hope that is seen is no hope at all:" theological constructions of hope in psychotherapy. 
  • "I felt like a slut": the cultural context and women's response to being raped. 
  • "John Henryism" and blood pressure in a Dutch population. 
  • "Rehospitalization" versus "recidivism". 
  • 'Effects of risperidone augmentation in patients with treatment-resistant depression: results of open-label treatment followed by double-blind continuation'. 
  • 'Just say no': A preliminary evaluation of a three-stage model of integrated treatment for substance use problems in conditions of medium security 
  • 108. Hippocampal Subfield Volumes Relate to Unique Phenotypes of PTSD: International Analysis by the PGC-ENIGMA PTSD Working Group 
  • 12-month prevalence and concomitants of DSM-IV depression and anxiety disorders in two violence-prone cities in Brazil. 
  • 12-month trajectories of depressive symptoms among nurses-Contribution of personality, job characteristics, coping, and burnout. 
  • 18-Month outcome of clozapine treatment for 100 patients in a state psychiatric hospital 
  • 196. Onset of alzheimer's disease in susceptible subjects: Influence of APOE 
  • 2. ECT and Anticonvulsant Medications 
  • 2011 Annual report of the American Board of Psychiatry and Neurology, Inc. 
  • 24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum. 
  • 3-HYDROXYKYNURENINE AND COGNITIVE IMPAIRMENT IN FIRST-EPISODE NEUROLEPTIC-NAIVE PATIENTS WITH SCHIZOPHRENIA 
  • 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. 
  • 3. ECT in the Presence of Brain Tumor and Increased Intracranial Pressure 
  • 3. Magnetic Resonance Spectroscopic Correlates of the Response to ECT 
  • 34. Serotonin transporter genotypes, CSF 5HIAA, and cardiovascular reactivity to stress 
  • 410. Interactive effects in the anterior cingulate of sadness and selective attention: a PET study 
  • 5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice. 
  • 5-HTTLPR and DISC1 risk genotypes for elevated PTSD symptoms in US military veterans. 
  • 5-HTTLPR genotype potentiates the effects of war zone stressors on the emergence of PTSD, depressive and anxiety symptoms in soldiers deployed to iraq. 
  • 5-hydroxytryptamine in the hindbrain of depressive suicides. 
  • 5HTTLPR genotypes and environmental stress interact to affect sleep quality 
  • 9 -Tetrahydrocannabinol: a hypotensive effect in rats. 
  • A 102-center prospective study of seizure in association with bupropion. 
  • A 12-Month prospective study of the effects of PTSD-depression comorbidity on suicidal behavior in Iraq/Afghanistan-era veterans. 
  • A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder. 
  • A 2-year follow-up of social phobia. Status after a brief medication trial. 
  • A 3-year longitudinal study examining the effect of resilience on suicidality in veterans. 
  • A 43-year-old woman with symptoms of PTSD 
  • A Bayesian model averaging approach to examining changes in quality of life among returning Iraq and Afghanistan veterans. 
  • A Call to Restructure Psychiatry General and Subspecialty Training. 
  • A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer. 
  • A Common Polymorphism in a Williams Syndrome Gene Predicts Amygdala Reactivity and Extraversion in Healthy Adults. 
  • A Complex Systems Approach to Causal Discovery in Psychiatry. 
  • A Connectome-wide Functional Signature of Transdiagnostic Risk for Mental Illness. 
  • A Consensus Meeting on Effective Research Practice in PTSD 
  • A DNA methylation biomarker of alcohol consumption. 
  • A Functional Interleukin-18 Haplotype Predicts Depression and Anxiety through Increased Threat-Related Amygdala Reactivity in Women but Not Men. 
  • A Geriatrics Perspective on Dementia Prevention and Treatment. 
  • A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. 
  • A MULTI-DIMENSIONAL MODEL OF MENTAL HEALTH IN ADULTS WITH CHRONIC PAIN 
  • A Multi-Site, Naturalistic Study of RTMS for Major Depressive Disorder 
  • A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder. 
  • A Next Step in Suicide Prevention. 
  • A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study. 
  • A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study 
  • A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. 
  • A Pilot Study of Neuroplasticity Based Cognitive Remediation in Adolescents with Psychosis 
  • A Preliminary Examination of the Effects of Transdiagnostic Versus Single Diagnosis Protocols on Anger During the Treatment of Anxiety Disorders 
  • A Preliminary Investigation of a Relapse Prevention Mobile Application to Maintain Smoking Abstinence Among Individuals With Posttraumatic Stress Disorder. 
  • A Primer on Foraging and the Explore/Exploit Trade-Off for Psychiatry Research. 
  • A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care. 
  • A Qualitative Study of Mental Health Problems Among Orphaned Children and Adolescents in Tanzania. 
  • A Randomized Clinical Trial of Nicotine Preloading for Smoking Cessation in People with Posttraumatic Stress Disorder. 
  • A Randomized Clinical Trial of a Money Management Intervention for Veterans With Psychiatric Disabilities. 
  • A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness. 
  • A Randomized Controlled Trial of Team-Based Learning Versus Lectures with Break-Out Groups on Knowledge Retention. 
  • A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. 
  • A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. 
  • A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. 
  • A Reanalysis of Arrest Rates. 
  • A Response to Proposed Budget Cuts Affecting Children's Mental Health: Protecting Policies and Programs That Promote Collective Efficacy. 
  • A Statistical Analysis of the Classification of Depression in a Mixed Community and Clinical Sample 
  • A Step Toward Optimizing Treatment Schedules for Continuation ECT: Response to Rasmussen. 
  • A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction. 
  • A Test of Causal Hypotheses of Psychopathic Traits: Reduced Emotional Responsiveness or Anomalous Attentional Control? 
  • A Unique Dual Cortico-Striatal Action of a Beta-Arrestin Biased Dopamine D2 Receptor Ligand 
  • A bootstrapped commingling analysis of platelet monoamine oxidase activity levels corrected for cigarette smoking 
  • A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. 
  • A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians. 
  • A brief depression scale for use in the medically ill. 
  • A brief history of psychiatric classification. From the ancients to DSM-IV. 
  • A case of delirium, motor disturbances, and autonomic dysfunction due to baclofen and tizanidine withdrawal: a review of the literature. 
  • A case of intermittent delirious mania. 
  • A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom? 
  • A caution on the use of the MMPI K-correction in research on psychosomatic medicine. 
  • A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). 
  • A clinical trial comparing interviewer and computer-assisted assessment among clients with severe mental illness. 
  • A collaborative care depression management program for cardiac inpatients: Depression characteristics and in-hospital outcomes 
  • A collaborative care depression management program for cardiac inpatients: depression characteristics and in-hospital outcomes. 
  • A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives 
  • A combined treatment approach to anxiety in the medically ill. 
  • A comparative evaluation of three discriminant scales for endogenous depression. 
  • A comparison between the growth hormone responses to amphetamine and clonidine. 
  • A comparison of cardio-metabolic risk between the deficit and non-deficit subtypes of schizophrenia. 
  • A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. 
  • A comparison of inpatients with primary unipolar depression and depression secondary to anxiety. 
  • A comparison of phenelzine and imipramine in depressed inpatients. 
  • A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. 
  • A comparison of spinal cord, cortical and superficial circulation. 
  • A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging. 
  • A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls 
  • A comparison of the SPRINT and CAPS assessment scales for posttraumatic stress disorder. 
  • A comparison of the effects of caffeine following abstinence and normal caffeine use. 
  • A comparison of tolerability profiles of patients with major depressive disorder receiving selective serotonin reputake inhibitors (SSRIS) in a naturalistic clinical care setting. 
  • A conceptual introduction to cognitive remediation for memory deficits associated with right unilateral electroconvulsive therapy. 
  • A critical evaluation of the complex PTSD literature: implications for DSM-5. 
  • A critique of the effectiveness of assertive community treatment. 
  • A day-centered approach to modeling cortisol: diurnal cortisol profiles and their associations among U.S. adults. 
  • A diagnostic and family study of posttraumatic stress disorder. 
  • A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults. 
  • A dimensional liability model of age differences in mental disorder prevalence: Evidence from a national sample 
  • A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice. 
  • A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression 
  • A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. 
  • A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal 
  • A double-blind comparison of bupropion and amitriptyline in depressed inpatients. 
  • A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients. 
  • A double-blind comparison of sertraline and fluoxetine in depressed elderly patients 
  • A double-blind comparison of three dosages of flutroline (CP-36,584) in the treatment of schizophrenia 
  • A double-blind crossover comparison of antiparkinson drug therapy: Amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function 
  • A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD). 
  • A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). 
  • A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A study):(Psychotherapy and Psychosomatics (2012) 81, (87-97)) 
  • A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression (Journal of Clinical Psychiatry (2010) 71, 1 (32-40)) 
  • A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. 
  • A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. 
  • A factor analysis of the signs and symptoms of mania. 
  • A family study of chronic post-traumatic stress disorder following rape trauma. 
  • A family-systems model for inpatient treatment of adolescents. 
  • A fidelity measure for integrated management of depression in primary care. 
  • A follow-up study of post partum illness, 1946-1978. 
  • A functional alternative splicing mutation in human tryptophan hydroxylase-2. 
  • A functional prodynorphin promoter polymorphism and opioid dependence. 
  • A genetic association study of the mu opioid receptor and severe opioid dependence 
  • A genetic association study of the mu opioid receptor and severe opioid dependence. 
  • A genome-wide analysis of putative functional and exonic variation associated with extremely high intelligence. 
  • A genome-wide analysis of putative functional and exonic variation associated with extremely high intelligence. 
  • A genome-wide association study for extremely high intelligence. 
  • A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing. 
  • A genome-wide association study of depressive symptoms. 
  • A genome-wide association study of suicide attempts and suicidal ideation in U.S. military veterans. 
  • A genome-wide screen for genes influencing conduct disorder 
  • A guide to guidelines for the treatment of PTSD and related conditions. 
  • A healthy aging program for older adults: effects on self-efficacy and morale. 
  • A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth. 
  • A history of the concept of atypical depression 
  • A history of the concept of atypical depression. 
  • A history of the concept of atypical depression. 
  • A hospital-based treatment of suicide attempt patients with problematic alcohol use: Rationale and treatment development. 
  • A knowledge network for a dynamic taxonomy of psychiatric disease. 
  • A longitudinal analysis of the overlap between violence and victimization among adults with mental illnesses. 
  • A longitudinal study of neurocognitive function in individuals at-risk for psychosis. 
  • A longitudinal study of the bi-directional relationship between tobacco smoking and psychological distress in a community sample of young Australian women. 
  • A magnetic resonance imaging study of putamen nuclei in major depression 
  • A magnetic resonance imaging study of putamen nuclei in major depression. 
  • A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressors. 
  • A meta-analysis of mentalizing impairments in adults with schizophrenia and autism spectrum disorder. 
  • A meta-analysis of the relationship between symptom severity of Posttraumatic Stress Disorder and executive function. 
  • A model comparison approach to trauma-related guilt as a mediator of the relationship between PTSD symptoms and suicidal ideation among veterans. 
  • A mouse knockout 
  • A multi-scanner study of subcortical brain volume abnormalities in schizophrenia. 
  • A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. 
  • A multiplicity of approaches to characterize geriatric depression and its outcomes. 
  • A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. 
  • A national study of violent behavior in persons with schizophrenia. 
  • A naturalistic study of maintenance ECT: Implications for optimizing the inter-treatment interval. 
  • A naturalistic study of the effects of smoking on the cognitive side effects of ECT. 
  • A naturalistic, multi-site study of repetitive transcranial magnetic stimulation therapy for depression. 
  • A neuroanatomic model for depression. 
  • A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology. 
  • A new MRI ratio method for in-vivo estimation of signal hypointensity in aging and Alzheimer's disease. 
  • A new and timely delusion: the complaint of having AIDS. 
  • A new method of classification for psychophysiologic disorders. 
  • A new treatment algorithm for posttraumatic stress disorder 
  • A novel Alzheimer disease locus located near the gene encoding tau protein. 
  • A pair of male monozygotic twins discordant for homosexuality. 
  • A path model of chronic stress, the metabolic syndrome, and coronary heart disease. 
  • A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia. 
  • A phenomenological investigation of women with Tourette or other chronic tic disorders. 
  • A pilot longitudinal study of hippocampal volumes in pediatric maltreatment-related posttraumatic stress disorder. 
  • A pilot randomized controlled trial in subthreshold PTSD with paroxetine in veterans who served after September 11th, 2001 
  • A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans. 
  • A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans. 
  • A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment. 
  • A pilot study of PTSD symptoms among Kalahari Bushmen. 
  • A pilot study of a structured interview addressing sexual function in men with schizophrenia. 
  • A pilot study of a weight management program with food provision in schizophrenia. 
  • A pilot study of amygdala volumes in pediatric generalized anxiety disorder. 
  • A pilot study of assertive community treatment for patients with chronic psychotic disorders. 
  • A pilot study of mirtazapine in post-traumatic stress disorder. 
  • A pilot study of phenelzine in the treatment of post-traumatic stress disorder. 
  • A placebo-controlled study of Kava kava in generalized anxiety disorder. 
  • A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. 
  • A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. 
  • A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo. 
  • A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. 
  • A practical guide to biobehavioral assessment and treatment of chronic pain 
  • A preliminary metabolomic analysis of older adults with and without depression 
  • A preliminary study of association between adolescent estradiol level and dorsolateral prefrontal cortex activity during emotion regulation. 
  • A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. 
  • A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. 
  • A preventative intervention for disruptive young boys may reduce adult criminality by reducing antisocial behaviour in adolescence. 
  • A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. 
  • A primate model of anterograde and retrograde amnesia produced by convulsive treatment. 
  • A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. 
  • A prospective study of inter-episode consistency of manic and mixed subtypes of bipolar disorder. 
  • A prospective study of religion/spirituality and depressive symptoms among adolescent psychiatric patients. 
  • A prospective study of the offspring of bipolar parents responsive and nonresponsive to lithium treatment. 
  • A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. 
  • A psychodynamic perspective on relational structures. 
  • A psychoendocrine study of premenstrual tension syndrome. A model for endogenous depression? 
  • A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). 
  • A psychopharmacology course for psychiatry residents utilizing active-learning and residents-as-teachers to develop life-long learning skills. 
  • A psychotherapeutic approach to silent children. 
  • A public health approach to address the mental health burden of youth in situations of political violence and humanitarian emergencies. 
  • A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. 
  • A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder. 
  • A randomized controlled trial of ganaxolone in posttraumatic stress disorder. 
  • A randomized controlled trial of outpatient commitment in North Carolina. 
  • A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram. 
  • A randomized controlled trial to assess effectiveness of a spiritually-based intervention to help chronically ill adults. 
  • A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. 
  • A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP). 
  • A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. 
  • A randomized trial of the effect of prayer on depression and anxiety. 
  • A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia 
  • A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. 
  • A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. 
  • A randomized, double-blind, placebo-controlled trial of sodium oxybate in fibromyalgia syndrome [FMS] 
  • A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with OROS methylphenidate in Treatment Resistant Depression 
  • A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with oros methylphenidate in treatment resistant depression 
  • A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. 
  • A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia. 
  • A randomized, placebo-controlled, double-blind trial of paroxetine controlled release (CR) in irritable bowel syndrome 
  • A recovery-oriented money management intervention. 
  • A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity 
  • A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. 
  • A repeat proton magnetic resonance spectroscopy study in social phobia. 
  • A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. 
  • A replicated molecular-genetic basis for subtyping antisocial behavior in ADHD 
  • A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. 
  • A research development workshop to stimulate outcome research in consultation-liaison psychiatry. 
  • A research strategy for investigating interactions between measured genes and measured environments 
  • A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone. 
  • A retrospective study exploring the effects of intramuscular aripiprazole on QTc change in agitated medically ill patients. 
  • A review of continuation electroconvulsive therapy: application, safety, and efficacy. 
  • A review of current evidence for acetyl-l-carnitine in the treatment of depression. 
  • A review of current evidence for vilazodone in major depressive disorder. 
  • A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. 
  • A revised measure of occupational stress for firefighters: Psychometric properties and relationship to posttraumatic stress disorder, depression, and substance abuse 
  • A school-based post-Katrina therapeutic intervention. 
  • A screening questionnaire for mother-infant bonding disorders 
  • A single high dose of cocaine induces differential sensitization to specific behaviors across adolescence. 
  • A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. 
  • A spiritual problem? Primary care physicians' and psychiatrists' interpretations of medically unexplained symptoms. 
  • A statistical analysis of the classification of depression in a mixed community and clinical sample. 
  • A study of depressive typologies using grade of membership analysis. 
  • A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia. 
  • A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. 
  • A survey of health care practitioners' knowledge of the QT interval. 
  • A survey of medical toxicology training in psychiatry residency programs. 
  • A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. 
  • A survey of stakeholder knowledge, experience, and opinions of advance directives for mental health in Virginia. 
  • A susceptibility gene for affective disorders and the response of the human amygdala. 
  • A systematic overview of measurement-based care in the treatment of childhood and adolescent depression. 
  • A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. 
  • A systematic review of interventions aimed at improving the cardiovascular health of people diagnosed with personality disorders. 
  • A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder. 
  • A systematic review of research on religion in four major psychiatric journals: 1991-1995. 
  • A systematic review of the combined use of electroconvulsive therapy and psychotherapy for depression. 
  • A systematic review of the neurocognitive effects of magnetic seizure therapy. 
  • A systematic review of treatments for refractory depression in older people. 
  • A taxometric investigation of dissociation in Vietnam veterans. 
  • A test of generalizability of cardiovascular reactivity using a controlled ambulatory procedure. 
  • A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder. 
  • A test of whether coping styles moderate the effect of PTSD symptoms on alcohol outcomes. 
  • A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C). 
  • A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility. 
  • A three-component model for reengineering systems for the treatment of depression in primary care. 
  • A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. 
  • A typology of advance statements in mental health care. 
  • A visual guide to expected blood levels of long-acting injectable risperidone in clinical practice 
  • A volunteer community mental health clinic. 
  • A+KIDS, a web-based antipsychotic registry for North Carolina youths: an alternative to prior authorization. 
  • A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. 
  • A.E. Bennett Research Award. Developmental traumatology. Part II: Brain development. 
  • ACGME research requirements for residents in psychiatry. 
  • ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. 
  • ADDITIVE ASSOCIATION OF ANXIETY AND DEPRESSION WITH ALL-CAUSE MORTALITY IN INDIVIDUALS WITH CORONARY HEART DISEASE 
  • ADHD and manic symptoms: Diagnostic and treatment implications 
  • ADHD and nonsuicidal self-injury in male veterans with and without PTSD. 
  • ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge. 
  • ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence. 
  • ADRENERGIC GENE VARIANTS ARE ASSOCIATED WITH PLATELET AGGREGATION TO EPINEPHRINE 
  • AGTR1 gene variation: association with depression and frontotemporal morphology. 
  • AKT1 and neurocognition in schizophrenia (vol 41, pg 169, 2007) 
  • AKT1 and neurocognition in schizophrenia. 
  • ALPRAZOLAM ATTENUATES STRESS-INDUCED HYPERGLYCEMIA 
  • ANXIETY, DEPRESSION, AND HEART RATE VARIABILITY 
  • APOE genotype and hippocampal volume change in geriatric depression. 
  • AUTONOMIC BALANCE IN TYPE-A AND TYPE-B PERSONS - LARGER FOREARM VASOCONSTRICTION AND VAGAL REFLEX IN TYPE-BS DURING COLD FACE STIMULUS 
  • Abbreviating the Duke Social Support Index for use in chronically ill elderly individuals. 
  • Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms. 
  • Abnormal fronto-limbic engagement in incarcerated stimulant users during moral processing. 
  • Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia. 
  • Abnormalities in Inflammatory Lipid Levels in First Episode Schizophrenic Patients are Modulated by Risperidone 
  • Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia. 
  • Abnormalities in the response of plasma arginine vasopressin during hypertonic saline infusion in patients with eating disorders. 
  • About 7% of 4-year-olds in Norway meet criteria for a psychiatric diagnosis 
  • Absence of histological lesions in primate models of ECT and magnetic seizure therapy. 
  • Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues. 
  • Abuse and dependence on prescription opioids in adults: a mixture categorical and dimensional approach to diagnostic classification. 
  • Accelerated biological aging in schizophrenia 
  • Acceptance and Commitment Therapy for Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorders in Veterans: Pilot Treatment Outcomes. 
  • Access to medical care among persons with psychotic and major affective disorders. 
  • Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method. 
  • Accuracy of an intimate partner violence screening tool for female VHA patients: a replication and extension. 
  • Accuracy of dexamethasone suppression test in alcoholics. 
  • Accuracy of proactive case finding for mental disorders by community informants in Nepal. 
  • Accurate awareness of heartbeat in hypochondriacal and non-hypochondriacal patients. 
  • Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression. 
  • Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy. 
  • Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. 
  • Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder. 
  • Actigraphic-measured sleep disturbance predicts increased positive symptoms in adolescents at ultra high-risk for psychosis: A longitudinal study. 
  • Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. 
  • Actuarial prediction of psychotherapy retention among Iraq-Afghanistan veterans with posttraumatic stress disorder. 
  • Acute 5-HT reuptake blockade potentiates human amygdala reactivity. 
  • Acute and chronic nicotine effects on working memory in aged rats. 
  • Acute and subacute neuropsychiatric presentations in H1N1 viral encephalitis. 
  • Acute changes in cerebral blood flow associated with marijuana smoking. 
  • Acute changes in cranial blood flow after cocaine hydrochloride. 
  • Acute dystonic reaction with moderate-dose ziprasidone. 
  • Acute effects of trauma-focused research procedures on participant safety and distress. 
  • Acute memory impairment following electroconvulsive therapy. 1. Effects of electrical stimulus waveform and number of treatments. 
  • Acute memory impairment following electroconvulsive therapy. 2. Effects of electrode placement. 
  • Acute nicotine-induced tachyphylaxis is differentially manifest in the limbic system. 
  • Acute psychotic disorder after gastric bypass surgery: differential diagnosis and treatment. 
  • Acute service delivery in a police-mental health program for children exposed to violence and trauma. 
  • Acute stress disorder in youth: a multivariate prediction model. 
  • Acute treatment with trimethyltin alters alcohol self-selection. 
  • Acute tryptophan depletion - converging evidence for decreasing central nervous serotonin synthesis in rodents and humans 
  • Acute tryptophan depletion - converging evidence for decreasing central nervous serotonin synthesis in rodents and humans. 
  • Adapting smoking cessation treatment according to initial response to precessation nicotine patch. 
  • Adaptive Activation of a Stress Response Pathway Improves Learning and Memory Through Gs and β-Arrestin-1-Regulated Lactate Metabolism. 
  • Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics [4] 
  • Adding a tricyclic antidepressant to a monoamine oxidase inhibitor. 
  • Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: A double blind, placebo controlled, parallel design clinical trial 
  • Addressing Incomplete Psychiatric Histories in Adult ADHD: Response to Agnew-Blais and Arseneault. 
  • Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. 
  • Adequacy of antidepressant treatment by psychiatric residents: the antidepressant treatment history form as a possible assessment tool. 
  • Adherence to antipsychotics and cardiometabolic medication: association with health care utilization and costs. 
  • Adinazolam sustained-release treatment of panic disorder: a double-blind study. 
  • Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-Analysis. 
  • Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms. 
  • Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. 
  • Adjunctive risperidone, olanzapine and quetiapine for the treatment of hospitalized patients with bipolar I disorder: a retrospective study. 
  • Adjunctive use of olanzapine in mood disorders: five case reports. 
  • Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. 
  • Administrative update: utilization of services. I. Comparing use of public and private mental health services: the enduring barriers of race and age. 
  • Adolescent depression, cortisol and DHEA. 
  • Adolescent-onset nicotine self-administration modeled in female rats. 
  • Adolescents Who Self-Harm and Commit Violent Crime: Testing Early-Life Predictors of Dual Harm in a Longitudinal Cohort Study. 
  • Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up. 
  • Adrenal Gland Enlargement in Major Depression-Reply 
  • Adrenal gland enlargement in major depression [2] 
  • Adrenal gland enlargement in major depression. A computed tomographic study. 
  • Adrenocortical Sensitivity to Endogenous ACTH in the CRH Test 
  • Adrenocortical sensitivity to ACTH in humans. 
  • Adrenocortical sensitivity to low-dose ACTH administration in depressed patients. 
  • Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder. 
  • Adult onset of severe and pervasive antisocial behavior: A distinct syndrome? 
  • Adult outcomes of childhood bullying victimization. 
  • Adult vulnerability for psychiatric disorders: interactive effects of negative childhood experiences and recent stress. 
  • Advancements in treating intimate partner violence in veterans. 
  • Advances and emerging treatments in social phobia 
  • Advances in Pharmacotherapy of Late-Life Depression. 
  • Advances in opioid antagonist treatment for opioid addiction. 
  • Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease. 
  • Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder. 
  • Advancing research at the intersection of two systems. 
  • Advancing the boundaries of molecular imaging. 
  • Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index. 
  • Adverse childhood events are associated with obesity and disordered eating: results from a U.S. population-based survey of young adults. 
  • Adverse impact of coercive treatments on psychiatric inpatients' satisfaction with care. 
  • Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability. 
  • Adverse race-related events as a risk factor for posttraumatic stress disorder in Asian American Vietnam veterans. 
  • Adverse-effect profile of kava. 
  • Advocacy through science: Reply to comments on Resick et al. (2012) 
  • Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. 
  • Aerobic exercise reduces depressive symptoms in patients with chronic heart failure 
  • Affective context interferes with cognitive control in unipolar depression: an fMRI investigation. 
  • Affective disorders in five United States communities. 
  • Affective illness and HLA frequencies: no compelling association. 
  • African American and European American veterans' perspectives on receiving mental health treatment. 
  • Age and impaired subjective support. Predictors of depressive symptoms at one-year follow-up. 
  • Age and sex effects on brain morphology. 
  • Age dependent change of ventricular measures in schizophrenia: Cross-sectional analysis 
  • Age effects in serial hypothalamic-pituitary-adrenal monitoring. 
  • Age group differences in psychological distress: the role of psychosocial risk factors that vary with age. 
  • Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. 
  • Age-dependent reduction of amygdala volume in bipolar disorder. 
  • Aggression after traumatic brain injury: prevalence and correlates. 
  • Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder. 
  • Aging of the human corpus callosum: magnetic resonance imaging in normal volunteers. 
  • Aging- and Stress-Related Epigenetic Disinhibition of FKBP5 Contributes to NF-KB-Driven Inflammation and Cardiovascular Risk 
  • Aging-related diagnostic variations: need for diagnostic criteria appropriate for elderly psychiatric patients. 
  • Alcohol abuse and dependence in the rural South. 
  • Alcohol and ADH2 in Israel: Ashkenazis, Sephardics, and recent Russian immigrants 
  • Alcohol and drug dependence symptom items as brief screeners for substance use disorders: results from the Clinical Trials Network. 
  • Alcohol dependence and use of treatment services among women in the community. 
  • Alcohol dependency and affective illness among women of childbearing age 
  • Alcohol pharmacodynamics in young-elderly adults contrasted with young and middle-aged subjects. 
  • Alcohol problems and posttraumatic stress disorder in female crime victims. 
  • Alcohol use disorders and mood disorders: A National Institute on Alcohol Abuse and Alcoholism perspective 
  • Alcohol use disorders and the use of treatment services among college-age young adults. 
  • Alcohol-related problems and risk of suicide among college students: the mediating roles of belongingness and burdensomeness. 
  • All for One and One for All: Mental Disorders in One Dimension. 
  • Allan McLane Hamilton. 
  • Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. 
  • Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits. 
  • Allostatic load in the association of depressive symptoms with incident coronary heart disease: The Jackson Heart Study. 
  • Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder. 
  • Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. 
  • Alprazolam for endogenous depression. 
  • Alprazolam reduces stress hyperglycemia in ob/ob mice. 
  • Alprazolam-induced manic reaction. 
  • Alterations in baseline activity and quinpirole sensitivity in putative dopamine neurons in the substantia nigra and ventral tegmental area after withdrawal from cocaine pretreatment. 
  • Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity. 
  • Alterations in the neural circuitry for emotion and attention associated with posttraumatic stress symptomatology. 
  • Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. 
  • Altered Brain Developmental Trajectories in Adolescents After Initiating Drinking. 
  • Altered Insula Activity during Visceral Interoception in Weight-Restored Patients with Anorexia Nervosa. 
  • Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase. 
  • Altered cocaine potency in the nucleus accumbens following 7-day withdrawal from intermittent but not continuous treatment: voltammetric assessment of dopamine uptake in the rat. 
  • Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. 
  • Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. 
  • Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. 
  • Altered prefrontal dopaminergic function in chronic recreational ketamine users. 
  • Altered resting-state functional connectivity of basolateral and centromedial amygdala complexes in posttraumatic stress disorder. 
  • Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. 
  • Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis. 
  • Alternative Perspectives on Police Encounters and Psychotic Experiences [Invited Commentary on DeVylder et al, "Psychotic Experiences in the Context of Police Victimization"]. 
  • Alternative therapy use by psychiatric outpatients. 
  • Alternatives to the Emergency Department: In Reply. 
  • Alzheimer's disease: the importance of early diagnosis and appropriate management. 
  • Ambulatory cardiovascular activity and hostility ratings in women with chronic posttraumatic stress disorder. 
  • Ambulatory monitoring and physical health report in Vietnam veterans with and without chronic posttraumatic stress disorder. 
  • American Christian Engagement With Mental Health and Mental Illness. 
  • Amoxapine: Once versus divided daily doses in neurotic and endogenous depression 
  • Amphetamine disrupts P50 suppression in normal subjects. 
  • Amygdala Reactivity in Singaporeans at Ultra High Risk for the Development of Schizophrenia 
  • Amygdala Reward Reactivity Mediates the Association Between Preschool Stress Response and Depression Severity. 
  • Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. 
  • Amygdala volume changes in posttraumatic stress disorder in a large case-controlled veterans group. 
  • Amygdala, Hippocampus, and Ventral Medial Prefrontal Cortex Volumes Differ in Maltreated Youth with and without Chronic Posttraumatic Stress Disorder. 
  • Amygdala-prefrontal cortex functional connectivity during threat-induced anxiety and goal distraction. 
  • Amygdalar volume and behavioral development in autism. 
  • Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. 
  • Amyloid-associated depression: a prodromal depression of Alzheimer disease? 
  • An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. 
  • An American validation study of the Newcastle Diagnostic Scale. II. Relationship with clinical, demographic, familial and psychosocial features. 
  • An American validation study of the Newcastle diagnostic scale. I. Relationship with the dexamethasone suppression test. 
  • An American validation study of the Newcastle scale. III. Course during index hospitalization and six-month prospective follow-up. 
  • An Array of Serum Biomarkers May Predict Response to Transcranial Magnetic Stimulation in Major Depression Patients 
  • An Economic Evaluation of the Garrett Lee Smith Memorial Suicide Prevention Program. 
  • An Electrophysiological Biomarker That May Predict Treatment Response to ECT. 
  • An Inflammatory Pathway Links Atherosclerotic Cardiovascular Disease Risk to Neural Activity Evoked by the Cognitive Regulation of Emotion 
  • An Interprofessional Course on Substance Use Disorders for Health Professions Students. 
  • An Investigation of Treatment Engagement Among Returning Veterans With Problematic Anger. 
  • An RCT of Effects of Telephone Care Management on Treatment Adherence and Clinical Outcomes Among Veterans With PTSD. 
  • An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. 
  • An abbreviated version of the brief assessment of cognition in schizophrenia (BACS) 
  • An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the cache county study. 
  • An additional recommendation on reporting depression. 
  • An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. 
  • An application of item response theory to fMRI data: prospects and pitfalls. 
  • An application of the revised CONSORT standards to FDA summary reports of recently approved antidepressants and antipsychotics. 
  • An assessment of the Newcastle Anxiety Depression Index. 
  • An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. 
  • An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology. 
  • An empirically based alternative to DSM-5's disruptive mood dysregulation disorder for ICD-11. 
  • An epigenetic mechanism links socioeconomic status to changes in depression-related brain function in high-risk adolescents. 
  • An evaluation of the Feighner criteria for schizophrenia and affective disorders using long-term outcome data. 
  • An evaluation of two doses of isocarboxazid in depression. 
  • An evidence synthesis of care models to improve general medical outcomes for individuals with serious mental illness: a systematic review. 
  • An evidence-based medicine strategy for achieving remission in bipolar disorder. 
  • An examination of PTSD symptoms and relationship functioning in U.S. soldiers of the Iraq war over time. 
  • An examination of the broader effects of warzone experiences on returning Iraq/Afghanistan veterans' psychiatric health. 
  • An experience-sampling study of depressive symptoms and their social context. 
  • An experimental investigation of emotional reactivity and delayed emotional recovery in borderline personality disorder: the role of shame. 
  • An exploration of comorbid depression among female victims of intimate partner violence with posttraumatic stress disorder. 
  • An inflammatory pathway links atherosclerotic cardiovascular disease risk to neural activity evoked by the cognitive regulation of emotion. 
  • An international comparison of two systems of community mental health care. 
  • An investigation of vago-regulatory and health-behavior accounts for increased inflammation in posttraumatic stress disorder. 
  • An involvement of dopamine in higher order choice mechanisms in the monkey 
  • An involvement of dopamine in higher order choice mechanisms in the monkey. 
  • An observational study of pharmacological treatment in primary care of children with ADHD in the United kingdom. 
  • An obsessional variant of capgras symptom: a case report. 
  • An open label trial of C-1073 (mifepristone) for psychotic major depression. 
  • An open study of the pharmacokinetics and the tolerability of raclopride extended release capsules in psychiatric patients 
  • An open trial of morning light therapy for treatment of antepartum depression. 
  • An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants. 
  • An open-label trial of adjunctive oxcarbazepine for bipolar disorder. 
  • An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression. 
  • An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features. 
  • An outpatient evaluation of phenelzine and imipramine. 
  • Analgesic efficacy of milnacipran in animal models of chronic pain 
  • Analysis of DNA Methylation in Young People: Limited Evidence for an Association Between Victimization Stress and Epigenetic Variation in Blood. 
  • Analysis of blood-based gene expression signature in first-episode psychosis. 
  • Analysis of the RELN gene as a genetic risk factor for autism. 
  • Anatomic location and laterality of MRI signal hyperintensities in late-life depression. 
  • Anatomical variability predicts individual differences in ECT seizure threshold: a combined preclinical and computational modeling study 
  • Anger expression and ambulatory blood pressure: a comparison of state and trait measures. 
  • Anger, social support, and suicide risk in U.S. military veterans. 
  • Angioedema occurring in patient prescribed iloperidone and haloperidol: a cross-sensitivity reaction to antipsychotics from different chemical classes. 
  • Angiotensin receptor gene polymorphisms and 2-year change in hyperintense lesion volume in men. 
  • Animal models for schizophrenia: the hippocampally lesioned animal. 
  • Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). 
  • Animal models provide insight into psychosomatic factors in diabetes. 
  • Ankyrin-G regulates forebrain connectivity and network synchronization via interaction with GABARAP. 
  • Antenatal thyroid correlates of postpartum depression. 
  • Anterior cingulate cortex gray matter volume mediates an association between 2D:4D ratio and trait aggression in women but not men. 
  • Anti-N-Methyl-d-Aspartate Receptor Encephalitis Presenting With Features of Kleine-Levin Syndrome and Demyelination. 
  • Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. 
  • Anticholinergic prophylaxis in young adults treated with neuroleptic drugs 
  • Anticipating DSM-V: opportunities and challenges for cognition and psychosis. 
  • Anticipatory and residual effects of an active coping task on pre- and post-stress baselines. 
  • Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders. 
  • Antidepressant drug therapy in psychotic depression. 
  • Antidepressant effects of nicotine in an animal model of depression. 
  • Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. 
  • Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion. 
  • Antidepressant treatment practice in the face of STAR*D and STEP-BD. 
  • Antidepressant treatment response in bipolar II disorder. 
  • Antidepressant use by race. 
  • Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. 
  • Antineutrophil cytoplasmic antibodies associated with neurological vasculitic syndromes - Four cases 
  • Antinuclear antibodies and thyroid function in sexually abused girls. 
  • Antipsychotic drug effects on brain morphology in first-episode psychosis. 
  • Antipsychotic drugs for depression? 
  • Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study 
  • Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. 
  • Antipsychotic medication use by Medicaid recipients with severe mental illness 
  • Antipsychotic medication use by Medicaid recipients: are there racial variations? 
  • Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia 
  • Antipsychotic-induced weight gain and therapeutic response: a differential association. 
  • Antipsychotics and sudden death: is thioridazine the only bad actor? 
  • Antipsychotics and the risk of sudden cardiac death. 
  • Antisocial and related disorders in a southern community. An application of grade of membership analysis. 
  • Antisocial and related disorders in a southern community: An application of grade of membership analysis 
  • Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine Model. 
  • Anxiety Disorders in Late Life. 
  • Anxiety Disorders in Long-Term Survivors of Adult Cancers 
  • Anxiety and cerebral blood flow. 
  • Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. 
  • Anxiety and vagal control of heart rate. 
  • Anxiety as a symptom of mixed mania: implications for DSM-5. 
  • Anxiety in medically ill older patients: a review and update. 
  • Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder 
  • Anxiety or irritability can lead to misdiagnosis of bipolar disorder: results from systematic consultations at the MGH Collaborative Care Initiative (CCI) Consultation Service 
  • Anxiety predicts mortality and morbidity after coronary artery and valve surgery--a 4-year follow-up study. 
  • Anxiety reduces baroreflex cardiac control in older adults with major depression. 
  • Anxiety sensitivity as a predictor of the clinical course of panic disorder: a 1-year follow-up study 
  • Anxiety, depression, and heart rate variability. 
  • Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction. 
  • Anxiety-proneness and coronary heart disease. 
  • Anxiety-proneness and coronary heart disease. 
  • Anxiety/depression: current management and future directions. Biologic markers and treatment response. 
  • Apathy in neuropsychiatric disorders 
  • Apolipoprotein E genotype and major depression in a community of older adults. The Cache County Study. 
  • Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects. 
  • Apolipoprotein E-epsilon 4 frequency in geriatric depression. 
  • Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type. 
  • Application of biological markers in depression secondary to thyrotoxicosis. 
  • Application of microdialysis and voltammetry to assess dopamine functions in genetically altered mice: correlation with locomotor activity. 
  • Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging. 
  • Applying a stepped-care approach to the treatment of obesity. 
  • Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. 
  • Are Iraq and Afghanistan veterans using mental health services? New data from a national random-sample survey. 
  • Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. 
  • Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models. 
  • Are children and adolescents with food allergies at increased risk for psychopathology? 
  • Are expectations for community mental health increasing among older adults in China? 
  • Are psychiatrists' characteristics related to how they care for depression in the medically ill? Results from a national case-vignette survey. 
  • Are smoking and alcohol misuse associated with subsequent hospitalizations for ambulatory care sensitive conditions? 
  • Arguable assumptions, Questionable conclusions (reply to Munafo) 
  • Arguable assumptions, debatable conclusions. 
  • Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. 
  • Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting. 
  • Aripiprazole augmentation for treatment of patients with inadequate antidepressants response. 
  • Aripiprazole in refractory depression? 
  • Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence. 
  • Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. 
  • Ascending digits task as a measure of executive function in geriatric depression. 
  • Assertive community treatment: an update of randomized trials. 
  • Assertive community treatment: facilitators and barriers to implementation in routine mental health settings. 
  • Assessing and managing voilence risk in clinical practice 
  • Assessing anxious features in depressed outpatients. 
  • Assessing blinding in trials of psychiatric disorders: a meta-analysis based on blinding index. 
  • Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. 
  • Assessing depression symptoms in those with insomnia: an examination of the beck depression inventory second edition (BDI-II). 
  • Assessing diagnostic approaches to depression in medically ill older adults: how reliably can mental health professionals make judgments about the cause of symptoms? 
  • Assessing illicit drug use among adults with schizophrenia. 
  • Assessing methylphenidate preference in ADHD patients using a choice procedure. 
  • Assessing outcomes for consumers in New York's assisted outpatient treatment program. 
  • Assessing patient beliefs in a clinical trial of Hypericum perforatum in major depression. 
  • Assessing risk of violent behavior among veterans with severe mental illness. 
  • Assessing the New York City involuntary outpatient commitment pilot program. 
  • Assessing the New York City involuntary outpatient treatment program. 
  • Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats. 
  • Assessing the practices and perceptions of dually-trained physicians: a pilot study. 
  • Assessing the referral interface and communication between psychiatry and primary care 
  • Assessment and management of depression in older adults 
  • Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. 
  • Assessment of Myelin Compromise in Mild Traumatic Brain Injury with Quantitative Susceptibility Mapping 
  • Assessment of a new self-rating scale for post-traumatic stress disorder. 
  • Assessment of four stakeholder groups' preferences concerning outpatient commitment for persons with schizophrenia. 
  • Assessment of gene expression in peripheral blood using RNAseq before and after weight restoration in anorexia nervosa. 
  • Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. 
  • Assisted outpatient treatment in New York: regional differences in New York's assisted outpatient treatment program. 
  • Association and linkage studies of candidate genes involved in GABAergic neurotransmission in lithium-responsive bipolar disorder. 
  • Association between anxiety and C-reactive protein levels in stable coronary heart disease patients. 
  • Association between depression severity and amygdala reactivity during sad face viewing in depressed preschoolers: an fMRI study. 
  • Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia. 
  • Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patients. 
  • Association between post-dexamethasone cortisol level and blood pressure in depressed inpatients. 
  • Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. 
  • Association of DHEA, DHEAS, and cortisol with childhood trauma exposure and post-traumatic stress disorder. 
  • Association of Epidemiologic Factors and Genetic Variants Influencing Hypothalamic-Pituitary-Adrenocortical Axis Function With Postconcussive Symptoms After Minor Motor Vehicle Collision. 
  • Association of Obesity and Levels of Inflammatory Markers on Treatment Outcome with Adjunctive (6S)-5-methyl-5,6,7,8-tetrahydropteroyl-L-glutamic Acid (CH3-FH4) in MDD Patients Who are Inadequate Responders to SSRIs 
  • Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. 
  • Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness. 
  • Association of depression and survival in patients with chronic heart failure over 12 Years. 
  • Association of depressive and anxiety symptoms with 24-hour urinary catecholamines in individuals with untreated high blood pressure. 
  • Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. 
  • Association of gene variants of the renin-angiotensin system with accelerated hippocampal volume loss and cognitive decline in old age. 
  • Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. 
  • Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs. 
  • Association of somatic symptoms with depression and anxiety in clinical patients of general hospitals in Guangzhou, China. 
  • Association of the choline acetyltransferase gene with responsiveness to acetylcholinesterase inhibitors in Alzheimer's disease. 
  • Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. 
  • Association of trauma exposure with psychiatric morbidity in military veterans who have served since September 11, 2001. 
  • Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome. 
  • Associations among disaster exposure, intimate relationship adjustment, and PTSD symptoms: can disaster exposure enhance a relationship? 
  • Associations among the NEO Personality Inventory, Revised and the serotonin transporter gene-linked polymorphic region in elders: effects of depression and gender. 
  • Associations among the NEO personality inventory, revised and the serotonin transporter gene-linked polymorphic region in elders: Effects of depression and gender 
  • Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia 
  • Associations between cannabis use and retinal vessel diameter in young adults. 
  • Associations between depression and anxiety symptoms and retinal vessel caliber in adolescents and young adults. 
  • Associations between dimensions of religious commitment and mental health reported in the American Journal of Psychiatry and Archives of General Psychiatry: 1978-1989. 
  • Associations between functioning and PTSD symptom clusters in a dismantling trial of cognitive processing therapy in female interpersonal violence survivors. 
  • Associations between neuropsychiatric and health status outcomes in individuals with probable mTBI. 
  • Associations between positive emotional well-being and stress-induced myocardial ischemia: Well-being scores predict exercise-induced ischemia. 
  • Associations between the impact of terrorism and health perceptions of patients. 
  • Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. 
  • Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. 
  • Astrocytic activation as evidence for brain damage. 
  • Asymmetry of rCBF in schizophrenia: relationship to AP-gradient and duration of illness. 
  • Atrocities exposure in Vietnam combat veterans with chronic posttraumatic stress disorder: relationship to combat exposure, symptom severity, guilt, and interpersonal violence. 
  • Attendance at religious services, interleukin-6, and other biological parameters of immune function in older adults. 
  • Attention and rewards in the control of psychophysiologic states 
  • Attention bias to threat faces in severe mood dysregulation. 
  • Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome. 
  • Attention deficits in schizophrenia--preliminary evidence of dissociable transient and sustained deficits. 
  • Attention-deficit/hyperactivity disorder: Part II. Treatment strategies 
  • Attentional and eye tracking deficits correlate with negative symptoms in schizophrenia. 
  • Attentional functioning in schizotypal personality disorder. 
  • Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals. 
  • Attenuation of Frontostriatal Connectivity During Reward Processing Predicts Response to Psychotherapy in Major Depressive Disorder. 
  • Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide. 
  • Attitudes toward borderline personality disorder: a survey of 706 mental health clinicians. 
  • Attrition in Randomized Controlled Clinical Trials: Methodological Issues in Psychopharmacology 
  • Atypical antidopaminergic properties of CI-686: a potential antipsychotic agent. 
  • Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder. 
  • Atypical antipsychotic drugs and diabetes mellitus in the USFDA adverse event reporting system (AERS) database in pediatric and adult patients 
  • Atypical antipsychotic drugs in treatment-refractory schizophrenia 
  • Atypical depression. 
  • Atypical depression: a comprehensive review. 
  • Atypical facial pain and trigeminal neuralgia: a comparison study. 
  • Atypical modulation of cognitive control by arousal in autism. 
  • Atypical neuroleptic malignant syndrome caused by clozapine and venlafaxine: early brief treatment with dantrolene. 
  • Augmentation of ECT seizures with caffeine. 
  • Augmentation of dopaminergic agents for major depressive disorder. 
  • Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. 
  • Authors' reply 
  • Authors' reply [4] 
  • Authors' reply. 
  • Autism Pay-per-view: Evidence for Differential Implicit Reward Value of Social and Nonsocial Stimuli in Children with Autism from an Econometric Choice Task 
  • Autism and the serotonin transporter: the long and short of it. 
  • Autism as a disorder of neural information processing: directions for research and targets for therapy. 
  • Autism in 1959: Joey the mechanical boy. 
  • Autistic disorder and chromosome 7: Evidence for a paternal effect. 
  • Autobiographical amnesia with ECT: an analysis of the roles of stimulus wave form, electrode placement, stimulus energy, and seizure length. 
  • Avoidant Restrictive Food Intake Disorder. 
  • Awareness and perceptions of electroconvulsive therapy among psychiatric patients: a cross-sectional survey from teaching hospitals in Karachi, Pakistan. 
  • BAS and BIS in assessment of bipolar disorder 
  • BDNF Gene Polymorphism (Val66Met) Predicts Amygdala and Hippocampus Activation in Children Diagnosed with Anxiety as Preschoolers 
  • BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis. 
  • BIOBEHAVIORAL MEDIATORS OF SES EFFECTS ON CRP IN A NATIONALLY REPRESENTATIVE US SAMPLE 
  • BIOLOGICAL MECHANISMS OF CORONARY-PRONE BEHAVIOR IN MIDDLE-AGED MEN 
  • BIS and BAS interact with perceived parental affectionless control to predict personality disorder symptomatology. 
  • BLOOD PRESSURE 'NON-DIPPING' STATUS IS ASSOCIATED WITH GREATER OVERNIGHT EPINEPHRINE EXCRETION 
  • Back to school: review of school based interventions: comment on Rolfsness and Idsoe (2011). 
  • Baclofen disrupts passive avoidance retention in rats. 
  • Bacterial infection early in life protects against stressor-induced depressive-like symptoms in adult rats. 
  • Baroreceptor sensitivity at rest and during stress in women with posttraumatic stress disorder or major depressive disorder. 
  • Barriers to employment for people with schizophrenia. 
  • Barriers to the use of Veterans Affairs health care services among female veterans who served in Iraq and Afghanistan. 
  • Baseline expression of alpha4beta2* nicotinic acetylcholine receptors predicts motivation to self-administer nicotine. 
  • Baseline neurocognitive assessment of 1364 patients with schizophrenia in the clinical antipsychotic trials for intervention effectiveness (CATIE) project 
  • Baseline neurocognitive deficits in the CATIE schizophrenia trial. 
  • Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. 
  • Basic auditory processing deficits and their association with auditory emotion recognition in schizophrenia. 
  • Battered parents: a new syndrome. 
  • Bayard Holmes (1852-1924) and Henry Cotton (1869-1933): Surgeon-psychiatrists and their tragic quest to cure schizophrenia. 
  • Behavior Change Counseling of Patients with Substance Use Disorders by Health Professions Students. 
  • Behavior and emotion modulation deficits in preschoolers at risk for bipolar disorder. 
  • Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders. 
  • Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks. 
  • Behavioral and psychological approaches to the assessment and treatment of chronic pain. 
  • Behavioral approaches to Raynaud's disease. 
  • Behavioral assessment of the type A behavior pattern. 
  • Behavioral avoidance test for childhood obsessive-compulsive disorder: a home-based observation. 
  • Behavioral differences between two inbred strains of Fawn-Hooded rat: a model of serotonin dysfunction. 
  • Behavioral economic substitutability of e-cigarettes, tobacco cigarettes, and nicotine gum. 
  • Behavioral effects of dopamine agonists across the estrous cycle in rats. 
  • Behavioral health integration model. 
  • Behavioral health mediators of the link between posttraumatic stress disorder and dyslipidemia. 
  • Behavioral health programs in fire service: Surveying access and preferences. 
  • Behavioral indications for serotonin receptor hypersensitivity in panic disorder. 
  • Behavioral markers of coping and psychiatric symptoms among sexually abused children. 
  • Behavioral medicine 
  • Behavioral neurology and neuropsychiatry fellowship training: the Johns Hopkins model. 
  • Behavioral observations at age 3 years predict adult psychiatric disorders. Longitudinal evidence from a birth cohort. 
  • Behavioral observations reflected on consultation requests from primary medical-surgical services: are they predictive of delirium diagnosis and outcomes? 
  • Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. 
  • Behavioral toxicity with alprazolam 
  • Behavioural activation: history, evidence and promise 
  • Belief in life after death and mental health: findings from a national survey. 
  • Beliefs about God, psychiatric symptoms, and evolutionary psychiatry. 
  • Beliefs about sleep in disorders characterized by sleep and mood disturbance. 
  • Beliefs in karma and reincarnation among survivors of violent trauma--a community survey. 
  • Beliefs, mental health, and evolutionary threat assessment systems in the brain. 
  • Benefits of child-focused anxiety treatments for parents and family functioning. 
  • Benzodiazepine receptor ligands with different intrinsic efficacies alter ethanol intake in alcohol-nonpreferring (NP) rats 
  • Benzodiazepine use and dependency risk in geriatric inpatients 
  • Benzodiazepine use and dependency risk in geriatric inpatients 
  • Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report. 
  • Benzodiazepines, posttraumatic stress disorder, and veterans: good news and why we're not done yet. 
  • Best practices: comparing medication treatments in mental health: drug class reviews and policy challenges. 
  • Beta-blockers and depression. 
  • Better, Faster, Safer: Exploring Biomarkers of Response to Transform Electroconvulsive Therapy. 
  • Beyond Thiamine: Treatment for Cognitive Impairment in Korsakoff's Syndrome. 
  • Beyond symptom counts to case-wise probabilities. 
  • Bias in a protocol for a meta-analysis of 5-HTTLPR, stress, and depression. 
  • Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. 
  • Biobehavioral Prognostic Factors in Chronic Obstructive Pulmonary Disease: Results From the INSPIRE-II Trial. 
  • Biobehavioral basis of coronary-prone behavior in middle-age men. Part II: Serum cholesterol, the Type A behavior pattern, and hostility as interactive modulators of physiological reactivity. 
  • Biobehavioral basis of coronary-prone behavior in middle-aged men. Part I: Evidence for chronic SNS activation in Type As. 
  • Biochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depression. 
  • Biologic findings of post-traumatic stress disorder and child maltreatment. 
  • Biological 'markers' for endogenous depression. Effect of age, severity of illness, weight loss, and polarity. 
  • Biological annotation of genetic loci associated with intelligence in a meta-analysis of 87,740 individuals. 
  • Biological characterization of social phobia. 
  • Biological correlates of abuse in women with premenstrual dysphoric disorder and healthy controls. 
  • Biological embedding of stress through inflammation processes in childhood. 
  • Biological markers for endogenous depression in series and parallel. 
  • Biological risk factors in late life depression. 
  • Biological therapies for posttraumatic stress disorder: an overview. 
  • Biology of social phobia 
  • Biomarkers in DSM-5: lost in translation. 
  • Biosocial implications growing from high‐risk research 
  • Bipolar Depression: Pregnancy, Postpartum, and Lactation. 
  • Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study. 
  • Blocking GABA(A) receptors in the anterior ventral tegmental area attenuates ethanol intake of the alcohol-preferring P rat 
  • Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. 
  • Blood pressure during mental stress predicts left ventricular mass in men and women with high blood pressure 
  • Blood pressure reactivity and marital distress in employed women. 
  • Blood pressure-related hypoalgesia in bulimia nervosa. 
  • Blunted Ventral Striatum Development in Adolescence Reflects Emotional Neglect and Predicts Depressive Symptoms. 
  • Blunted cortisol responses to stress signal social and behavioral problems among maltreated/bullied 12-year-old children. 
  • Blunted striatal response to monetary reward anticipation during smoking abstinence predicts lapse during a contingency-managed quit attempt. 
  • Body investment, depression, and alcohol use as risk factors for suicide proneness in college students. 
  • Body mass index, eating attitudes, and symptoms of depression and anxiety in pregnancy and the postpartum period. 
  • Body weight and reported versus measured weight loss as confounders of the dexamethasone suppression test. 
  • Book Review 
  • Borderline Personality Disorder and the Effects of Instructed Emotional Avoidance or Acceptance in Daily Life. 
  • Borderline personality disorder and PTSD. 
  • Botanical medicines for anxiety: do they have a place? 
  • Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial. 
  • Boundary of amygdala and hippocampus. 
  • Brain Stimulation Therapies for Cliniciansby Edmund S. Higgins, M.D., and Mark S. George, M.D. Washington, D.C., American Psychiatric Publishing, Inc., 2009, 203 pp., $70.00. 
  • Brain activation during affective visual cues in schizophrenia: A pilot study using fMRI [3] 
  • Brain activation during decisions involving behavioral risk: Adolescents v. adults 
  • Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. 
  • Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. 
  • Brain fluoxetine measurements using fluorine magnetic resonance spectroscopy in patients with social phobia. 
  • Brain imaging and psychiatric disorders 
  • Brain imaging correlates. 
  • Brain magnetic resonance imaging findings in ECT-induced delirium. 
  • Brain magnetic resonance spectroscopy: Role in assessing outcomes in Alzheimer's disease 
  • Brain mechanisms of social anxiety disorder: Comments 
  • Brain network functional connectivity and cognitive performance in major depressive disorder. 
  • Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. 
  • Brain stimulation in neurology and psychiatry: perspectives on an evolving field. 
  • Brain stimulation in neuropsychiatry. 
  • Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study. 
  • Brain volumes in psychotic youth with schizophrenia and mood disorders. 
  • Brain-derived neurotrophic factor (BDNF) Val66Met and adulthood chronic stress interact to affect depressive symptoms. 
  • Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism interacts with gender to influence cortisol responses to mental stress. 
  • Breast cancer patients have improved immune and neuroendocrine functions following massage therapy. 
  • Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment. 
  • Bridging the gap: recruitment of African-American women into mental health research studies. 
  • Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients. 
  • Brief psychotherapy for depression: a systematic review and meta-analysis. 
  • Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects. 
  • Bringing back melancholia. 
  • British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. 
  • British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. 
  • Broken heart: depression in cardiovascular disease. 
  • Building a Community of Health Professionals to Establish a Shared Learning Experience in Psychiatry and Substance Use Disorders for Health Professions Students. 
  • Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence. 
  • Bupropion HCL and sleep in patients with depression 
  • Bupropion in chronic low back pain. 
  • Bupropion reinstates cocaine seeking behavior in rats 
  • Bupropion sustained release: a therapeutic overview. 
  • Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial. 
  • Bursts and the efficacy of selective serotonin reuptake inhibitors. 
  • C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. 
  • CACNA1C GENE AND SCHIZOPHRENIA: A CASE CONTROL AND PHARMACOGENETIC STUDY SHORT TITLE: CACN1C GENE AND SCHIZOPHRENIA 
  • CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study. 
  • CACNA1C genomewide supported psychosis genetic variation affects cortical brain white matter integrity in Chinese patients with schizophrenia. 
  • CAD-MDD: not diagnostic, lacks screening data. 
  • CARDIOVASCULAR LEVELS DURING ENVIRONMENTAL CHALLENGES IN HIGH AND LOW HOSTILE PATIENTS WITH A RECENT MYOCARDIAL-INFARCTION 
  • CARDIOVASCULAR REACTIVITY AND LEFT VENTRICULAR MASS IN HYPERTENSIVE MEN AND WOMEN 
  • CARDIOVASCULAR REACTIVITY ASSOCIATED WITH INDUCED ANGER AND DEPRESSIVE AFFECT 
  • CATECHOLAMINE RECEPTORS - MOLECULAR CHARACTERIZATION AND PHYSIOLOGICAL IMPLICATIONS 
  • CLINICAL AND FUNCTIONAL OUTCOMES IN YOUNG ADULTHOOD OF CHILDREN WITH PSYCHOTIC SYMPTOMS: A LONGITUDINAL TWIN COHORT STUDY 
  • CLOZAPINE DECREASES DRIVE TO SMOKE 
  • CMINDS does not have identical tests to the CATIE and MATRICS batteries. Commentary on O'Halloran et al. 
  • COGNITIVE DYSFUNCTION AND COMMUNITY FUNCTIONING IN SCHIZOPHRENIA: RESULTS FROM THE MATRICS PSYCHOMETRIC AND STANDARDIZATION STUDY (PASS) 
  • COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome. 
  • CRITICAL ANALYSIS OF THE CURRENT TREATMENT GUIDELINES FOR COMPLEX PTSD IN ADULTS. 
  • CSF CRH in abstinent cocaine-dependent patients. 
  • CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression. 
  • CSF prostaglandin levels in depressed and schizophrenic patients. 
  • CSF-5-HIAA, stress, and cytokine and adhesion molecule expression on blood monocytes 
  • Caffeine affects cardiovascular and neuroendocrine activation at work and home. 
  • Caffeine and cardiovascular responses to stress. 
  • Caffeine and cholesterol: interactions with hostility. 
  • Caffeine augmentation of ECT. 
  • Caffeine effects on cardiovascular and neuroendocrine responses to acute psychosocial stress and their relationship to level of habitual caffeine consumption. 
  • Caffeine raises blood pressure at work. 
  • Calcitonin gene-related peptide (CGRP) levels and alcohol 
  • Callous unemotional traits in children with disruptive behavior disorder: Predictors of developmental trajectories and adolescent outcomes. 
  • Can We Use Brain Oscillations to Guide Treatment of MDD? 
  • Can a Framework Be Established for the Safe Use of Ketamine? 
  • Can a costly intervention be cost-effective?: An analysis of violence prevention. 
  • Can a nonequivalent choice of dosing regimen bias the results of flexible dose double blind trials? The CATIE schizophrenia trial. 
  • Can food and addiction change the game? 
  • Can involuntary outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with severely mentally ill individuals. 
  • Can mandated outpatient treatment prevent tragedies? 
  • Candidate gene polymorphisms and birth weight (BW) in the national longitudinal study of adolescent health (add health) 
  • Candidate neuroanatomic substrates of psychosis in old-aged depression. 
  • Cannabis use disorder and suicide attempts in Iraq/Afghanistan-era veterans. 
  • Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. 
  • Cannabis use in adolescence and risk for adult psychosis: A birth cohort study 
  • Capability for suicide interacts with states of heightened arousal to predict death by suicide beyond the effects of depression and hopelessness. 
  • Capturing the ebb and flow of psychiatric symptoms with dynamical systems models. 
  • Carbon dioxide levels and cerebral blood flow. 
  • Carbon monoxide-related organic mood disorder successfully treated with ECT. 
  • Cardiovascular correlates of the psychotherapeutic process. 
  • Cardiovascular effects of antidepressant drugs 
  • Cardiovascular reactivity to laboratory stressors in maritally distressed women 
  • Cardiovascular response to unilateral electroconvulsive therapy. 
  • Cardiovascular responses in the laboratory and in the natural environment: is blood pressure reactivity to laboratory-induced mental stress related to ambulatory blood pressure during everyday life? 
  • Cardiovascular responses to an active coping challenge as predictors of blood pressure patterns 10 to 15 years later. 
  • Cardiovascular responses to behavioral stressors: laboratory-field generalization and inter-task consistency. 
  • Cardiovascular risks in relation to posttraumatic stress severity among young trauma-exposed women. 
  • Care-giver stress 
  • Career progress in online and blended learning environments. 
  • Caregiver burden and psychological distress in partners of veterans with chronic posttraumatic stress disorder. 
  • Caregiver strain and youth suicide attempt: Are they related? 
  • Caregivers as money managers for adults with severe mental illness: how treatment providers can help. 
  • Caregiving for persons with mental illness: the impact of outpatient commitment on caregiving strain. 
  • Caring for Families Separated by Changing Immigration Policies and Enforcement: A Cultural Psychiatry Perspective. 
  • Case finding and mental health services for children in the aftermath of the Oklahoma City bombing. 
  • Case report of phenothiazine-induced torsade de pointes 
  • Case report of treatment of severe mood disorder in an inpatient setting: when less is more. 
  • Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine. 
  • Case report: possible neuroleptic malignant syndrome associated with olanzapine. 
  • Case studies in neuropsychiatry II: Conversion pseudodementia 
  • Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics. 
  • Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder. 
  • Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder. 
  • Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. 
  • Case-mix adjustment of adolescent mental health treatment outcomes. 
  • Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. 
  • Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation. 
  • Catatonic coma with profound bradycardia. 
  • Catechol O-methyltransferase in red blood cells of schizophrenic, depressed, and normal human subjects. 
  • Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. 
  • Catechol-O-methyltransferase activity and classification of depression. 
  • Cause and effect in "alcoholic tremor". 
  • Causes of death in schizophrenia and manic-depression. 
  • Cellular regulation of the benzodiazepine/GABA receptor: arachidonic acid, calcium, and cerebral ischemia. 
  • Central nervous system serotonin and clustering of hostility, psychosocial, metabolic, and cardiovascular endophenotypes in men. 
  • Central nervous system serotonin function and cardiovascular responses to stress. 
  • Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. 
  • Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder. 
  • Cerebral blood flow changes induced by CO2 in anxiety. 
  • Cerebral blood flow responses to CO2 and acetazolamide: the effect of anxiety. 
  • Cerebral blood flow responses to inhaled carbon dioxide in schizophrenia. 
  • Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. 
  • Cerebral ischemic symptoms in anxiety disorders. 
  • Cerebral vasodilation and vasoconstriction associated with acute anxiety. 
  • Cerebral white matter disease in late-onset paranoid psychosis. 
  • Cerebrospinal fluid DHEA levels are elevated in Alzheimer's disease, related to neuropathological disease stage, and correlated with brain DHEA levels 
  • Cerebrospinal fluid and plasma free cortisol concentrations in depression. 
  • Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. 
  • Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants. 
  • Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. 
  • Cerebrovascular changes in late life depression 
  • Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. 
  • Certified psychiatric clinical nurse specialists. 
  • Challenges in the diagnosis and treatment of depression in autism spectrum disorders across the lifespan. 
  • Challenging assumptions from emotion dysregulation psychological treatments. 
  • Challenging psychiatric discrimination in insurance 
  • Change in Hippocampus Volume and Longitudinal Course of Late-Life Depression 
  • Change in left ventricular ejection fraction during mental stress predicts 5-year clinical events in patients with coronary artery disease 
  • Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. 
  • Changes in cerebral blood flow after diazepam evaluated with 3 measurement techniques 
  • Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients. 
  • Changes in cerebral blood velocity after intravenous diazepam. 
  • Changes in children's behavior after a natural disaster. 
  • Changes in coping strategies, relationship to the perpetrator, and posttraumatic distress in female crime victims. 
  • Changes in depressive symptoms and glycemic control in diabetes mellitus. 
  • Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. 
  • Changes in guideline-recommended medication possession after implementing Kendra's law in New York. 
  • Changes in middle cerebral artery velocity after marijuana. 
  • Changes in positive affect in cognitive-behavioral treatment of anxiety disorders 
  • Changes in religious beliefs following trauma. 
  • Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. 
  • Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment. 
  • Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care. 
  • Changing Rates of Mental Health Disorders Among Veterans Treated in the VHA During Troop Drawdown, 2007-2013. 
  • Changing face of pain: evolution of pain research in psychosomatic medicine. 
  • Changing how we think about insomnia 
  • Chaplains' Engagement with Suicidality among Their Service Users: Findings from the VA/DoD Integrated Mental Health Strategy. 
  • Characteristic hostility in schizophrenic outpatients. 
  • Characteristics of anti-psychotic medication prescribing on inpatient obstetrics floors 
  • Characteristics of antipsychotic medication prescribing on inpatient obstetric floors. 
  • Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. 
  • Characteristics of representative payeeship involving families of beneficiaries with psychiatric disabilities. 
  • Characteristics of schizophrenic and depressed patients excluded from clinical research. 
  • Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. 
  • Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. 
  • Characteristics of third-party money management for persons with psychiatric disabilities. 
  • Characteristics of very poor outcome schizophrenia. 
  • Characterization of an inversion breakpoint in a multiplex autistic disorder family: Defining the candidate region on chromosome 7q. 
  • Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice. 
  • Characterizing anger-related affect in individuals with posttraumatic stress disorder using ecological momentary assessment. 
  • Characterizing the effects of sertraline in post-traumatic stress disorder. 
  • Characterizing the referral interface between psychiatry and primary care 
  • Chest pain self-management training for patients with coronary artery disease. 
  • Child abuse and adult major depression: no evidence of protective gene. 
  • Child mental health and maternal depression history in Pakistan. 
  • Child μ-opioid receptor gene variant influences parent-child relations. 
  • Child-, adolescent- and young adult-onset depressions: differential risk factors in development? 
  • Childhood Bullying Victimization and Overweight in Young Adulthood: A Cohort Study. 
  • Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. 
  • Childhood Sexual Abuse and Fear of Abandonment Moderate the Relation of Intimate Partner Violence to Severity of Dissociation. 
  • Childhood and adolescent depression. I. Epidemiological and aetiological aspects. 
  • Childhood and adolescent depression. II: Research in clinical populations. 
  • Childhood and adolescent psychiatric disorders as predictors of young adult disorders. 
  • Childhood maltreatment and hypothalamic-pituitary-adrenal axis reactivity. 
  • Childhood maltreatment and the risk of intimate partner violence: a nationally representative study. 
  • Childhood maltreatment, juvenile disorders and adult post-traumatic stress disorder: a prospective investigation. 
  • Childhood neuropsychological deficits associated with adult obsessive-compulsive disorder. 
  • Childhood origins of violent behaviour in adults with schizophreniform disorder. 
  • Childhood psychiatric disorders and young adult crime: a prospective, population-based study. 
  • Childhood psychotic symptoms share etiological and clinical features with adult schizophrenia: Results from a representative birth cohort. 
  • Childhood psychotic symptoms share etiological and clinical features with adult schizophrenia: Results from a representative borth cohort. 
  • Childhood risk factors associated with adult obsessive-compulsive symptoms and obsessive-compulsive disorder 
  • Childhood socioeconomic status and serotonin transporter gene polymorphism enhance cardiovascular reactivity to mental stress. 
  • Childhood somatic complaints predict generalized anxiety and depressive disorders during young adulthood in a community sample. 
  • Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study. 
  • Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. 
  • Childhood traumatic stress and obesity in women: the intervening effects of PTSD and MDD. 
  • Children and evidence-based practice. 
  • Children's response to terrorism: a critical review of the literature. 
  • Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. 
  • Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature. 
  • Chronic alcohol consumption in alcohol-preferring P rats attenuates subsequent conditioned taste aversion produced by ethanol injections 
  • Chronic fluoxetine increases extra-hippocampal neurogenesis in adult mice. 
  • Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response. 
  • Chronic low back pain and depression. 
  • Chronic neuroleptic effects on spatial reversal learning in monkeys. 
  • Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats. 
  • Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats. 
  • Chronic nicotine interactions with clozapine and risperidone and attentional function in rats. 
  • Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs. 
  • Chronic pain in psychiatric [correction of psychotic] patients. 
  • Chronic posttraumatic stress disorder and chronic pain in Vietnam combat veterans. 
  • Chronic stress and adaptation. 
  • Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. 
  • Chronic underactivity of medial frontal cortical beta2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats. 
  • Chronic very low dose naltrexone administration attenuates opioid withdrawal expression. 
  • Chronicity and a low anteroposterior gradient of cerebral blood flow in schizophrenia. 
  • Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. 
  • Cingulum bundle white matter lesions influence antidepressant response in late-life depression: a pilot study. 
  • Circadian Contrasts in Heart Rate Variability Associated With Posttraumatic Stress Disorder Symptoms in a Young Adult Cohort. 
  • Circadian rhythms in cognitive functioning among patients with schizophrenia: impact on signal detection in clinical trials of potential pro-cognitive therapies. 
  • Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder. 
  • Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. 
  • Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies. 
  • Citalopram and quality of life in lung transplant recipients. 
  • Citalopram and the Curate's egg in geriatric depression. 
  • Classically conditioned enhancement of hyperinsulinemia in the ob/ob mouse. 
  • Classically conditioned hyperglycemia in the obese mouse. 
  • Classification of depression by grade of membership: a confirmation study. 
  • Classification of depressive disorders: A multiaxial approach 
  • Classification of trauma and stressor-related disorders in DSM-5. 
  • Classification of white matter lesions on magnetic resonance imaging in elderly persons. 
  • Classifying insomnia in a clinically useful way. 
  • Classifying psychophysiologic disorders: a new idea. 
  • Classifying psychosomatic disorders in DSM-III. 
  • Clinic Outcome Assessment of a Brief Course Neurofeedback for Childhood ADHD Symptoms. 
  • Clinical Care Update: The chronically mentally ill group treatment for individuals with schizophrenia 
  • Clinical Characteristics and Outcomes Associated With High-Dose Intravenous Thiamine Administration in Patients With Encephalopathy. 
  • Clinical Computing: Clinical Management Research Information System (CRIS). 
  • Clinical Decision Making About Psychopathy and Violence Risk Assessment in Public Sector Mental Health Settings 
  • Clinical Factors Associated with Successful Discharge from Assertive Community Treatment. 
  • Clinical Predictors of White Matter Disruption in Chronic Mild Traumatic Brain Injury among Post-9/11 Veterans 
  • Clinical Research in depression 
  • Clinical and phenomenological comparisons of late-onset and early-onset depression. 
  • Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. 
  • Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. 
  • Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. 
  • Clinical correlates of anxious depression among elderly patients with depression. 
  • Clinical correlates of cognitive decline in vascular dementia. 
  • Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. 
  • Clinical decision making and views about psychiatric advance directives. 
  • Clinical epidemiology of long-term suicide risk in a nationwide population-based cohort study in South Korea. 
  • Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial. 
  • Clinical experience with substance P receptor (NK1) antagonists in depression. 
  • Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. 
  • Clinical features in depression in old age: A case for minor depression 
  • Clinical implications of spirituality to mental health: review of evidence and practical guidelines. 
  • Clinical issues in use of atypical antipsychotics for depressed patients. 
  • Clinical needs assessment of middle and high school students following the 1995 Oklahoma City bombing. 
  • Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data. 
  • Clinical relevance of the distinction between alcohol dependence with and without a physiological component 
  • Clinical science and biomarkers: against RDoC. 
  • Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? 
  • Clinical usefulness of clozapine [6] 
  • Clinical utility of the Primary Care--PTSD Screen among U.S. veterans who served since September 11, 2001. 
  • Clinical variables associated with early administration of antipsychotics in bipolar mania. 
  • Clinical, demographic and social characteristics of psychotic depression. 
  • Clinician-administered PTSD scale: a review of the first ten years of research. 
  • Clinicians' attitudes regarding barriers to the implementation of psychiatric advance directives. 
  • Clinicians' utilization of child mental health telephone consultation in primary care: findings from Massachusetts. 
  • Clomipramine and glucocorticoid receptor function. 
  • Closing remarks 
  • Clozapine decreases smoking in patients with chronic schizophrenia. 
  • Clozapine effects on memory function are reversed by hippocampal damage 
  • Clozapine increases the neurosteroid pregnenolone in rat hippocampus, cerebral cortex, and serum: Relevance to superior efficacy? 
  • Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: Candidate mechanism for superior efficacy? 
  • Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT) 
  • Clozapine treatment in Russia: A review of clinical research 
  • Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder 
  • Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. 
  • Clues to the cognitive and perceptual origins of social isolation and psychosis in schizophrenia. 
  • Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. 
  • Cocaine self-administration reduces excitatory responses in the mouse nucleus accumbens shell. 
  • Coenzyme Q10: a review of its promise as a neuroprotectant. 
  • Cognition and schizophrenia: is there a role for cognitive assessments in diagnosis and treatment? 
  • Cognition and the concept of schizotaxia 
  • Cognition as a key to alliance, adherence, and functional outcomes 
  • Cognition as an outcome measure in schizophrenia. 
  • Cognition in schizophrenia: summary Nice Consultation Meeting 2012. 
  • Cognitive Aging: What Every Geriatric Psychiatrist Should Know. 
  • Cognitive Behavioral Strategies During Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder and Concomitant Major Depressive Disorder 
  • Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial. 
  • Cognitive ability in early adulthood and risk of 5 specific psychiatric disorders in middle age: the Vietnam experience study. 
  • Cognitive and psychotic symptoms in idiopathic hypereosinophilic syndrome 
  • Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects 
  • Cognitive behavioral approaches to the treatment of pain 
  • Cognitive behavioral therapy and cancer 
  • Cognitive behavioral treatment for young children with obsessive-compulsive disorder. 
  • Cognitive behavioural therapy (CBT) with exercise led to higher levels of continuous smoking cessation in women than did CBT without exercise: Commentary 
  • Cognitive behavioural treatments have long-term benefits in female rape survivors with post-traumatic stress disorder 
  • Cognitive burden of anticholinergic medications in psychotic disorders. 
  • Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies. 
  • Cognitive deficits in patients with schizophrenia: effects and treatment. 
  • Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). 
  • Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. 
  • Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. 
  • Cognitive effects of nicotine. 
  • Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. 
  • Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder. 
  • Cognitive enhancement in schizophrenia: Ending the therapeutic nihilism 
  • Cognitive enhancing effects of rTMS administered to the prefrontal cortex in patients with depression: A systematic review and meta-analysis of individual task effects. 
  • Cognitive flexibility in verbal and nonverbal domains and decision making in anorexia nervosa patients: a pilot study. 
  • Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. 
  • Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. 
  • Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. 
  • Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness. 
  • Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission. 
  • Cognitive impairment as a target for pharmacological treatment in schizophrenia. 
  • Cognitive impairment in elderly depressed individuals with APOE epsilon 4 
  • Cognitive impairment in patients with bipolar disorder 
  • Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment 
  • Cognitive impairment in schizophrenia and implications of atypical neuroleptic treatment 
  • Cognitive improvement correlates with weight gain in schizophrenia subjects receiving quetiapine but not other antipsychotics: Data from the CATIE trial 
  • Cognitive performance in antidepressant-free recurrent major depressive disorder. 
  • Cognitive processing therapy for posttraumatic stress disorder delivered to rural veterans via telemental health: a randomized noninferiority clinical trial. 
  • Cognitive subdomain responses to galantamine in Alzheimer's disease. 
  • Cognitive-behavioral conjoint therapy for PTSD: pilot results from a community sample. 
  • Cognitive-behavioral therapy for adolescent depression 
  • Collaborating with our medical colleagues 
  • Collaborative care for late-life depression 
  • Collaborative mental health and primary care for bipolar disorder. 
  • Combat exposure, posttraumatic stress disorder, and head injuries differentially relate to alterations in cortical thickness in military Veterans. 
  • Combination Treatment With Varenicline and Bupropion in an Adaptive Smoking Cessation Paradigm 
  • Combination pharmacotherapy in alcoholism: a novel treatment approach. 
  • Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. 
  • Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. 
  • Combined Agonist-Antagonist Treatment for Nicotine and Other Drug Dependencies. 
  • Combined PTSD and depressive symptoms interact with post-deployment social support to predict suicidal ideation in Operation Enduring Freedom and Operation Iraqi Freedom veterans. 
  • Combined catecholamine and indoleamine depletion following response to ECT. 
  • Combined ecological momentary assessment and global positioning system tracking to assess smoking behavior: a proof of concept study. 
  • Combined exposure to nicotine and ethanol in adolescent mice differentially affects anxiety levels during exposure, short-term, and long-term withdrawal. 
  • Commentaries 
  • Commentary on 'Forum: use of antidepressants in children and adolescents'. 
  • Commentary: Sir Arthur Mitchell--pioneer of psychiatric epidemiology and of community care. 
  • Commentary: psychiatric advance directives and recovery-oriented care. 
  • Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder". 
  • Comments on dexamethasone suppression test results. 
  • Common sense, insight, and neuropsychological test performance in schizophrenia patients. 
  • Common-variant associations with fragile X syndrome. 
  • Communication to the editor: Response to Bass 
  • Community integration of formerly homeless men and women with severe mental illness after hospital discharge. 
  • Comorbid Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Analysis. 
  • Comorbid HIV encephalopathy and cocaine use as a risk factor for new-onset seizure disorders. 
  • Comorbid alcohol dependence and anxiety disorders: A national survey 
  • Comorbid posttraumatic stress disorder is associated with suicidality in male veterans with schizophrenia or schizoaffective disorder. 
  • Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey. 
  • Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people. 
  • Comorbidity and depression treatment. 
  • Comorbidity and quality of life in adults with hair pulling disorder. 
  • Comorbidity between abuse of an adult and DSM-III-R mental disorders: evidence from an epidemiological study. 
  • Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. 
  • Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. 
  • Comorbidity of depression with other medical diseases in the elderly. 
  • Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. 
  • Comparable dopamine 2 receptor occupancy [10] (multiple letters) 
  • Comparative diagnostic criteria for melancholia and endogenous depression. 
  • Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzapine versus low doses of haloperidol (American Journal of Psychiatry (2004) 161, (985-995)) 
  • Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. 
  • Comparative effectiveness of dual-action versus single-action antidepressants for the treatment of depression in people living with HIV/AIDS. 
  • Comparative effectiveness of second-generation antidepressants for accompanying anxiety, insomnia, and pain in depressed patients: a systematic review. 
  • Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis. 
  • Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol (American Journal of Psychiatry (2003) 160, (1396-1404)) 
  • Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. 
  • Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study. 
  • Comparative genomic evidence for the involvement of schizophrenia risk genes in antipsychotic effects. 
  • Comparative mortality risks of antipsychotic medications in community-dwelling older adults. 
  • Comparing Use of Public and Private Mental Health Services: The Enduring Barriers of Race and Age 
  • Comparing neighborhoods of adults with serious mental illness and of the general population: research implications. 
  • Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta-analytic studies. 
  • Comparing the Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Quality of Life 
  • Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. 
  • Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. 
  • Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison. 
  • Comparison in humans of the potency and pharmacokinetics of intravenously injected cocaethylene and cocaine. 
  • Comparison of 50- and 100-g L -tryptophan depletion and loading formulations for altering 5-HT synthesis: pharmacokinetics, side effects, and mood states. 
  • Comparison of Antipsychotics for Metabolic Problems (CAMP): A NIMH schizophrenia trials network study 
  • Comparison of Premenstrual Symptoms in Black and White Community Samples 
  • Comparison of academic and nonacademic sites in multi-center clinical trials. 
  • Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. 
  • Comparison of early and delayed inpatient dexamethasone suppression tests. 
  • Comparison of electric field strength and spatial distribution of electroconvulsive therapy and magnetic seizure therapy in a realistic human head model. 
  • Comparison of lifetime psychiatric diagnoses in Premenstrual Syndrome Clinic and community samples. 
  • Comparison of major and minor depression in older medical inpatients with chronic heart and pulmonary disease. 
  • Comparison of mental health and disablement between primary care patients and end-stage renal disease patients 
  • Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study. 
  • Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia. 
  • Comparison of post-disaster psychiatric disorders after terrorist bombings in Nairobi and Oklahoma City. 
  • Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. 
  • Comparison of the posttraumatic stress disorder scale versus the clinician-administered posttraumatic stress disorder scale in domestic violence survivors. 
  • Comparison of treatment options for depression in heart failure: A network meta-analysis. 
  • Comparison of urinary-free cortisol in depressed and nondepressed patients with malignancy. 
  • Competent adolescents from different socioeconomic and ethnic contexts. 
  • Completeness of response and quality of life in mood and anxiety disorders 
  • Completeness of response and quality of life in mood and anxiety disorders. 
  • Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome. 
  • Complex PTSD in victims exposed to sexual and physical abuse: results from the DSM-IV Field Trial for Posttraumatic Stress Disorder. 
  • Components and correlates of family burden in schizophrenia. 
  • Components of Type A, hostility, and anger-in: relationship to angiographic findings. 
  • Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS). 
  • Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis. 
  • Concealed medicines for people with schizophrenia: a U.S. perspective. 
  • Concept of interpersonal distance in borderline personality disorder (Reply) 
  • Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. 
  • Conceptualizing comorbid PTSD and depression among treatment-seeking, active duty military service members. 
  • Concerns about data reporting and interpretation in "Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial". 
  • Concerns about measuring "spirituality" in research. 
  • Concordance of genetic variation that increases risk for anxiety disorders and posttraumatic stress disorders and that influences their underlying neurocircuitry. 
  • Concordance of self-rated and observer-rated dysphoric symptoms in mania. 
  • Conduct problems subtypes in males predict differential adult health burden 
  • Confirmation of alcohol preference quantitative trait loci in the replicate high alcohol drinking and low alcohol drinking rat lines 
  • Confirmatory factor analysis: an introduction for psychosomatic medicine researchers. 
  • Conflict and mental health: a cross-sectional epidemiological study in Nepal. 
  • Conflict of interest? 
  • Confusion about outpatient commitment. 
  • Connecting Mentally Ill Detainees in Large Urban Jails with Community Care. 
  • Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. 
  • Consensus criteria for traumatic grief. A preliminary empirical test. 
  • Consensus statement on depression, anxiety, and cardiovascular disease. 
  • Consensus statement on depression, anxiety, and functional gastrointestinal disorders. 
  • Consensus statement on depression, anxiety, and oncology. 
  • Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. 
  • Considering PTSD for DSM-5. 
  • Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB). 
  • Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer’s Disease-Neuropsychological Assessment Battery (CERAD-NAB) 
  • Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research. 
  • Constant current vs constant voltage ECT devices. 
  • Constitutional Implications of Firearm Restrictions for Veterans with Fiduciaries 
  • Consumer perceptions of involuntary outpatient commitment. 
  • Consumer views of representative payee use of disability funds to leverage treatment adherence. 
  • Consumer, provider, and informal caregiver opinions on psychiatric advance directives. 
  • Consumers who call the Anxiety Disorders Association of America: characteristics and satisfaction. 
  • Consumers' perceptions of the fairness and effectiveness of mandated community treatment and related pressures. 
  • Contemporary management of comorbid anxiety and depression in geriatric patients. 
  • Contextual predictors of mental health service use among children open to child welfare. 
  • Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). 
  • Continuation of clozapine during chemotherapy: a case report and review of literature. 
  • Continuation treatment of panic disorder with high-potency benzodiazepines. 
  • Continuing medication and hospitalization outcomes after assisted outpatient treatment in New York. 
  • Continuity and stability of preschool depression from childhood through adolescence and following the onset of puberty. 
  • Continuity of antipsychotic medication management for Medicaid patients with schizophrenia. 
  • Continuity of medication management in Medicaid patients with chronic comorbid conditions: An examination by mental health status. 
  • Contribution of job strain, job status and marital status to laboratory and ambulatory blood pressure in patients with mild hypertension. 
  • Controlling Stimulation Strength and Focality in Electroconvulsive Therapy via Current Amplitude and Electrode Size and Spacing: Comparison With Magnetic Seizure Therapy. 
  • Controlling stimulation strength and focality in electroconvulsive therapy via current amplitude and electrode size and spacing: comparison with magnetic seizure therapy. 
  • Controversies in community-based psychiatric epidemiology: let the data speak for themselves. 
  • Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. 
  • Converting positive and negative symptom scores between PANSS and SAPS/SANS. 
  • Convulsive therapy: 50 years later. 
  • Convulsive threshold differences in right unilateral and bilateral ECT. 
  • Coordination of Brain-Wide Activity Dynamics by Dopaminergic Neurons. 
  • Coping and quality of life in patients awaiting lung transplantation. 
  • Coping as a mediator in the relationships of spiritual well-being to mental health in black women with type 2 diabetes. 
  • Coping power for preschool-aged children: a pilot randomized control trial study. 
  • Coping style in relation to the consumption of factor concentrate in HIV-infected hemophiliacs during the years after their infection became known. 
  • Coping styles in heart failure patients with depressive symptoms. 
  • Coping with arthritis pain: The role of daily spiritual experiences and religious and spiritual coping 
  • Coping with genetic testing for breast cancer susceptibility. 
  • Correction: Ankyrin-G regulates forebrain connectivity and network synchronization via interaction with GABARAP. 
  • Correlates and Prevalence of Aggression at Six Months and One Year After First-Time Traumatic Brain Injury. 
  • Correlates of Future Violence in People Being Treated for Schizophrenia. 
  • Correlates of Irritability in College Students With Depressive Symptoms 
  • Correlates of anger and hostility in Iraq and Afghanistan war veterans. 
  • Correlates of postpartum common mental disorders: results from a population-based study in Amhara region, Ethiopia. 
  • Correlates of remission in primary care patients treated for minor depression. 
  • Correlates of suicidal ideation among an elderly depressed sample. 
  • Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. 
  • Corrigendum to: "TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: An open label study" [Eur Psychiatr 2008;23:390-5] (DOI:10.1016/j.eurpsy.2008.04.004) 
  • Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. 
  • Cortical activity differs during nicotine deprivation versus satiation in heavy smokers. 
  • Cortical and subcortical white matter abnormalities in adults with remitted first-episode mania revealed by Tract-Based Spatial Statistics. 
  • Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. 
  • Cortical white matter microstructural abnormalities in bipolar disorder. 
  • Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats. 
  • Cortisol escape from morphine suppression. 
  • Cortisol levels and responses to mammography screening in breast cancer survivors: a pilot study. 
  • Cortisol response to stress in female youths exposed to childhood maltreatment: results of the youth mood project. 
  • Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia. 
  • Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. 
  • Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders. 
  • Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. 
  • Cost-effectiveness of improving primary care treatment of late-life depression. 
  • Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. 
  • Cost-effectiveness of treatments for adolescent depression: results from TADS. 
  • Cost-sharing requirements and access to mental health care among medicare enrollees with schizophrenia. 
  • Costs of criminal justice involvement among persons with serious mental illness in connecticut. 
  • Countertransference in the expectant father. 
  • Couples training, pharmacotherapy, and behavior therapy in the treatment of obesity. 
  • Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol 
  • Course of suicide ideation and predictors of change in depressed older adults. 
  • Covariate analysis of late-onset Alzheimer disease refines the chromosome 12 locus. 
  • Covariation of psychological attributes and incident coronary heart disease in U.S. Air Force veterans of the Vietnam war. 
  • Cranial electrostimulation for headache: meta-analysis. 
  • Criminal justice system involvement among people with schizophrenia. 
  • Criminal victimization of persons with severe mental illness. 
  • Crisis treatment of a preadolescent who accidentally killed his twin. 
  • Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems. 
  • Cross-cultural gene- environment interactions in depression, post-traumatic stress disorder, and the cortisol awakening response: FKBP5 polymorphisms and childhood trauma in South Asia. 
  • Cross-reaction to maprotiline. 
  • Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia 
  • Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. 
  • Crossing the secular divide: government and faith-based organizations as partners in health. 
  • Cultivating Freud's Garden in France 
  • Cumulative Effects of Neighborhood Social Adversity and Personal Crime Victimization on Adolescent Psychotic Experiences. 
  • Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. 
  • Current and future treatments for cognitive deficits in dementia. 
  • Current concepts in schizophrenia: International symposia report new standards for assessment and treatment. Part I: Pathophysiology research prompts assessment updates 
  • Current state of psychiatry in Saudi Arabia. 
  • Current tobacco use, nicotine dependence, and transitions across stages of alcohol involvement: A latent transition analysis approach. 
  • Current, emerging, and newly available insomnia medications. 
  • Cynicism and paranoid alienation in the Cook and Medley HO Scale. 
  • Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. 
  • D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder. 
  • D-amphetamine in obsessive-compulsive disorder. 
  • DAOA variants and schizophrenia: influence on diagnosis and treatment outcomes. 
  • DBNDD1, HSPs and TAAR6 variations influence schizophrenic phenotype and treatment response 
  • DEPRESSION PREDICTS LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE INDIVIDUALS 
  • DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli. 
  • DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action. 
  • DIFFERENCES IN PAIN-RELATED SYMPTOMS AMONG ADULT OUTPATIENTS CONSIDERED FOR CHRONIC OPIOID MANAGEMENT AND SPINAL CORD STIMULATOR IMPLANTATION. 
  • DIFFERENTIAL-EFFECTS OF ANTAGONISTIC AND NEUROTIC HOSTILITY ON CARDIOVASCULAR-RESPONSES IN WOMEN 
  • DISC1–ATF4 transcriptional repression complex: dual regulation of the cAMP-PDE4 cascade by DISC1 
  • DOPAMINE D2 RECEPTOR OCCUPANCY AND COGNITION IN SCHIZOPHRENIA: ANALYSIS OF THE CATIE DATA 
  • DORSOLATERAL PREFRONTAL CORTEX DRIVES MESOLIMBIC DOPAMINERGIC REGIONS DURING MOTIVATED BEHAVIOR: INSIGHTS FROM DYNAMIC CAUSAL MODELING AND FMRI IN AT-RISK ADOLESCENTS 
  • DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. 
  • DSM-5 posttraumatic stress disorder: factor structure and rates of diagnosis. 
  • DSM-III personality disorder in obsessive-compulsive study volunteers: A controlled study 
  • DSM-III personality disorders: diagnostic overlap and internal consistency of individual DSM-III criteria. 
  • DSM-V PTSD diagnostic criteria for children and adolescents: a developmental perspective and recommendations. 
  • DSM-V: should PTSD be in a class of its own? 
  • DURATION OF HYPERTENSION BLUNTS CEREBROVASCULAR REACTIVITY IN TREATMENT-RESISTANT HYPERTENSIVES 
  • Daily Left Prefrontal TMS for Major Depression: A Sham-Controlled Multi-Site Randomized Trial (NIH Optimization of TMS for Depression Study, OPT-TMS) 
  • Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. 
  • Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. 
  • Daily ratings of premenstrual symptoms, II: Differentiating women with severe symptoms from women with normal menstrual cycles 
  • Daily ratings of premenstrual symptoms, I: Awareness effects 
  • Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults. 
  • Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults 
  • Datapoints: Effects of changing from five to ten preauthorized outpatient sessions. 
  • Datapoints: Use of medications and counseling for depression by Asian and multiple-race adolescents aged 12-17 years. 
  • Davidson Trauma Scale (DTS): normative scores in the general population and effect sizes in placebo-controlled SSRI trials. 
  • Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice. 
  • Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice. 
  • Debate on late luteal phase dysphoric disorder. 
  • Decision model for the acute treatment of mania. 
  • Decision-making and prepotent response inhibition functions in excessive internet users. 
  • Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. 
  • Decisional competence to complete psychiatric advance directives 
  • Decrease in speech pause times with treatment of endogenous depression. 
  • Decreased Resting-State Activity in the Precuneus Is Associated With Depressive Episodes in Recurrent Depression. 
  • Decreased alcohol consumption by verapamil in alcohol preferring rats. 
  • Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. 
  • Deep-vein thrombosis with antipsychotic drugs. 
  • Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice. 
  • Deficit in the GABAergic neuroactive steroid allopregnanolone in Alzheimer's dementia and relevance to neuropathological disease stage: Investigations in temporal cortex 
  • Deficit of theory of mind in individuals at ultra-high-risk for schizophrenia 
  • Defining a cognitive function decrement in schizophrenia. 
  • Defining an appropriate management strategy for social anxiety disorder. 
  • Defining the role of baclofen for the treatment of alcohol dependence: a systematic review of the evidence. 
  • Defining treatment-resistant depression: a comprehensive review of the literature. 
  • Definitions, measurements, and management in insomnia 
  • Delayed onset of neuroleptic malignant syndrome after discontinuation of thioridazine. 
  • Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. 
  • Deliberate self-harm and suicidal ideation among male Iraq/Afghanistan-era veterans seeking treatment for PTSD. 
  • Delirium in a patient with natural killer/T-cell lymphoma without overt central nervous system involvement 
  • Delirium with psychotic features possibly associated with mesotherapy. 
  • Delirium: where do we stand? 
  • Delta-9-Tetrahydrocannabinol Exposure Alters Sperm Methylation Profiles: Concurrent Results From Humans and Rats 
  • Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder. 
  • Dentate gyrus volume deficit in schizophrenia. 
  • Depersonalization after marijuana smoking. 
  • Depressed mood is a factor in glycemic control in type 1 diabetes. 
  • Depression Suppresses Treatment Response for Traumatic Loss-Related Posttraumatic Stress Disorder in Active Duty Military Personnel. 
  • Depression among military spouses: Demographic, military, and service member psychological health risk factors. 
  • Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. 
  • Depression and Cardiovascular Disorders in the Elderly. 
  • Depression and anxiety disorder among older male inmates at a federal correctional facility. 
  • Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. 
  • Depression and benign intracranial hypertension. 
  • Depression and cardiovascular disease: mechanisms of interaction. 
  • Depression and cognitive impairment in older adults 
  • Depression and failure of cholesterol lowering after acute myocardial infarction 
  • Depression and five year survival following acute myocardial infarction: a prospective study. 
  • Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. 
  • Depression and health-related quality of life. 
  • Depression and heart disease: evidence of a link, and its therapeutic implications. 
  • Depression and ischemic heart disease: overview of the evidence and treatment implications. 
  • Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. 
  • Depression and level of functioning in patients with rheumatoid arthritis. 
  • Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. 
  • Depression and urinary free cortisol. 
  • Depression as a psychopathological disorder in chronic low back pain patients. 
  • Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment 
  • Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. 
  • Depression awareness training and the clergy. 
  • Depression in diabetes and obesity: racial/ethnic/gender issues in older adults. 
  • Depression in early-onset Alzheimer's disease: clinical and neuroendocrine correlates. 
  • Depression in hospitalized older patients with congestive heart failure. 
  • Depression in late life 
  • Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. 
  • Depression in the elderly. Myths and misconceptions. 
  • Depression in the elderly: A timely update 
  • Depression in the medically ill: a common and serious disorder. 
  • Depression in veterans of the first Gulf War and comparable military controls. 
  • Depression increases in women during early to late menopause but decreases after menopause. 
  • Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. 
  • Depression rating scales. A critical review. 
  • Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. 
  • Depression, anxiety, and functional impairment in children with trichotillomania. 
  • Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory University. 
  • Depression, heart rate variability, and acute myocardial infarction 
  • Depression, smoking abstinence and HPA function in women smokers. 
  • Depression, suicidal ideation, and associated factors: a cross-sectional study in rural Haiti. 
  • Depression, urinary free cortisol excretion and lymphocyte function. 
  • Depressive Symptoms, Exercise Capacity, and Clinical Outcomes After Lung Transplantation. 
  • Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues. 
  • Depressive illness and placebo response 
  • Depressive pseudodementia: a suggested diagnostic profile. 
  • Depressive state- and disease-related alterations in neural responses to affective and executive challenges in geriatric depression. 
  • Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. 
  • Depressive symptoms and associated factors in systemic lupus erythematosus. 
  • Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification. 
  • Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease. 
  • Depressive symptoms and mild cognitive impairment in the elderly: an ominous combination. 
  • Depressive symptoms and survival of patients with coronary artery disease. 
  • Depressive symptoms in the elderly: association with total white blood cell count. 
  • Depressive symptoms in the second trimester relate to low oxytocin levels in African-American women: a pilot study. 
  • Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. 
  • Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder. 
  • Design and field procedures in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A). 
  • Desipramine toxicity with terbinafine. 
  • Detecting reliable cognitive change in individual patients with the MATRICS Consensus Cognitive Battery. 
  • Detection and treatment of major depression in older medically ill hospitalized patients. 
  • Detection of dementia in the elderly using telephone screening of cognitive status 
  • Detection of depression in low resource settings: validation of the Patient Health Questionnaire (PHQ-9) and cultural concepts of distress in Nepal. 
  • Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair. 
  • Determinants of care seeking for mental health problems in rural Haiti: culture, cost, or competency. 
  • Determinants of resting regional cerebral blood flow in normal subjects 
  • Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. 
  • Determining the Culprit: Stress, Fat, or Carbohydrates. 
  • Determining when impairment constitutes incapacity for informed consent in schizophrenia research. 
  • Developing Quality Indicators for Family Support Services in Community Team-Based Mental Health Care 
  • Developing a screening index for community studies of somatization disorder. 
  • Developing and validating a perinatal depression screening tool in Kenya blending Western criteria with local idioms: A mixed methods study. 
  • Developing nicotinic therapy for cognitive impairment of schizophrenia and aging-related dementia 
  • Developing quality indicators for family support services in community team-based mental health care. 
  • Development and Validation of the Moral Injury Scales for Youth. 
  • Development and natural history of mood disorders. 
  • Development and neural bases of face recognition in autism. 
  • Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function. 
  • Development of a brief self-report measure of the type A (coronary prone) behavior pattern. 
  • Development of a computer-based behavioral assessment of checking behavior in obsessive-compulsive disorder. 
  • Development of a criteria set and a structured interview for disorders of extreme stress (SIDES) 
  • Development of a criteria set and a structured interview for disorders of extreme stress (SIDES). 
  • Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). 
  • Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. 
  • Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents 
  • Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents: factor composition and structure across development 
  • Development of an organic affective syndrome during a hyperbaric diving experiment. 
  • Developmental change in amygdala reactivity during adolescence: effects of family history of depression and stressful life events. 
  • Developmental programming of brain and behavior by perinatal diet: focus on inflammatory mechanisms. 
  • Developmental traumatology: a contributory mechanism for alcohol and substance use disorders. 
  • Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics. 
  • Deviation from expected cognitive ability across psychotic disorders. 
  • Dexamethasone Suppression Test and Diagnosis of Melancholia-Reply 
  • Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors. 
  • Dexamethasone suppression test and selection of antidepressant medications. 
  • Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport. 
  • Dexamethasone suppression test in primary degenerative dementia. 
  • Dexamethasone suppression test: a review of contemporary confusion. 
  • Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. 
  • Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research. 
  • Dextroamphetamine modulates the response of the human amygdala. 
  • Dextroamphetamine-induced changes in regional cerebral blood flow 
  • Diagnosed mental disorder in children and use of health services in four organized health care settings. 
  • Diagnosing RDC endogenous depression and DSM-III melancholia. 
  • Diagnosing depression in patients with medical illness. 
  • Diagnosis and management of memory loss and cognitive disorders among elderly persons. 
  • Diagnosis of Alzheimer's disease in epidemiologic studies by staged review of clinical data 
  • Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria. 
  • Diagnosis of major depression in cancer patients according to four sets of criteria. 
  • Diagnosis, epidemiology, and clinical course of geriatric depression 
  • Diagnostic depressive symptoms of the mixed bipolar episode. 
  • Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report. 
  • Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms. 
  • Diagnostic significance of vegetative symptoms in depression. 
  • Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS-C16 and QIDS-SR16) in the elderly. 
  • Diagnostic utility of the dexamethasone suppression test. 
  • Dialectical behavior therapy for borderline personality disorder 
  • Dialectical behavior therapy for patients dually diagnosed with borderline personality disorder and substance use disorders 
  • Dialectical behavior therapy: Efficacy, mechanisms, and application 
  • Dialectical behavior therapy: current status, recent developments, and future directions. 
  • Diazepam for catatonia 
  • Differences in Seizure Expression Between Magnetic Seizure Therapy and Electroconvulsive Shock. 
  • Differences in brain volumes among males and female hormone-therapy users and nonusers. 
  • Differences in early childhood risk factors for juvenile-onset and adult-onset depression. 
  • Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. 
  • Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers. 
  • Differences in psychiatric symptoms and barriers to mental health care between volunteer and career firefighters. 
  • Differences in the hypothermic response to ethanol in rats selectively bred for oral ethanol preference and nonpreference 
  • Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients 
  • Differences in white matter fiber tract development present from 6 to 24 months in infants with autism 
  • Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. 
  • Differential characteristics of young and midlife adult users of psychotherapy, psychotropic medications, or both: information from a population representative sample in São Paulo, Brazil. 
  • Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder. 
  • Differential effects of clozapine and haloperidol on interval timing in the supraseconds range. 
  • Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. 
  • Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats. 
  • Differential patterns of initial and sustained responses in amygdala and cortical regions to emotional stimuli in schizophrenia patients and healthy participants. 
  • Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin. 
  • Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. 
  • Differential sensitivity to dexamethasone suppression in an animal model of the DST. 
  • Differential service utilization associated with trauma-informed integrated treatment for women with co-occurring disorders. 
  • Differential therapeutic response by history during treatment with neuroleptic threshold haloperidol doses. 
  • Differentiation of Reward Dependent Behavior Circuitry from Reward Anticipation with fMRI-Guided TMS 
  • Differentiation of depression from chronic pain with the dexamethasone suppression test and DSM-III. 
  • Diffusion Tensor Imaging of OEF/OIF Veterans with and without Exposure to Primary Blast Forces 
  • Diffusion tensor imaging: background, potential, and utility in psychiatric research. 
  • Dimensional diagnosis and the medical student's grasp of psychiatry. 
  • Dimensions of self-rated mood in depressed, manic, and normal subjects. 
  • Discontinuation of clonazepam in the treatment of social phobia. 
  • Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. 
  • Discriminative tryptophan pathway in first-episode neuroleptic-naive patients with schizophrenia 
  • Discussing Out-of-Pocket Expenses During Clinical Appointments: An Observational Study of Patient-Psychiatrist Interactions. 
  • Disengagement of visual attention in infancy is associated with emerging autism in toddlerhood. 
  • Disorder- and Treatment-Specific Therapeutic Competence Scales for Posttraumatic Stress Disorder Intervention: Development and Psychometric Properties. 
  • Disorders of extreme stress: The empirical foundation of a complex adaptation to trauma. 
  • Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia. 
  • Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study. 
  • Disrupted task related activation to action selection and conflict resolution in patients with schizophrenia 
  • Disruption of component processes of spatial working memory by electroconvulsive shock but not magnetic seizure therapy. 
  • Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling cascades mediating noradrenergic and cholinergic neurotransmitter/neurotrophic responses. 
  • Disseminating the partnership: The Pew Memorial Trust State-University Collaboration Project 
  • Dissemination of evidence-based mental health interventions: importance to the trauma field. 
  • Dissemination of evidence-based psychological treatments for posttraumatic stress disorder in the Veterans Health Administration. 
  • Dissemination to community-based practices 
  • Dissimilar neuropsychiatric presentations of two siblings with juvenile neuronal ceroid lipofuscinosis (Batten disease). 
  • Dissociated effects of anticipating smoking versus monetary reward in the caudate as a function of smoking abstinence. 
  • Dissociation of TSH adrenocortical disturbances in endogenous depression. 
  • Dissociation, affect dysregulation and somatization: The complexity of adaptation to trauma 
  • Dissociation, somatization, and affect dysregulation: The complexity of adaptation to trauma 
  • Dissociation, somatization, and affect dysregulation: the complexity of adaptation of trauma. 
  • Distinct Trauma Types in Military Service Members Seeking Treatment for Posttraumatic Stress Disorder. 
  • Distress and affective dysregulation in patients with borderline personality disorder: a psychophysiological ambulatory monitoring study. 
  • Distress associated with cancer as measured by the illness distress scale. 
  • Distress tolerance to auditory feedback and functional connectivity with the auditory cortex. 
  • Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. 
  • Divergence of an association between depressive symptoms and a dopamine polygenic score in Caucasians and Asians 
  • Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. 
  • Divergent responses of the amygdala and ventral striatum predict stress-related problem drinking in young adults: possible differential markers of affective and impulsive pathways of risk for alcohol use disorder. 
  • Do adolescent offspring of women with PTSD experience higher levels of chronic and episodic stress? 
  • Do anticonvulsants hinder clozapine treatment? 
  • Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major medical disorders? 
  • Do dehydroepiandrosterone, progesterone, and testosterone influence women's depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women 
  • Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. 
  • Do novel antipsychotics improve cognition? A report of a meta-analysis 
  • Do people turn to religion in times of stress?: an examination of change in religiousness among elderly, medically ill patients. 
  • Do repeated courses of ECT cause brain damage detectable by MRI? (I: Reply) 
  • Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. 
  • Does Childhood Trauma Moderate Polygenic Risk for Depression? A Meta-analysis of 5765 Subjects From the Psychiatric Genomics Consortium. 
  • Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression? 
  • Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. 
  • Does age make a difference in the effects of physical health and social support on the outcome of a major depressive episode? 
  • Does antidepressant therapy improve cognitive function in elderly depressed patients? 
  • Does autonoetic agnosia underlie specific psychotic symptoms in schizophrenia? 
  • Does body mass index moderate the association between posttraumatic stress disorder symptoms and suicidal ideation in Iraq/Afghanistan veterans? 
  • Does change in ECT electrode placement help temporomandibular joint pain? 
  • Does cognitive-behavioral therapy for PTSD improve perceived health and sleep impairment? 
  • Does family history indicate a more serious form of illness? The case for depression, anxiety, alcohol dependence and drug dependence 
  • Does military sexual trauma moderate the impact of critical warzone experiences? 
  • Does multimodal treatment of ADHD decrease other diagnoses? 
  • Does physiologic response to loud tones change following cognitive-behavioral treatment for posttraumatic stress disorder? 
  • Does prenatal nicotine exposure sensitize the brain to nicotine-induced neurotoxicity in adolescence? 
  • Does social support buffer functional decline in elderly patients with unipolar depression? 
  • Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial. 
  • Does treatment influence mortality in depressives? A follow-up of 1076 patients with major affective disorders 
  • Does writing about suicidal thoughts and feelings reduce them? 
  • Domestic violence increases risk of psychiatric disorder in women but not in men: A longitudinal cohort study 
  • Domestic violence is followed by increased risk of psychiatric disorder among women, but not men 
  • Dominance rank causally affects personality and glucocorticoid regulation in female rhesus macaques. 
  • Don't give up on GWAS. 
  • Donepezil for Down's syndrome. 
  • Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. 
  • Dopamine efflux during withdrawal from continuous or intermittent cocaine. 
  • Dopamine-modulated aversive emotion processing fails in alcohol-dependent patients. 
  • Dopaminergic correlates of attentional performance in unmedicated schizophrenic patients 
  • Dopaminergic role in cannabis-induced psychosis? Genetic and imaging evidence 
  • Dorsolateral prefrontal cortex and anterior cingulate cortex white matter alterations in late-life depression. 
  • Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study 
  • Dose response relationship between plasma ACTH and cortisol after the infusion of ACTH1-24. 
  • Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia. 
  • Dosing recommendations and prescribing patterns for depressed medically ill hospitalized older patients. 
  • Double depression: A distinctive subtype of unipolar depression - Discussion 
  • Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. 
  • Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. 
  • Downregulation of TOMM40 expression in the blood of Alzheimer disease subjects compared with matched controls. 
  • Dr Barber and colleagues reply 
  • Dr Kantrowitz and Colleagues Reply. 
  • Dr McClintock and Colleagues Reply. 
  • Dr McClintock and Colleagues Reply. 
  • Dr. Capehart replies. 
  • Dr. Insel and colleagues reply [2] 
  • Dr. Keefe and colleagues reply 
  • Dr. Lieberman and Colleagues Reply 
  • Dr. Lieberman and Colleagues reply [17] 
  • Dr. McClintock and Colleagues reply 
  • Dr. O'Brien replies [6] 
  • Dr. Perrone-Bizzozero and W. Michael Bullock reply 
  • Dr. Rosenheck and Colleagues Reply 
  • Dr. Rosenheck and colleagues reply [2] 
  • Dr. Swanson and colleagues reply [4] 
  • Dreams of flying in narcoleptic patients. 
  • Drinking and Smoking History and Antidepressant Plasma Levels 
  • Drs. Blazer and Wu reply 
  • Drug and alcohol trajectories among adults with schizophrenia: data from the CATIE study. 
  • Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder. 
  • Drug therapy of post-traumatic stress disorder. 
  • Drugs of the psychopharmacological revolution in clinical psychiatry. 
  • Dual diagnosis: 15 years of progress. 
  • Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial. 
  • Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. 
  • Duration of untreated psychosis and the pathway to care in KwaZulu-Natal, South Africa. 
  • Dynamic Resting-State Functional Connectivity in Major Depression. 
  • Dynamically Timed Stimulation of Corticolimbic Circuitry Activates a Stress-Compensatory Pathway. 
  • Dysbindin gene (DTNBP1) and schizophrenia in Korean population. 
  • Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects. 
  • Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder. 
  • Dysthymia in community and clinical samples of older adults. 
  • Dystonia, neuroleptic dose, and anticholinergic drugs. 
  • E-cigarette prevalence and correlates of use among adolescents versus adults: A review and comparison 
  • E-cigarette prevalence and correlates of use among adolescents versus adults: a review and comparison. 
  • ECT and TMS: past, present, and future. 
  • ECT and seizure threshold: effects of stimulus wave form and electrode placement. 
  • ECT failure rate among specific devices - Drs. Krystal and Weiner reply 
  • ECT failure rate among specific devices. 
  • ECT in bipolar and unipolar depression: differences in speed of response. 
  • ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk. 
  • ECT in the treatment of status epilepticus. 
  • ECT instrumentation 
  • ECT stimulus intensity: are present ECT devices too limited? 
  • ECT use in unipolar and bipolar depression. 
  • ECT-induced alteration of psychogenic amnesia. 
  • ECT-induced amnesia and postictal EEG suppression. 
  • ECT-induced delirium and further ECT: a case report. 
  • ECT-induced delirium in depressed patients with Parkinson's disease. 
  • ECT-induced status epilepticus and further ECT: a case report. 
  • EEG correlates of the response to ECT 
  • EEG correlates of the response to ECT: a possible antidepressant role of brain-derived neurotrophic factor. 
  • EEG effects of ECT: implications for rTMS. 
  • EEG evidence of more "intense" seizure activity with bilateral ECT. 
  • EEG studies of sleep and the dexamethasone suppression test in the diagnosis of depression 
  • EEG studies of sleep in the diagnosis of depression. 
  • EFFECT OF CENTRAL NERVOUS SYSTEM SEROTONIN FUNCTION ON INFLAMMATION, ADIPOSITY AND INSULIN SENSITIVITY 
  • EFFECT OF FAMILY HISTORY OF HYPERTENSION ON CARDIOVASCULAR-RESPONSES TO INTRAVENOUS INFUSIONS OF ISOPROTERENOL (ISO) OR NOREPINEPHRINE (NE) 
  • EFFECT OF THE APOE ε4 ALLELE AND COMBAT EXPOSURE ON PTSD AMONG IRAQ/AFGHANISTAN-ERA VETERANS. 
  • EFFECTS OF RELIGIOUS VERSUS STANDARD COGNITIVE-BEHAVIORAL THERAPY ON OPTIMISM IN PERSONS WITH MAJOR DEPRESSION AND CHRONIC MEDICAL ILLNESS. 
  • EFFICACY AND TOLERABILITY OF ADJUNCTIVE ARMODAFINIL IN PATIENTS WITH SCHIZOPHRENIA 
  • EIGHT-MONTH STABILITY OF PLASMA EPINEPHRINE AND CORTISOL IN FASTED ADULTS AT BASELINE AND IN RESPONSE TO A GLUCOSE BOLUS 
  • ELECTRICAL DOSAGE, STIMULUS PARAMETERS, AND ELECTRODE PLACEMENT 
  • EMDR for treatment of PTSD. 
  • EPIGENETIC SIGNATURES OF CHILDHOOD AND ADOLESCENT VICTIMISATION USING A GENETICALLY SENSITIVE LONGITUDINAL COHORT STUDY 
  • EPINEPHRINE, CORTISOL AND NON-ESTERIFIED FATTY ACID LEVELS DURING AN INTRAVENOUS GLUCOSE TOLERANCE TEST ARE ASSOCIATED WITH THE ACUTE INSULIN RESPONSE (AIR), AN EARLY RISK MARKER FOR TYPE 2 DIABETES 
  • EURODEP Consortium and late-life depression. 
  • EVALUATING POTENTIAL IATROGENIC SUICIDE RISK IN TRAUMA-FOCUSED GROUP COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF PTSD IN ACTIVE DUTY MILITARY PERSONNEL. 
  • EXAMINING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) INATTENTION SYMPTOMS AS ANTECEDENTS OF PSYCHOSIS RISK IN 22Q11.2 DELETION SYNDROME (22Q11.2DS) 
  • EXERCISE TRAINING AND MAJOR DEPRESSION 
  • EXPLORATORY FINDINGS MAY IMPLICATE GENE'S VARIANTS, RELATED TO ANTIPSYCHOTIC MECHANISMS OF ACTION, WITH SCHIZOPHRENIA PSYCHOPATHOLOGICAL FEATURES 
  • Early Correction of N-Methyl-D-Aspartate Receptor Function Improves Autistic-like Social Behaviors in Adult Shank2-/- Mice. 
  • Early and late side effects of phenelzine. 
  • Early childhood factors associated with the development of post-traumatic stress disorder: results from a longitudinal birth cohort. 
  • Early nurture epigenetically tunes the oxytocin receptor. 
  • Early pharmacological treatment of autism: a rationale for developmental treatment. 
  • Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical? 
  • Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. 
  • Easing the burden of social anxiety disorder. 
  • Economic grand rounds: Can states implement involuntary outpatient commitment within existing state budgets? 
  • Economic inequality is related to cross-national prevalence of psychotic symptoms. 
  • Editorial: A recap and farewell from the editor 
  • Editorial: Exploring psychobiological, psychosocial, and cultural aspects of patient care: The International Journal of Psychiatry in Medicine in the 21st century 
  • Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. 
  • Effect of Adjunctivel-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype 
  • Effect of Bupropion SR on the Quality of Life of Elderly Depressed Patients With Comorbid Medical Disorders. 
  • Effect of ECT treatment number on the ictal EEG. 
  • Effect of Electroconvulsive Shock and Magnetic Seizure on Gene Expression Profiles in the Prefrontal Cortex of the Rhesus Monkey 
  • Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats. 
  • Effect of Supplementary Motor Area Modulation on Motor Cortex Excitability in Obsessive-Compulsive Disorder: Relations to Clinical Improvement 
  • Effect of a paraprofessional home-visiting intervention on American Indian teen mothers’ and infants’ behavioral risks: a randomized controlled trial. 
  • Effect of antidepressant drugs in mice lacking the norepinephrine transporter. 
  • Effect of bromocriptine on affect and libido in hyperprolactinemia. 
  • Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study. 
  • Effect of chronic stress associated with unemployment on salivary cortisol: overall cortisol levels, diurnal rhythm, and acute stress reactivity. 
  • Effect of daily dosing duration of direct and indirect dopamine receptor agonists: cocaine cross-tolerance following chronic regimens. 
  • Effect of electroconvulsive shock and magnetic seizure on gene expression profiles in the prefrontal cortex of the rhesus monkey 
  • Effect of electroconvulsive shock and magnetic seizure on gene expression profiles in the prefrontal cortex of the rhesus monkey 
  • Effect of gamma interferon on the hypothalamic-pituitary-adrenal system. 
  • Effect of genetic variation in the nicotinic receptor genes on risk for posttraumatic stress disorder. 
  • Effect of kava extract on vagal cardiac control in generalized anxiety disorder: preliminary findings. 
  • Effect of nitrous oxide on cerebral blood velocity while reclining and standing. 
  • Effect of olanzapine versus placebo on the neuropsychological status of prodromal subjects 
  • Effect of patients' reasons for refusing treatment on implementing psychiatric advance directives. 
  • Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. 
  • Effect of sex on ethanol consumption and conditioned taste aversion in adolescent and adult rats. 
  • Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. 
  • Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: A pilot study on differential effects of sex hormones on antidepressant effects 
  • Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review. 
  • Effectiveness of atypical antipsychotic medications in reducing violent behavior among persons with schizophrenia in community-based treatment. 
  • Effectiveness of atypical antipsychotics for substance use in schizophrenia patients. 
  • Effectiveness of chromium in atypical depression: a placebo-controlled trial. 
  • Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. 
  • Effectiveness of disease management programs in depression: a systematic review. 
  • Effectiveness of escitalopram vs venlafaxine XR in major depression in a real world clinical setting 
  • Effectiveness of involuntary outpatient commitment. 
  • Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence. 
  • Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study. 
  • Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study 
  • Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. 
  • Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. 
  • Effectiveness of paroxetine and problem solving treatment for PC patients with minor depression or dysthymia 
  • Effectiveness of paroxetine and problem solving treatment for primary care patients age 18-59 with minor depression or dysthymia 
  • Effectiveness of paroxetine and problem-solving treatment for elders with minor depression or dysthymia 
  • Effectiveness of paroxetine and problem-solving treatment for younger adults with minor depression or dysthymia 
  • Effectiveness of psychological treatments for depression and alcohol use disorder delivered by community-based counsellors: two pragmatic randomised controlled trials within primary healthcare in Nepal. 
  • Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. 
  • Effectiveness of switching from antipsychotic polypharmacy to monotherapy. 
  • Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial. 
  • Effects of 24 hour smoking abstinence on sustained and event-related brain activity during continuous working memory: Preliminary results of an fMRI study 
  • Effects of 5HTTLPR on cardiovascular response to an emotional stressor. 
  • Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats. 
  • Effects of Acute Course Electroconvulsive Therapy on Global Cognitive Function in Elderly Adults with Depression 
  • Effects of ECT on brain structure: a pilot prospective magnetic resonance imaging study. 
  • Effects of ECT on diabetes mellitus. An attempt to account for conflicting data. 
  • Effects of Exercise and Sertraline on Measures of Coronary Heart Disease Risk in Patients With Major Depression: Results From the SMILE-II Randomized Clinical Trial. 
  • Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. 
  • Effects of LifeSkills training on medical students' performance in dealing with complex clinical cases. 
  • Effects of Schizophrenia Polygenic Risk Scores on Brain Activity and Performance During Working Memory Subprocesses in Healthy Young Adults. 
  • Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients. 
  • Effects of a right unilateral ultrabrief pulse electroconvulsive therapy course on health related quality of life in elderly depressed patients. 
  • Effects of aerobic exercise on white matter hyperintensities: An exploratory analysis. 
  • Effects of aerobic exercise training on hemodynamic responses during psychosocial stress in normotensive and borderline hypertensive type A men: a preliminary report. 
  • Effects of age and gender on the relationship between anxiety and coronary artery disease. 
  • Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. 
  • Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers 
  • Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. 
  • Effects of antipsychotic medication on psychiatric service utilization and cost. 
  • Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. 
  • Effects of antipsychotic medications on sleep in schizophrenia. 
  • Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. 
  • Effects of bright light on responsiveness to a muscarinic agonist in rats selectively bred for endogenously increased cholinergic function. 
  • Effects of childbearing on the natural history of panic disorder with comorbid mood disorder. 
  • Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. 
  • Effects of chronic lithium and rubidium administration upon experimentally induced conflict behavior 
  • Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats. 
  • Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia. 
  • Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia. 
  • Effects of cognitive remediation on negative symptoms dimensions: exploring the role of working memory. 
  • Effects of concomitant risperidone and lithium treatment [1] 
  • Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial. 
  • Effects of coping on health outcome among women with gastrointestinal disorders. 
  • Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. 
  • Effects of depression on QT interval variability after myocardial infarction. 
  • Effects of dopamine agonists and antagonists in Tourette's disease. 
  • Effects of early life stress on depression, cognitive performance and brain morphology. 
  • Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy. 
  • Effects of electroconvulsive therapy on plasma vasopressin and oxytocin. 
  • Effects of errors in a multicenter medical study: preventing misinterpreted data. 
  • Effects of exercise and weight loss on blood pressure during daily life 
  • Effects of exercise and weight loss on depressive symptoms among men and women with hypertension. 
  • Effects of exercise on the Type A (coronary prone) behavior pattern. 
  • Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. 
  • Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials. 
  • Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial. 
  • Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats. 
  • Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. 
  • Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness. 
  • Effects of legal mechanisms on perceived coercion and treatment adherence among persons with severe mental illness. 
  • Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. 
  • Effects of medical illness and somatic symptoms on treatment of depression in a family medicine residency practice. 
  • Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats. 
  • Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers. 
  • Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. 
  • Effects of oral ethanol self-administration on the EEG of alcohol preferring and -nonpreferring rats 
  • Effects of paroxetine and venlafaxine XR on heart rate variability in depression. 
  • Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. 
  • Effects of periadolescent versus adult cocaine exposure on cocaine conditioned place preference and motor sensitization in mice. 
  • Effects of postnatal parental smoking on parent and teacher ratings of ADHD and oppositional symptoms. 
  • Effects of postpartum psychiatric illnesses on family planning. 
  • Effects of pregabalin on heart rate variability in patients with painful diabetic neuropathy. 
  • Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of rhesus monkeys. 
  • Effects of propranolol on cardiovascular and neuroendocrine responses to mental arithmetic in type A men. 
  • Effects of psychotherapy on brain function: Brain imaging studies indicate changes 
  • Effects of repeated alcohol deprivations on operant ethanol self-administration by alcohol-preferring (P) rats 
  • Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats. 
  • Effects of single and repeated alcohol withdrawal on kindling. 
  • Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. 
  • Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder. 
  • Effects of smoking on the acoustic startle response and prepulse inhibition in smokers with and without posttraumatic stress disorder. 
  • Effects of social support and resilient coping on violent behavior in military veterans. 
  • Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons. 
  • Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial. 
  • Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus. 
  • Effects of time-limited vs unlimited compensation on pain behavior and treatment outcome in low back pain patients. 
  • Effects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats. 
  • Effects of transdermal nicotine on lateralized identification and memory interference. 
  • Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. 
  • Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice. 
  • Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study. 
  • Efficacy and correlates of therapeutic response to sertraline in geriatric depression with comorbid medical illness 
  • Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. 
  • Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. 
  • Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. 
  • Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review. 
  • Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature. 
  • Efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with major depressive disorder treated with an antidepressant 
  • Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder 
  • Efficacy and safety of lisdexamfetamine dimesylate in adults with executive dysfunction and partial or full remission of major depressive disorder 
  • Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials. 
  • Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. 
  • Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. 
  • Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. 
  • Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial. 
  • Efficacy of ECT in the treatment of depression: Wave form and electrode placement considerations 
  • Efficacy of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy (ECT): Data from Phase I of the PRIDE Study 
  • Efficacy of a multimodal treatment for disruptive behavior disorders in children and adolescents: focus on internalizing problems. 
  • Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation [3] 
  • Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. 
  • Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies. 
  • Efficacy of olanzapine in social anxiety disorder: a pilot study. 
  • Efficacy of risperidone on positive features of schizophrenia. 
  • Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. 
  • Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. 
  • Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials. 
  • Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. 
  • Efficiency of outpatient ECT. 
  • Efficient trial designs to reduce placebo requirements. 
  • Eighty-five per cent of what? Discrepancies in the weight cut-off for anorexia nervosa substantially affect the prevalence of underweight. 
  • Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. 
  • Electrocardiogram Characteristics and Their Association With Psychotropic Drugs Among Patients With Schizophrenia. 
  • Electroconvulsive Therapy and All-Cause Mortality in Texas, 1998-2013. 
  • Electroconvulsive therapy as an alternative to deep brain stimulation for medication-refractory Tourette syndrome 
  • Electroconvulsive therapy device classification: response to FDA advisory panel hearing and recommendations. 
  • Electroconvulsive therapy does not change serum CK, LD, or LD isoenzymes. 
  • Electroconvulsive therapy for catatonia in neuropsychiatric systemic lupus erythematosus. 
  • Electroconvulsive therapy for severe major depressive disorder after orthotopic liver transplantation. 
  • Electroconvulsive therapy in child and adolescent psychiatry 
  • Electroconvulsive therapy in the United States: how often is it used? 
  • Electroconvulsive therapy in the presence of brain tumor. Case reports and an evaluation of risk. 
  • Electroconvulsive therapy is equally effective in unipolar and bipolar depression. 
  • Electroconvulsive therapy of depression in patients with white matter hyperintensity. 
  • Electroconvulsive therapy stimulus parameters: rethinking dosage. 
  • Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain. 
  • Electrophysiological and diffusion tensor imaging evidence of delayed corollary discharges in patients with schizophrenia. 
  • Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories. 
  • Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. 
  • Elevated gray and white matter densities in cocaine abstainers compared to current users 
  • Elevated hematocrit in patients with schizophrenia. 
  • Elevated inflammation levels in depressed adults with a history of childhood maltreatment (vol 65, pg 409, 2008) 
  • Elevated inflammation levels in depressed adults with a history of childhood maltreatment. 
  • Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation. 
  • Elevated plasma A beta(1-42) in geriatric depression 
  • Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients. 
  • Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. 
  • Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons. 
  • Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) mice. 
  • Emergency Department Boarding: Nowhere Else to Go. 
  • Emergency Psychiatry Experience, Resident Burnout, and Future Plans to Treat Publicly Funded Patients. 
  • Emergency psychiatry: an emergency treatment hub-and-spoke model for psychiatric emergency services. 
  • Emotion recognition and social/role dysfunction in non-clinical psychosis. 
  • Emotion suppression in borderline personality disorder: an experience sampling study. 
  • Emotion: The science of sentiment 
  • Emotional adjustment in survivors of sexual assault living with HIV-AIDS. 
  • Emotional antecedents of hot flashes during daily life. 
  • Emotional consequences of victimization and discrimination in "special populations" of women. 
  • Emotional distress and quality of life in caregivers of patients awaiting lung transplant. 
  • Emotional learning during dissociative states in borderline personality disorder. 
  • Emotional reactions to pain predict psychological distress in adult patients with Sickle Cell Disease (SCD). 
  • Emotional responses to interpersonal rejection. 
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. 
  • Empirical assessment of the factorial structure of clinical symptoms in schizophrenic patients: formal thought disorder. 
  • Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale. 
  • Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia. 
  • Endocrine activity in air traffic controllers at work. I. Characterization of cortisol and growth hormone levels during the day. 
  • Endocrine activity in air traffic controllers at work. II. Biological, psychological and work correlates. 
  • Endocrine activity in air traffic controllers at work. III. Relationship to physical and psychiatric morbidity. 
  • Endothelial function and cardiovascular hemodynamics during stress 
  • Endothelial function and hemodynamic responses during mental stress. 
  • Endurance of Neural Response to Rewards Predicts Post-Treatment Depression Severity 
  • Enduring effects of adolescent drug exposure. 
  • Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions. 
  • Enhanced affective aggression in genetically bred hypercholinergic rats. 
  • Enhanced behavioral response to repeated-dose cocaine in adolescent rats. 
  • Enhanced cortisol suppression following dexamethasone administration in domestic violence survivors. 
  • Enhanced endocannabinoids promote fear plasticity 
  • Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. 
  • Enhancement of rTMS Neuromodulatory Effects with Novel Waveforms Demonstrated via Controllable Pulse Parameter TMS (cTMS) 
  • Enhancement of serotoninergic function - A sometimes insufficient cause of antidepressant action 
  • Enhancing "usual practice" treatment foster care: findings from a randomized trial on improving youths' outcomes. 
  • Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. 
  • Enigmas in psychiatry. 
  • Enkephalin-dopamine interactions in behavioral arousal. 
  • Epidemiologic data and planning mental health services. A tale of two surveys. 
  • Epidemiology of child traumatic stress. 
  • Epidemiology of dysphoria and depression in an elderly population. 
  • Epidemiology of persecutory ideation in an elderly population in the community. 
  • Epidemiology of recurrent major and minor depression with a seasonal pattern. The National Comorbidity Survey. 
  • Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. 
  • Epigenetic programming by stress and glucocorticoids along the human lifespan. 
  • Epigenetics of Posttraumatic Stress Disorder: Current Evidence, Challenges, and Future Directions. 
  • Epigenome-Wide Association of PTSD from Heterogeneous Cohorts with a Common Multi-Site Analysis Pipeline 
  • Epigenome-wide Association Study of Attention-Deficit/Hyperactivity Disorder Symptoms in Adults. 
  • Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment. 
  • Epstein-Barr virus antibodies in whole blood spots: a minimally invasive method for assessing an aspect of cell-mediated immunity. 
  • Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: a systematic review and individual participant data meta-analysis. 
  • Errata 
  • Erratum 
  • Erratum to "Project among African-Americans to explore risks for schizophrenia (PAARTNERS): Recruitment and assessment methods" [Schizophrenia Research 87 (1-3) (2006) 32-44] (DOI:10.1016/j.schres.2006.06.027) 
  • Erratum to: DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action. 
  • Erratum: AKT1 and neurocognition in schizophrenia (Australian and New Zealand Journal of Psychiatry (2007) 41 (169-177)) 
  • Erratum: Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates (Archives of General Psychiatry (February 2001) 58 (199-200)) 
  • Erratum: Enhanced behavioral response to related-dose cocaine in adolescent rats (Psychopharmacology (2005) 183 (218-225) DOI: doi.org/10.1007/s00213-005- 0159-4) 
  • Erratum: Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: A systematic review and individual participant data meta-analysis (Journal of Physical Chemistry (2019) DOI: 10.1017/S0033291719001314) 
  • Erratum: Focal electrically administered seizure therapy: A novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction (Neuropsychopharmacology (2009) 34 (2002-2010) DOI: 10.1038/npp.2009.12) 
  • Erratum: Full and partial PTSD among earthquake survivors in rural Taiwan (Journal of Psychiatric Research (2005) 38 (313-322) DOI: 10.1016/j.jpsychires. 2003.08.005) 
  • Erratum: Hierarchical temporal processing deficit model of reality distortion and psychoses (Molecular Psychiatry (2011) 16, (129-144) DOI: 10.1038/mp.2010.63) 
  • Erratum: Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (Journal of Clinical Psychopharmacology (August 2006) 26, (373-378)) 
  • Erratum: Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (Journal of Clinical Psychopharmacology (August 2006) 26, (373-378)) 
  • Erratum: Novelty seeking and stereotypic activation of behavior in mice with disruption of the DatI gene (Neuropsychopharmacology (April 27, 2005), DOI:10.1038/sj.npp.1300724) 
  • Erratum: Predictors of response to monoamine oxidase inhibitors: Do they exist? (Eur Arch Psychiatry Clin Neurosci (1992) 241: 181-186) 
  • Erratum: Rates of depressive and anxiety disorders in a residential mother-infant unit for unsettled infants (Australian and New Zealand Journal of Psychiatry (2007) 41 (836-842)) 
  • Erratum: Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication (Journal of Clinical Psychopharmacology (2011) 31:2 (180-186)) 
  • Erratum: Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation: A preliminary study 
  • Erratum: The Cost of Assisted Outpatient Treatment: Can It Save States Money? (American Journal of Psychiatry) 
  • Erratum: VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms (Neuropsychopharmacology (2006) 31 (1345-1355) DOI: 10.1038/sj.npp.1301082) 
  • Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder. 
  • Errors in assessing DSM-IV substance use disorders [4] 
  • Escape from dexamethasone suppression: possible role of an impaired inhibitory opioid mechanism. 
  • Escitalopram for treatment of night eating syndrome: a 12-week, randomized, placebo-controlled trial. 
  • Escitalopram in specific phobia: results of a placebo-controlled pilot trial. 
  • Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study. 
  • Escitalopram treatment of trichotillomania. 
  • Establishing a methodology to examine the effects of war-zone PTSD on the family: the family foundations study. 
  • Establishing the Brief Assessment of Cognition - Short form. 
  • Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. 
  • Estimating between- and within-individual variation in cortisol levels using multilevel models. 
  • Estimating prevalence of serious emotional disturbance in schools using a brief screening scale. 
  • Estimating suicidality as an outcome measure in clinical trials of suicide in schizophrenia. 
  • Estimating the prevalence of borderline personality disorder in the community 
  • Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys. 
  • Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. 
  • Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. 
  • Ethanol locomotor sensitization, but not tolerance correlates with selection for alcohol preference in high- and low-alcohol preferring mice 
  • Ethnic differences in resting heart rate variability: a systematic review and meta-analysis. 
  • Ethnic/racial differences in weight-related concerns and behaviors among adolescent girls and boys: findings from Project EAT. 
  • Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort. 
  • Etiological paradigms of depression: The relationship between perceived causes, empowerment, treatment preferences, and stigma 
  • European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors. 
  • Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults. 
  • Evaluating medicinal herbs. 
  • Evaluating the Effectiveness of Community and Hospital Medical Record Integration on Management of Behavioral Health in the Emergency Department. 
  • Evaluation and modification of exercise patterns in the natural environment. 
  • Evaluation of Clinical Biofeedback 
  • Evaluation of Feighner criteria using longterm outcome data on schizophrenia and affective disorders 
  • Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure. 
  • Evaluation of Improvement in Externalizing Behaviors and Callous-Unemotional Traits in Children with Disruptive Behavior Disorder: A 1-Year Follow Up Clinic-Based Study. 
  • Evaluation of a district mental healthcare plan in a low-resource setting in Nepal: outcomes at community, facility and individual levels 
  • Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial. 
  • Evaluation of cognitive function in bipolar disorder using the Brief Assessment of Cognition in Affective Disorders (BAC-A). 
  • Evaluation of outcome in brief psychotherapy 
  • Evaluation of the Effects of Severe Depression on Global Cognitive Function and Memory. 
  • Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. 
  • Evaluation of the central nervous system risks of ECT 
  • Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow. 
  • Every-other-day acetylmethadol disturbs circadian cycles of human motility 
  • Evidence for a menstrual-linked artifact in determining rates of depression. 
  • Evidence for altered cerebellar vermis neuronal integrity in schizophrenia. 
  • Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. 
  • Evidence for genetic linkage of autism to chromosomes 7 and 4 
  • Evidence for impaired cortical inhibition in patients with unipolar major depression. 
  • Evidence for multiple loci from a genome scan of autism kindreds. 
  • Evidence for the diagnostic criteria of delirium: an update. 
  • Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index. 
  • Evidence of CNIH3 involvement in opioid dependence. 
  • Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. 
  • Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression. 
  • Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. 
  • Evidence of white matter tract disruption in MRI hyperintensities. 
  • Evidence report on: Treatment of depression - Newer pharmacotherapies 
  • Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. 
  • Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. 
  • Evidence-based medicine and psychiatric practice. 
  • Evidence-based practice in child and adolescent mental health services. 
  • Evolving approaches to management of osteoarthritis 
  • Exacerbation of psychotic disorder during pregnancy in the context of medication discontinuation. 
  • Examination of Treatment Effects on Hazardous Drinking Among Service Members With Posttraumatic Stress Disorder. 
  • Examination of the indirect effects of combat exposure on suicidal behavior in veterans. 
  • Examination stress in Singapore primary schoolchildren: how compliance by subjects can impact on study results. 
  • Examining DSM criteria for trichotillomania in a dimensional framework: implications for DSM-5 and diagnostic practice. 
  • Examining reactivity patterns in burnout and other indicators of chronic stress. 
  • Examining the Crux of Autonomic Dysfunction in Posttraumatic Stress Disorder: Whether Chronic or Situational Distress Underlies Elevated Heart Rate and Attenuated Heart Rate Variability. 
  • Examining the Unanticipated Adverse Consequences of Youth Suicide Prevention Strategies: A Literature Review with Recommendations for Prevention Programs. 
  • Examining the effects of initial smoking abstinence on response to smoking-related stimuli and response inhibition in a human laboratory model. 
  • Examining the relationship between adjunctive psychotherapy use and antipsychotic persistence and hospitalization. 
  • Examining the relationship between negative affect and posttraumatic stress disorder symptoms among smokers using ecological momentary assessment. 
  • Excess mortality in schizophrenia and affective disorders. Do suicides and accidental deaths solely account for this excess? 
  • Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes. 
  • Executive control, ERP and pro-inflammatory activity in emotionally exhausted middle-aged employees. Comparison between subclinical burnout and mild to moderate depression. 
  • Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. 
  • Exercise and pharmacotherapy in the treatment of major depressive disorder. 
  • Exercise therapy for the prevention and treatment of depression 
  • Exercise training in healthy type A middle-aged men: effects on behavioral and cardiovascular responses. 
  • Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. 
  • Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis. 
  • Experiential sampling in the study of multiple personality disorder. 
  • Explained and unexplained medical symptoms in generalized anxiety and panic disorder: relationship to the somatoform disorders. 
  • Explaining rare acts of violence: the limits of evidence from population research. 
  • Explanatory models and mental health treatment: is vodou an obstacle to psychiatric treatment in rural Haiti? 
  • Exploration of NO2 and PM2.5 air pollution and mental health problems using high-resolution data in London-based children from a UK longitudinal cohort study. 
  • Exploration of the resilience construct in posttraumatic stress disorder severity and functional correlates in military combat veterans who have served since September 11, 2001. 
  • Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis. 
  • Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorder. 
  • Exploring common changes after acute mental stress and acute tryptophan depletion: Resting-state fMRI studies. 
  • Exploring the relationship between posttraumatic stress disorder symptoms and momentary heart rate variability. 
  • Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age: a longitudinal study. 
  • Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. 
  • Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. 
  • Extrapyramidal side-effects of antipsychotics in a randomised trial. 
  • Eye Tracking Reveals Abnormal Visual Preference for Geometric Images as an Early Biomarker of an Autism Spectrum Disorder Subtype Associated With Increased Symptom Severity. 
  • Eye movement impairment and schizotypal psychopathology. 
  • Eye tracking impairment in clinically identified patients with schizotypal personality disorder. 
  • Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. 
  • Eye-tracking, attention and amphetamine challenge. 
  • F113. Hippocampal Connectivity Insulates High-Risk Adolescents From the Relationship Between Stress and Depressive Symptoms 
  • F179. Epigenetic Biomarkers in Women With Posttraumatic Stress Disorder After CRF1 Receptor Antagonist Treatment 
  • FACS analysis of neuronal-glial interactions in the nucleus accumbens following morphine administration. 
  • FDA considers classification of ECT. 
  • FINDING THE SITES OF GLUTAMATE CIRCUITRY ABNORMALITY IN SCHIZOPHRENIA WITH PROTON MRS 
  • FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications. 
  • Facets of openness predict mortality in patients with cardiac disease. 
  • Facial expressions and EEG in infants of intrusive and withdrawn mothers with depressive symptoms. 
  • Facial expressions of emotion reveal neuroendocrine and cardiovascular stress responses. 
  • Facial expressions of emotion reveal neuroendocrine and cardiovascular stress responses. 
  • Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness. 
  • Facilitation of Psychiatric Advance Directives by Peers and Clinicians on Assertive Community Treatment Teams. 
  • Factor Structure and Psychometric Properties of the Peritraumatic and Posttraumatic Emotions Questionnaires Among Active Duty Military Personnel With Posttraumatic Stress Disorder. 
  • Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis. 
  • Factorial invariance of posttraumatic stress disorder symptoms across three veteran samples. 
  • Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil. 
  • Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder. 
  • Failure of isocarboxazid and haloperidol to alleviate delusional depression in a pilot study. 
  • Failures in learning-dependent predictive perception as the key cognitive vulnerability to psychosis in schizophrenia. 
  • Familial influence and childhood trauma in female alcoholism. 
  • Familial leukoencephalopathy in bipolar disorder. 
  • Familial psychiatric illness in chronic posttraumatic stress disorder. 
  • Familial schizophrenia and treatment response. 
  • Family history of depression and therapeutic outcome: findings from STAR*D. 
  • Family history of hypertension influences neurobehavioral function in hypertensive patients. 
  • Family history of psychiatric disorder and low self-confidence: predictors of depressive symptoms at 12-month follow-up. 
  • Fast feedback regulation of ACTH by cortisol. 
  • Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. 
  • Fear Learning Circuitry in PTSD is Biased Toward Generalization of Conditioned Response 
  • Fear and anxiety from principle to practice: implications for when to treat youth with anxiety disorders. 
  • Feasibility and effectiveness of cognitive-behavioral therapy for posttraumatic stress disorder in preschool children: two case reports. 
  • Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial. 
  • Feasibility of client reports to measure treatment outcome in schizophrenia. 
  • Feasibility of integrated depression care in an HIV clinic. 
  • Feasibility of nurse-led antidepressant medication management of depression in an HIV clinic in Tanzania. 
  • Feedback to physicians plus telephone care management improved outcomes in primary care patients with depression: Commentary 
  • Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery. 
  • Fetal brain development of twins assessed in utero by ultrasound: implications for schizophrenia. 
  • Fetal brain development of twins assessedIn utero by ultrasound 
  • Field editor communication 
  • Fighting on the side of life: a special issue on suicide in bipolar disorder. 
  • Fink M. Electroconvulsive Therapy 
  • First family-based test for association of neuregulin with bipolar affective disorder. 
  • First- and second-generation antipsychotics. 
  • First-line pharmacotherapy approaches for generalized anxiety disorder 
  • First-line pharmacotherapy approaches for generalized anxiety disorder. 
  • Fish oil, blood vessels, and depression. 
  • Five-year follow-up of the myocaridal ischemia intervention trial: Clinical outcomes and economic analysis 
  • Fixed versus seizure threshold-based dosing of right unilateral ECT. 
  • Flexible dosing schedules for continuation electroconvulsive therapy. 
  • Flexible system criteria in chronic schizophrenia 
  • Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. 
  • Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. 
  • Fluoxetine in post-traumatic stress disorder 
  • Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. 
  • Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder. 
  • Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trial. 
  • Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. 
  • Fluvoxamine in civilians with posttraumatic stress disorder. 
  • Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder. 
  • Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. 
  • Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. 
  • Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder. 
  • Fluxetine, comprehensive cognitive behavioral therapy (CCBT) and placebo in generalized social phobia 
  • Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. 
  • Focal brain dysfunction in a 41-year old man with familial alternating hemiplegia. 
  • Focal brain stimulation with repetitive transcranial magnetic stimulation (rTMS): implications for the neural circuitry of depression. 
  • Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction. 
  • Focal prefrontal seizures induced by bilateral ECT. 
  • Focality of Neural Stimulation with Magnetic Seizure Therapy (MST) and Electroconvulsive Therapy (ECT) in Humans and Non-Human Primates 
  • Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders. 
  • Focus on social anxiety disorder: Introduction 
  • Folates and S-Adenosylmethionine for Major Depressive Disorder 
  • Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. 
  • Foreword. After the tsunami: mental health challenges to the community for today and tomorrow. 
  • Forms of atypical depression and their response to antidepressant drugs. 
  • Four definitions of endogenous depression and the dexamethasone suppression test. 
  • Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. 
  • Frequencies of signs and symptoms in mixed and pure episodes of mania: implications for the study of manic episodes. 
  • Frequency and heritability of depression symptomatology in the second half of life: evidence from Danish twins over 45. 
  • Frequency-Dependent Effects of rTMS on Neurogenesis, Synaptic Plasticity, and Behavior 
  • Freud and the human connectome. 
  • From Good Habit to Bad: Corticostriatal Synaptic and Circuit Mechanisms in Habit and Compulsion 
  • Front line workers' attitudes towards psychiatric advance directives. 
  • Frontal Cortex GABA and Glutamate-Glutamine Levels in Schizophrenia Measured with Magnetic Resonance Spectroscopy 
  • Frontal functioning and plasma HVA in the relatives of schizophrenic patients 
  • Frontiers in TMS technology development: Controllable pulse shape TMS (cTMS) and magnetic seizure therapy (MST) at 100 Hz 
  • Frontomedial electrode placement with low current amplitude: a case report 
  • Frontoparietal attentional network activation differs between smokers and nonsmokers during affective cognition. 
  • Full and partial PTSD among earthquake survivors in rural Taiwan. 
  • Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies. 
  • Functional MRI assessment of atypical and conventional antipsychotic effects on cognitive function in schizophrenia patients 
  • Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity. 
  • Functional brain activation to emotionally valenced faces in school-aged children with a history of preschool-onset major depression. 
  • Functional changes in the activity of brain regions underlying emotion processing in the elderly. 
  • Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. 
  • Functional correlates of military sexual assault in male veterans. 
  • Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing 
  • Functional genetic variants in the vesicular monoamine transporter 1 modulate emotion processing. 
  • Functional hyperdopaminergia in dopamine transporter knock-out mice. 
  • Functional impairment and utilization of services associated with posttraumatic stress in the community. 
  • Functional magnetic resonance imaging guided transcranial magnetic stimulation in obsessive-compulsive disorder. 
  • Functional magnetic resonance imaging of autism spectrum disorders. 
  • Functional neuroimaging of emotionally intense autobiographical memories in post-traumatic stress disorder. 
  • Functional neuroimaging of social and executive processes in individuals with autism 
  • Functional organization of activation patterns in children: whole brain fMRI imaging during three different cognitive tasks. 
  • Functional outcomes and characteristics of olanzapine cognitive super-responders 
  • Functional outcomes in schizophrenia. 
  • Functional status in depressed patients: the relationship to disease severity and disease resolution. 
  • Functioning and interpersonal relationships as predictors of response in treatment-resistant depression. 
  • Funeral mania in recurrent bipolar affective disorders: Reports of three cases 
  • Funeral mania in recurrent bipolar affective disorders: reports of three cases. 
  • Further discussion of EMDR for treatment of PTSD. 
  • Further evidence for a role of the ADRB2 gene in risk for posttraumatic stress disorder. 
  • Further genetic characterization of the fawn-hooded (FH/Wjd) rat, an animal model of comorbid depression and alcoholism. 
  • Further psychometric assessment of the TOP-8: a brief interview-based measure of PTSD. 
  • Further selection of rat lines differing in 5-HT-1A receptor sensitivity: behavioral and functional correlates. 
  • Further studies on platelet serotonin transporter binding in depression. 
  • Future directions in preventing relapse to substance abuse among clients with severe mental illnesses. 
  • Future directions in primary care/mental health research 
  • GABA AND GLUTAMATE DYSFUNCTION IN SCHIZOPHRENIA: DISTINGUISHING MEDICATION EFFECTS FROM NEUROBIOLOGY 
  • GABA AND GLUTAMATE-GLUTAMINE LEVELS IN THE FRONTAL CORTEX IN SCHIZOPHRENIA: A MAGNETIC RESONANCE SPECTROSCOPY STUDY 
  • GENDER AND FAMILY HISTORY (FH) OF CARDIOVASCULAR (CV) DISEASE MODULATE THE EXPRESSION OF CV AND NEUROENDOCRINE (NE) HYPERREACTIVITY TO BEHAVIORAL CHALLENGES AMONG TYPE-A PERSONS 
  • GENOME-WIDE ASSOCIATION STUDY OF ANTIDEPRESSANT RESPONSE: INVOLVEMENT OF THE INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY PATHWAY 
  • GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder. 
  • GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium. 
  • GWAS meta-analysis reveals novel loci and genetic correlates for general cognitive function: a report from the COGENT consortium. 
  • Gabapentin in the treatment of mental illness: the echo chamber of the case series. 
  • Galantamine for treatment-resistant schizophrenia [3] 
  • Gas exchange and exercise capacity affect neurocognitive performance in patients with lung disease. 
  • Gender difference in cocaine-induced HPA axis activation. 
  • Gender differences in antidepressant and activating drug effects on self-perceptions. 
  • Gender differences in associations between DSM-5 posttraumatic stress disorder symptom clusters and functional impairment in war veterans. 
  • Gender differences in blood pressure control during a variety of behavioral stressors. 
  • Gender differences in hepatitis C infection and risks among persons with severe mental illness. 
  • Gender differences in posttraumatic stress symptoms among OEF/OIF veterans: an item response theory analysis. 
  • Gender differences in risk factors for transition from mild cognitive impairment to Alzheimer's disease: A CREDOS study. 
  • Gender, concurrent estrogen use and cognition in Alzheimer's disease 
  • Gender, hostility & lymphocyte CD62L 
  • Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. 
  • Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications. 
  • Gene-environment interaction research in psychiatric epidemiology: a framework and implications for study design. 
  • Gene-environment interactions in psychiatry: joining forces with neuroscience. 
  • General and specific cognitive deficits in bipolar depression: the Brief Assessment of Cognition in Affective Disorders (BAC-A) 
  • General aspects of the history of psychiatry 
  • General medical and specialty mental health service use for major depression. 
  • General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. 
  • General practice encounters for psychological problems in rural, remote and metropolitan areas in Australia. 
  • Generalizability of Pharmacologic and Psychotherapy Clinical Trial Results for Posttraumatic Stress Disorder to Community Samples. 
  • Generalized Enhancement of Episodic Memory by Prior Reward Experience 
  • Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. 
  • Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32. 
  • Generalized anxiety disorder and panic disorder in the elderly: a review. 
  • Generalized anxiety disorder: acute and chronic treatment. 
  • Generalized anxiety disorder: nature and course. 
  • Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. 
  • Generalized social anxiety disorder and avoidant personality disorder: structural analysis and treatment outcome. 
  • Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1. 
  • Genetic Heterogeneity in Depressive Symptoms Following the Death of a Spouse: Polygenic Score Analysis of the U.S. Health and Retirement Study. 
  • Genetic Moderation of Stress Effects on Corticolimbic Circuitry. 
  • Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. 
  • Genetic and hormonal sensitivity to threat: testing a serotonin transporter genotype × testosterone interaction. 
  • Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. 
  • Genetic approaches to studying norepinephrine function: knockout of the mouse norepinephrine transporter gene. 
  • Genetic association study of individual symptoms in depression. 
  • Genetic correlates of insight in schizophrenia. 
  • Genetic polymorphisms in the dopamine system predict heterogeneity in intelligence and adult prognosis among children with attention-deficit hyperactivity disorder: Evidence from two birth cohorts 
  • Genetic propensities to increase ethanol intake in response to stress: studies with selectively bred swim test susceptible (SUS), alcohol-preferring (P), and non-preferring (NP) lines of rats. 
  • Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. 
  • Genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and risk for treated depression after cancer diagnosis. 
  • Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families. 
  • Genetic variants within key nodes of the cascade of antipsychotic mechanisms: effects on treatment response and schizophrenia psychopathology 
  • Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. 
  • Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. 
  • Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. 
  • Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. 
  • Genetic vulnerability to affective psychopathology in childhood: a combined voxel-based morphometry and functional magnetic resonance imaging study. 
  • Genetics and the future of clinical psychiatry. 
  • Genetics of the human circadian clock and sleep homeostat. 
  • Geniculocalcarine hyperintensities on brain magnetic resonance imaging associated with visual hallucinations in the elderly. 
  • Genome-Wide Association of Neuroimaging Phenotypes in PTSD at Multiple Sites 
  • Genome-scale technologies foster advances in neurological and behavioral research 
  • Genome-wide DNA methylation profiling in monozygotic twins discordant for psychotic symptoms at age 12 
  • Genome-wide association study identifies a novel locus for cannabis dependence. 
  • Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway. 
  • Genome-wide association study of bipolar I disorder in the Han Chinese population. 
  • Genome-wide association study of obsessive-compulsive disorder. 
  • Genome-wide association study of posttraumatic stress disorder in a cohort of Iraq-Afghanistan era veterans. 
  • Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. 
  • Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium 
  • Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. 
  • Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. 
  • Genomic Approaches to Posttraumatic Stress Disorder: The Psychiatric Genomic Consortium Initiative. 
  • Genomic and molecular characterization of alzheimer disease 
  • Genomic expression in the epileptogenic hippocampus and psychiatric co-morbidities 
  • Genomic screen for Autistic Disorder. 
  • Genotypic Differences in Angiotensin Receptor Genes in Late-Life Depression 
  • Geriatric Psychiatry 
  • Geriatric Psychiatry. 
  • Geriatric depression and cognitive impairment. 
  • Geriatric depression: Further evidence for the 'vascular depression' hypothesis 
  • Geriatric psychiatry matures: Advantages and problems as the psychiatry of old age grows older 
  • Geriatric syndromes: An introduction 
  • Gestational and postnatal tobacco smoke exposure as predictor of ADHD, comorbid ODD/CD, and treatment response in the MTA 
  • Gestational dexamethasone treatment elicits sex-dependent alterations in locomotor activity, reward-based memory and hippocampal cholinergic function in adolescent and adult rats. 
  • Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse. 
  • Global Mental Health: Five Areas for Value-Driven Training Innovation. 
  • Glutamatergic dysfunction in OCD. 
  • Good news in the battle against military suicide. 
  • Graph Theoretical Analysis of Peritreatment Resting EEG in Depressed Patients Receiving Electroconvulsive Therapy and Magnetic Seizure Therapy 
  • Gray and white matter brain chemistry in young children with autism. 
  • Greater MRI lesion volumes in elderly depressed subjects than in control subjects. 
  • Group cognitive processing therapy delivered to veterans via telehealth: a pilot cohort. 
  • Group problem-solving skills training for self-harm: randomised controlled trial. 
  • Growth hormone-releasing factor stimulation test in depression. 
  • Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. 
  • Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus. 
  • Guideline series commentary [4] (multiple letters) 
  • Guideline-concordant antidepressant use among patients with major depressive disorder. 
  • Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic. 
  • Guidelines for treatment of PTSD. 
  • Guidelines on nicotine dose selection for in vivo research. 
  • Guns, Mental Illness, and the Law: Introduction to This Issue. 
  • HIGH SCORES ON THE COOK AND MEDLEY HOSTILITY (HO) SCALE PREDICT INCREASED CARDIOVASCULAR-RESPONSES TO HARASSMENT 
  • HIGH WORK DEMANDS AND DEPRESSION: THE MODERATING ROLE OF THE SEROTONIN TRANSPORTER GENE (5-HTT) AND WORK CONTROL 
  • HOSTILITY IS ASSOCIATED WITH LYMPHOCYTE BETA2 ADRENERGIC-RECEPTOR ADENYLATE-CYCLASE ACTIVITY 
  • HOT GENES IN SCHIZOPHRENIA: CASE-CONTROL, PHARMACOGENETICS AND EXPLORATORY ANALYSES IN TWO INDEPENDENT SAMPLES 
  • Haase hermeneutics, or, the exegesis of the neuroleptic threshold. 
  • Habit formation and the loss of control of an internal clock: inverse relationship between the level of baseline training and the clock-speed enhancing effects of methamphetamine. 
  • Habitual anger-coping styles: I. Effect on mean blood pressure and risk for essential hypertension. 
  • Haloperidol increases smoking in patients with schizophrenia. 
  • Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes. 
  • Handbook of Clinical Child Neuropsychology, 3rd ed 
  • Handbook of Spirituality and Worldview in Clinical Practice 
  • Handbook of the Sociology of Mental Health 
  • Harnessing the microbiota to treat neurological diseases 
  • Hazardous alcohol use and receipt of risk-reduction counseling among U.S. veterans of the wars in Iraq and Afghanistan. 
  • Head computed tomography interpretation in trauma: a primer. 
  • Head injury and combat-related posttraumatic stress disorder. 
  • Head injury in early adulthood and the lifetime risk of depression. 
  • Health care infrastructure post-Katrina: disaster planning to return health care workers to their home communities. 
  • Health reform in the private sector: initiatives of the American Managed Behavioral Healthcare Association. 
  • Health status, somatization, and severity of posttraumatic stress disorder in Vietnam combat veterans with posttraumatic stress disorder. 
  • Healthcare barriers among severely mentally ill homeless adults: evidence from the five-site health and risk study. 
  • Hearing Loss: The Silent Risk for Psychiatric Disorders in Late Life. 
  • Hearing loss and psychiatric disorders: a review. 
  • Heart rate turbulence, depression, and survival after acute myocardial infarction. 
  • Heat-shock protein-70 genes and response to antidepressants in major depression. 
  • Heightened connectivity between the ventral striatum and medial prefrontal cortex as a biomarker for stress-related psychopathology: understanding interactive effects of early and more recent stress. 
  • Hematocrit and anxiety 
  • Hemodynamic mechanisms of mental stress-induced ischemia 
  • Henri Begleiter, 1935-2006. 
  • Hepatitis C and depressive symptoms: psychological and social factors matter more than liver injury. 
  • Herbal remedies in psychiatric practice. 
  • Heritability of functioning in families with schizophrenia in relation to neurocognition. 
  • Heterogeneity in the response pattern of organ systems to stress: Mediators and mechanisms 
  • Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications. 
  • Heterogeneity of tardive dyskinesia. A multivariate analysis 
  • Heterogeneity of tardive dyskinesia. A multivariate analysis. 
  • Hierarchical temporal processing deficit model of reality distortion and psychoses. 
  • High dose magnetic seizure therapy (HD-MST) increases mossy fiber sprouting but not cellular proliferation in the primate dentate gyrus 
  • High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. 
  • High users of outpatient mental health services, I: Definition and characteristics. 
  • High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. 
  • High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. 
  • High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. 
  • High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. 
  • High-frequency prefrontal repetitive transcranial magnetic stimulation for the negative symptoms of schizophrenia: a case series. 
  • High-frequency repetitive TMS for suicidal ideation in adolescents with depression. 
  • Higher levels of CSF homovanillic acid in recently abstinent cocaine-dependent patients. 
  • Hippocampal abnormalities in depression. 
  • Hippocampal and Insular Response to Smoking-Related Environments: Neuroimaging Evidence for Drug-Context Effects in Nicotine Dependence. 
  • Hippocampal and striatal gray matter volume are associated with a smoking cessation treatment outcome: results of an exploratory voxel-based morphometric analysis. 
  • Hippocampal volume in adolescent-onset alcohol use disorders. 
  • Hippocampal volume in geriatric depression. 
  • Hippocampal volumes and depression subtypes. 
  • Hispanic ethnicity, language, and depression: physician-patient communication and patient use of alternative treatments. 
  • History of depression and survival after acute myocardial infarction. 
  • History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study. 
  • History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia. 
  • History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release. 
  • Homeopathic and psychiatric perspectives on grief. 
  • Homeopathic treatments in psychiatry: a systematic review of randomized placebo-controlled studies. 
  • Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naive Patients with Schizophrenia 
  • Homoclites revisited: the search for identification in hospitalized young adult patients. 
  • Hospital stressors experienced by elderly medical inpatients: developing a Hospital Stress Index. 
  • Hospitalized schizophrenic patient views about seclusion. 
  • Hostility and adrenergic receptor responsiveness: evidence of reduced beta-receptor responsiveness in high hostile men. 
  • Hostility and fasting glucose in African American women. 
  • Hostility and functional health status in women veterans with and without posttraumatic stress disorder: a preliminary study. 
  • Hostility and heart disease: Williams et al. (1980). 
  • Hostility and minimal model of glucose kinetics in African American women. 
  • Hostility and platelet reactivity in individuals without a history of cardiovascular disease events. 
  • Hostility and risk for disease 
  • Hostility as a predictor of survival in patients with coronary artery disease. 
  • Hostility is related to blunted beta-adrenergic receptor responsiveness among middle-aged women. 
  • Hostility, CHD incidence, and total mortality: a 25-year follow-up study of 255 physicians. 
  • Hostility, coronary risk and Alpha-adrenergic to Beta-adrenergic receptor density ratio 
  • Hostility, coronary risk, and alpha-adrenergic to beta-adrenergic receptor density ratio - Response 
  • Hostility, coronary risk, and alpha-adrenergic to beta-adrenergic receptor density ratio. 
  • Hostility, social support, and adrenergic receptor responsiveness among African-American and white men and women. 
  • Hot genes in schizophrenia: case-control, pharmacogenetics and exploratory analyses in two independent samples 
  • Hot genes in schizophrenia: case-control, pharmacogenetics and exploratory analyses in two independent samples 
  • Household responsibilities, income, and ambulatory blood pressure among working men and women. 
  • How Does Electroconvulsive Therapy Work? 
  • How Healthy Are We?: A National Study of Well-being at Midlife. Edited by O. G. Brim, C. D. Ryff and R. C. Kessler. (Pp. 687; $42.00; ISBN 0-226-07475-7.) University of Chicago Press: Chicago. 2003. 
  • How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. 
  • How competent are non-specialists trained to integrate mental health services in primary care? Global health perspectives from Uganda, Liberia, and Nepal. 
  • How do mental health courts work? 
  • How does deep brain stimulation work? 
  • How etiological explanations for depression impact perceptions of stigma, treatment effectiveness, and controllability of depression. 
  • How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality? 
  • How is acceptance of the brain disease model of addiction related to Australians' attitudes towards addicted individuals and treatments for addiction? 
  • How is recovery from social anxiety disorder defined?: Comments 
  • How kids are different: Child and adolescent services under managed care 
  • How mental health providers see managed care. 
  • How much haldol D does Larry really need? [5] 
  • How primary care physicians treat psychiatric disorders: a national survey of family practitioners. 
  • How reviews covered the unfolding scientific story of gabapentin for bipolar disorder. 
  • How should DSM-V criteria for schizophrenia include cognitive impairment? 
  • How should we construct psychiatric family history scores? A comparison of alternative approaches from the Dunedin Family Health History Study. 
  • How should we implement psychiatric advance directives? Views of consumers, caregivers, mental health providers and researchers. 
  • How should we teach psychopharmacology to residents? Results of the initial experience with the ASCP model curriculum 
  • How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS. 
  • How the circadian rhythm affects sleep, wakefulness, and overall health: background for understanding shift work disorder. 
  • How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. 
  • How well does cognitive-behavioral therapy treat symptoms of complex PTSD? An examination of child sexual abuse survivors within a clinical trial. 
  • Human choline transporter gene variation is associated with corticolimbic reactivity and autonomic-cholinergic function. 
  • Human plasma beta-endorphin through the menstrual cycle 
  • Human resource issues in rural mental health services. 
  • Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. 
  • Huntington's disease and behavioral dyscontrol. 
  • Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. 
  • Hypercortisolemia and hippocampal changes in depression. 
  • Hypercortisolism associated with social subordinance or social isolation among wild baboons. 
  • Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial. 
  • Hyperhidrosis in social anxiety disorder. 
  • Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review. 
  • Hyperintense lesions on magnetic resonance images in bipolar disorder. 
  • Hypertension affects neurobehavioral functioning. 
  • Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA. 
  • Hypocholesterolemia during mixed manic episodes. 
  • Hypochondriacal patients' beliefs about good health. 
  • Hypoglycemia: the standard and the fiction. 
  • Hypogyrification and its association with cognitive impairment in children with 22q11.2 deletion Syndrome: A preliminary report. 
  • Hypomania following withdrawal of trazodone. 
  • Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis. 
  • Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis. 
  • Hypothalamic-pituitary-adrenal axis genetic variation and early stress moderates amygdala function. 
  • Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. 
  • Hysterectomy and loss of fertility: implications for women's mental health. 
  • Hysterical psychosis and epilepsy: differential diagnosis. 
  • ICD-11 and operationalism: response. 
  • IMPACT OF A SINGLE NUCLEOTIDE POLYMORPHISM IN SIGMAR1 ON MAJOR DEPRESSION, BIPOLAR DISORDER AND TREATMENT RESPONSE 
  • INCREASED DEPRESSION AND ANXIETY ARE ASSOCIATED WITH LOWER LIPIDS 
  • IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness. 
  • IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs. 
  • Ictal EEG Correlates of Neurocognitive Outcome in Electroconvulsive Therapy and Magnetic Seizure Therapy 
  • Identification of borderline personality disorder with the NIMH Diagnostic Interview Schedule. 
  • Identification of patients with recent-onset psychosis in KwaZulu Natal, South Africa: a pilot study with traditional health practitioners and diagnostic instruments. 
  • Identifying and Referring Youths at Risk for Suicide Following Participation in School-Based Gatekeeper Training. 
  • Identifying clinical competencies that support rehabilitation and empowerment in individuals with severe mental illness. 
  • Identifying core curricular components for behavioral health training in internal medicine residency: Qualitative interviews with residents, faculty, and behavioral health clinicians. 
  • Identifying depressed older adults in primary care: a secondary analysis of a multisite randomized controlled trial. 
  • Identifying depression in primary care: a literature synthesis of case-finding instruments. 
  • Identifying depression in the first postpartum year: guidelines for office-based screening and referral. 
  • Identifying illness: pitfalls and discoveries. 
  • Identifying patterns of symptom change during a randomized controlled trial of cognitive processing therapy for military-related posttraumatic stress disorder. 
  • Identifying physicians most likely to benefit from depression education 
  • Ileus complicating haloperidol therapy 
  • Illness behavior as a predictor of pain and overt behavior patterns in chronic low back pain patients. 
  • Images in neuroscience. A mouse knockout. 
  • Images in neuroscience. Molecular biology, II. A dopamine transporter mouse knockout. 
  • Images in psychiatry 
  • Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential. 
  • Imaging and genetics advances in understanding geriatric depression. 
  • Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. 
  • Imaging genetics offers new predictive markers of individual differences in behavior and risk for psychiatric diseases 
  • Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. 
  • Imaging in acquired immune deficiency syndrome dementia complex (AIDS dementia complex): a review. 
  • Immigrant youth face barriers accessing mental health services in outpatient settings 
  • Impact of Early Intervention on Psychopathology, Crime, and Well-Being at Age 25 
  • Impact of Narrative Expressive Writing on Heart Rate, Heart Rate Variability, and Blood Pressure After Marital Separation. 
  • Impact of Racial Discrimination and Hostility on Adrenergic Receptor Responsiveness in African American Adults. 
  • Impact of an Alcohol Withdrawal Treatment Pathway on Hospital Length of Stay: A Retrospective Observational Study Comparing Pre and Post Pathway Implementation. 
  • Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial. 
  • Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. 
  • Impact of bereavement on progression of AIDS and HIV infection: A review (Psychosomatics (2009) 50, (433-439)) 
  • Impact of bereavement on progression of AIDS and HIV infection: a review. 
  • Impact of depressive symptoms on the treatment of generalized social anxiety disorder. 
  • Impact of early intervention on psychopathology, crime, and well-being at age 25. 
  • Impact of generalized social anxiety disorder in managed care. 
  • Impact of late-life depression on the social network. 
  • Impact of neuroleptic medications on continuous performance test measures in schizophrenia. 
  • Impact of outpatient commitment on victimization of people with severe mental illness. 
  • Impact of patients' psychiatric hospitalization on caregivers: a systematic review. 
  • Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS). 
  • Impact of psychological stress on the associations between apolipoprotein E variants and metabolic traits: findings in an American sample of caregivers and controls. 
  • Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia. 
  • Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates. 
  • Impact of sleep complaints and depression outcomes among participants in the standard medical intervention and long-term exercise study of exercise and pharmacotherapy for depression. 
  • Impact of sleep quality on amygdala reactivity, negative affect, and perceived stress. 
  • Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. 
  • Impacting late life depression: integrating a depression intervention into primary care. 
  • Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder. 
  • Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia. 
  • Impaired modulation of attention and emotion in schizophrenia. 
  • Impaired plasmalogens in patients with schizophrenia. 
  • Implementation considerations for multisite clinical trials with cognitive neuroscience tasks. 
  • Implementation of multifamily group treatment for veterans with traumatic brain injury. 
  • Implementing Integrated Mental Health and Chaplain Care in a National Quality Improvement Initiative. 
  • Implementing a disease management intervention for depression in primary care: a random work sampling study. 
  • Implementing evidence-based practices for persons with severe mental illnesses. 
  • Implications of health care reform for rural mental health services 
  • Importance of delta opioid receptors in maintaining high alcohol drinking 
  • Improved attention is associated with reductions in frontal lobe lactate levels in first episode psychosis 
  • Improvement in Depression Ratings after the First Electroconvulsive Therapy (ECT): Preliminary Data from Phase I of the PRIDE Study 
  • Improvement of anger at one week predicts the effects of sertraline and placebo in PTSD. 
  • Improving care for late-life depression: Results from a randomized controlled trial with 1,801 depressed older adults (presented in cooperation with the IMPACT Project Investigators) 
  • Improving depression outcomes in older adults with comorbid medical illness. 
  • Improving detection and treatment of mental disorders in community settings: development, validation and evaluation of community informant detection tool in Nepal 
  • Improving mental health and substance abuse services for adolescents 
  • Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. 
  • Improving understanding of research consent disclosures among persons with mental illness 
  • Impulse-control disorders in Parkinson's disease. 
  • Impulsivity, Apathy, and Executive Dysfunction in a Patient With Multiple Potential Etiologies 
  • In Reply 
  • In Reply 
  • In rape trauma PTSD, patient characteristics indicate which trauma-focused treatment they are most likely to complete. 
  • In reply [4] 
  • In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients. 
  • In vivo quantitation of basal ganglia and thalamic degenerative changes in two temporal lobectomy patients with affective disorder. 
  • Incidence of mental health hospitalizations, treated self-harm, and emergency room visits following new anxiety disorder diagnoses in privately insured U.S. children. 
  • Incident stressful and traumatic life events and human immunodeficiency virus sexual transmission risk behaviors in a longitudinal, multisite cohort study. 
  • Income and Employment of People Living With Combined HIV/AIDS, Chronic Mental Illness, and Substance Abuse Disorders 
  • Income inequality and depression: a systematic review and meta-analysis of the association and a scoping review of mechanisms. 
  • Increase in untreated cases of psychiatric disorders during the transition to adulthood. 
  • Increased Activation in Precuneus and Parahippocampus When Smokers View Tobacco Retail Outlets: Results of a GPS plus fMRI 'Community Neuroscience' Study 
  • Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation Outcomes. 
  • Increased Metabotropic Glutamate Receptor 5 Signaling Underlies Obsessive-Compulsive Disorder-like Behavioral and Striatal Circuit Abnormalities in Mice. 
  • Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. 
  • Increased health burden associated with comorbid depression in older Brazilians with diabetes. 
  • Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. 
  • Increased perception of post-ischemic paresthesias in depressed subjects. 
  • Increased pituitary volume in ...psychosis study. 
  • Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. 
  • Increasing Access to State Psychiatric Hospital Beds: Exploring Supply-Side Solutions. 
  • Increasing memory load modulates regional brain activity in older adults as measured by fMRI. 
  • Increasing sensitivity of early detection of psychosis with cognitive measures 
  • Incubating the research independence of a medical scientist training program graduate: a case study. 
  • Independent research by early investigators: an underutilized option. 
  • Indigenous perspectives on depression in rural regions of India and the United States. 
  • Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. 
  • Individual differences in the diurnal cycle of cortisol. 
  • Individual differences in typical reappraisal use predict amygdala and prefrontal responses. 
  • Individualized Low Amplitude Seizure Therapy (iLAST) - Magnetic and Electric Approaches to Enhance Focality and Safety for Depression Treatment 
  • Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy. 
  • Infection, the caudate, and movement disorder. 
  • Inferential statistical methods for strengthening the interpretation of laboratory test results. 
  • Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study. 
  • Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. 
  • Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. 
  • Influence of Criminal Justice Involvement and Psychiatric Diagnoses on Treatment Costs Among Adults With Serious Mental Illness. 
  • Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder. 
  • Influence of L-triiodothyronine on memory following repeated electroconvulsive shock in rats: implications for human electroconvulsive therapy. 
  • Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. 
  • Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. 
  • Influence of gender on the clinical presentation of generalized anxiety disorder, and response to treatment with Pregabalin 
  • Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression. 
  • Information processing for decision making in depressed women. A study of subjective expected utilities. 
  • Information-processing markers of vulnerability to schizophrenia: Performance of patients with schizotypal and nonschizotypal personality disorders 
  • Informed Consent for Electroconvulsive Therapy--Finding Balance. 
  • Informed consent for research in Borderline Personality Disorder. 
  • Informed use of the dexamethasone suppression test. 
  • Informing Federal Policy on Firearm Restrictions for Veterans with Fiduciaries: Risk Indicators in the Post-Deployment Mental Health Study. 
  • Inhibition of GH in maternal separation may be mediated through altered serotonergic activity at 5-HT2A and 5-HT2C receptors. 
  • Inhibition of phenylethanolamine-N-methyltransferase and brain-stimulated reward. 
  • Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine. 
  • Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. 
  • Initial results, reliability, and validity of a mental health survey of Mount Pinatubo disaster victims. 
  • Initial treatment decisions by level of care for youth in the CHAMPUS Tidewater Demonstration 
  • Inpatient and outpatient patterns of psychotropic drug prescribing by nonpsychiatrist physicians. 
  • Insight and the clinical outcome of schizophrenic patients 
  • Insight and treatment outcome in obsessive-compulsive disorder. 
  • Insight in first-episode psychosis. 
  • Insight in schizophrenia and mania. 
  • Insight in schizophrenia. Its relationship to acute psychopathology 
  • Insight is greater in mixed than in pure manic episodes of bipolar I disorder. 
  • Insights into the Roles of the Methyl-DNA Binding Protein MeCP2 in Addictive-like Behaviors 
  • Insomnia and heart disease: a review of epidemiologic studies. 
  • Insomnia is frequent in schizophrenia and associated with night eating and obesity. 
  • Insomnia: A health care (gap that is growing) 
  • Institutional rearing and psychiatric disorders in Romanian preschool children. 
  • Integrated Medicine and Psychiatry Curriculum for Psychiatry Residency Training: a Model Designed to Meet Growing Mental Health Workforce Needs. 
  • Integrated genetic and genomic approach in the SingaporeTranslational and Clinical Research in Psychosis Study: an overview. 
  • Integrated medical care in a mental health clinic improved quality of care and outcomes in serious mental disorders: Commentary 
  • Integrating therapies for anxiety disorders 
  • Intellectual, neurocognitive, and academic achievement in abstinent adolescents with cannabis use disorder. 
  • Interaction between Antidepressants and Perphenazine in Psychiatric Inpatients 
  • Interaction between mother's and father's affection as a risk factor for anxiety and depression symptoms--evidence for increased risk in adults who rate their father as having been more affectionate than their mother. 
  • Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. 
  • Interaction of oxytocin level and past depression may predict postpartum depressive symptom severity. 
  • Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions. 
  • Interactive associations of depression and sleep apnea with adverse clinical outcomes after acute myocardial infarction. 
  • Interest among veterans in spiritually-oriented therapy for inner conflict/moral injury in the setting of PTSD. 
  • Interference by carbamazepine with the dexamethasone suppression test. 
  • Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. 
  • Internal consistency, test-retest reliability, and predictive validity for a Likert-based version of the Sources of occupational stress-14 (SOOS-14) scale. 
  • Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder. 
  • International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. 
  • International advances in the treatment of social phobia. 
  • International consensus statement on major depressive disorder. 
  • International prescribing patterns for mood illness: the International Mood Network (IMN). 
  • Internet-delivered computerized cognitive & affective remediation training for the treatment of acute and chronic posttraumatic stress disorder: Two randomized clinical trials 
  • Interpersonal and self-reported hostility among combat veterans with and without posttraumatic stress disorder. 
  • Interpersonal trauma and posttraumatic stress disorder in patients with severe mental illness: demographic, clinical, and health correlates. 
  • Interpersonal trauma, war zone exposure, and posttraumatic stress disorder among veterans with schizophrenia. 
  • Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia. 
  • Interventions for suicidal youth: a review of the literature and developmental considerations. 
  • Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 
  • Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms. 
  • Intimate partner violence and new-onset depression: a longitudinal study of women's childhood and adult histories of abuse. 
  • Intimate relationships among returning soldiers: the mediating and moderating roles of negative emotionality, PTSD symptoms, and alcohol problems. 
  • Intracranial and extracranial blood flow during acute anxiety. 
  • Intracranial reward after Lilly 110140 (fluoxetine HCl): evidence for an inhibitory role for serotonin. 
  • Intractable seizures, compulsions, and coprolalia: a pediatric case study. 
  • Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series. 
  • Introduction to the CATIE special section. 
  • Introduction to the special section on CATIE baseline data: practical clinical trials in psychiatry: studies of schizophrenia from the CATIE network. 
  • Introduction to the special section on assisted outpatient treatment in New York State. 
  • Introduction. Social phobia in review: 1993 
  • Introduction: An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study 
  • Introduction: Definitions, measurements, and management in insomnia. 
  • Investigating patterns of neural response associated with childhood abuse v. childhood neglect 
  • Investigation of potential gene-gene interactions between APOE and RELN contributing to autism risk. 
  • Involuntary Outpatient Commitment and the Elusive Pursuit of Violence Prevention. 
  • Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness. 
  • Involuntary outpatient commitment and homelessness in persons with severe mental illness. 
  • Involuntary outpatient commitment, community treatment orders, and assisted outpatient treatment: what's in the data? 
  • Iowa Discriminant Index for endogenous depression: family history correlates. 
  • Ipsilateral subcortical atrophy associated with temporal lobectomy. 
  • Irreducible Mind: Toward a Psychology for the 21st Century 
  • Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study. 
  • Is Cumulative Exposure to Suicide Attempts and Deaths a Risk Factor for Suicidal Behavior Among Firefighters? A Preliminary Study. 
  • Is cognitive improvement with antipsychotic treatment pseudospecific? 
  • Is depression a disorder of electrical brain networks? 
  • Is depression associated with immune activation? 
  • Is depression associated with microvascular disease in patients with type 2 diabetes? 
  • Is domestic violence followed by an increased risk of psychiatric disorders among women but not among men? A longitudinal cohort study. 
  • Is mifepristone useful in psychotic depression? 
  • Is military sexual trauma associated with trading sex among women veterans seeking outpatient mental health care? 
  • Is obstructive sleep apnea associated with ADHD? 
  • Is the idle mind a Devil's workshop? 
  • Is there a definition of remission in late-life depression that predicts later relapse? 
  • Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. 
  • Is treatment for alcoholism effective in persons on methadone maintenance? 
  • Ischemic but not thermal pain sensitivity varies across the menstrual cycle. 
  • Isocarboxazid. Efficacy and tolerance. 
  • Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. 
  • Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. 
  • Issues in the treatment of major depression: Selection, efficacy, and safety 
  • It is time to take a stand for medical research and against terrorism targeting medical scientists. 
  • JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. 
  • Jhum-jhum: Depression, somatization and comorbidity in Nepal 
  • John Henryism and the health of African-Americans. 
  • John Henryism, Gender and Self-Reported among Roma/Gypsies in Serbia 
  • John Henryism, Gender and Self-reported Health Among Roma/Gypsies in Serbia. 
  • Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. 
  • Julia Rush's diary: coping with loss in the early nineteenth century. 
  • Juvenile Justice Anger Management (JJAM) Treatment for Girls: Results of a randomized controlled trial. 
  • Juvenile mental health histories of adults with anxiety disorders. 
  • Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials. 
  • Kava in generalized anxiety disorder: three placebo-controlled trials. 
  • Ketamine ("Ketalar"): a safer anaesthetic for ECT. 
  • Key lessons learned from the INDIGO global network on mental health related stigma and discrimination. 
  • Key updates in the clinical application of electroconvulsive therapy. 
  • Knowledge and attitudes about depression among non-generalists and generalists. 
  • Kraepelinian schizophrenia: A replication in an independent sample 
  • L-dopa challenge and relapse in schizophrenia. 
  • L-methylfolate as adjunctive therapy for SSRI-resistant major depression: Results of two randomized, double-blind,,parallel-sequential trials 
  • L-serine predicts self-reported pain in female OEF/OIF veterans 
  • LONGITUDINAL SUBSTANCE USE TRAJECTORIES FOR PERSONS WITH SCHIZOPHRENIA 
  • Laboratory and clinical tests of spatial working memory 
  • Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study. 
  • Lack of association between autism and SLC25A12. 
  • Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18F]fallypride PET. 
  • Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. 
  • Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias 
  • Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. 
  • Lack of influence of rs4680 (COMT) and rs6276 (DRD2) on diagnosis and clinical outcomes in patients with major depression. 
  • Lack of relapse with tryptophan depletion following successful treatment with ECT. 
  • Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. 
  • Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability. 
  • Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity. 
  • Late luteal phase dysphoric disorder. 
  • Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25. 
  • Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. 
  • Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction. 
  • Latent class analysis of discordance between results of drug use assessments in the CATIE data. 
  • Latent class analysis of the feared situations of social anxiety disorder: A population-based study 
  • Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). 
  • Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). 
  • Latent subtypes of depression in a community sample of older adults: can depression clusters predict future depression trajectories? 
  • Lateralization of auditory sensory gating and neuropsychological dysfunction in schizophrenia. 
  • Lateralized Effects of Prefrontal Transcranial Magnetic Stimulation on Emotional Working Memory 
  • Law & psychiatry: Gun laws and mental illness: how sensible are the current restrictions? 
  • Law Enforcement and Clinician Partnerships: Training of Trainers for CIT Teams in Liberia, West Africa. 
  • Leading indicators of community-based violent events among adults with mental illness. 
  • Learning and memory in combat veterans with posttraumatic stress disorder. 
  • Learning and recall in subjects at genetic risk for Alzheimer's disease. 
  • Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder. 
  • Left orbital frontal cortex volume and performance on the benton visual retention test in older depressives and controls. 
  • Leighton's theory of sentiments: explorations and speculations on barriers to interpersonal forgiveness. 
  • Lessons for ICD-11 coming after DSM-5. 
  • Lessons from SADHART, ENRICHD, and other trials. 
  • Letter to the Editor: Posttraumatic stress disorder has genetic overlap with cardiometabolic traits. 
  • Letter to the editor: Critique of Bahorik et al. (2013)--'Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors'. 
  • Letters to the editors 
  • Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation. 
  • Leukoencephalopathy and depression. 
  • Leukoencephalopathy in elderly depressed patients referred for ECT. 
  • Leukoencephalopathy in patients diagnosed as major depressive. 
  • Levels of Serum Brain-Derived Neurotrophic Factor in Schizophrenia. 
  • Levels of serum brain-derived neurotropic factor in individuals at ultra-high risk for psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS). 
  • Levels of urinary free cortisol in social phobia. 
  • Levetiracetam in social phobia: a placebo controlled pilot study. 
  • Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity. 
  • Lid retraction test. 
  • Life Span Studies of ADHD-Conceptual Challenges and Predictors of Persistence and Outcome. 
  • Life events and post-traumatic stress: the development of a new measure for children and adolescents. 
  • Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment. 
  • Lifetime Trauma and Depressive Symptoms Predict Mortality in HIV 
  • Lifetime and current prevalence of specific psychiatric disorders among Vietnam veterans and controls. 
  • Lifetime comorbidity, lifetime history of psychosis and suicide attempts, and current symptoms of patients with deteriorated affective disorder. 
  • Lifetime major depression and comorbid disorders among current-era women veterans. 
  • Lifetime perturbations of bipolar disorder. 
  • Lifetime trauma exposure among those with combat-related PTSD: Psychiatric risk among U.S. military personnel. 
  • Lifetime trauma exposure in veterans with military-related posttraumatic stress disorder: association with current symptomatology. 
  • Lifetime use of mental health and substance abuse treatment services by incarcerated women felons. 
  • Limbic system-adrenal cortex regulation in depression and schizophrenia. 
  • Limitations of computerized adaptive testing for anxiety. 
  • Linkage analysis of schizophrenia in African-American families. 
  • Linking physical and mental health: Comparing users and non-users of mental health services in medical care utilization 
  • Lisdexamfetamine Dimesylate Augmentation Effects on Executive Function in Major Depressive Disorder Based on Level of Executive Function Impairment 
  • Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. 
  • Lithium Toxicity after Roux-en-Y Gastric Bypass is Not Just Limited to Perioperative Period. 
  • Lithium treatment and mechanisms of aging. 
  • Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: A randomized comparative effectiveness trial of optimized personalized treatment with and without lithium 
  • Lithium-induced nephrotic syndrome. 
  • Lithium-induced renal ectasia. 
  • Lobar distribution of lesion volumes in late-life depression: the Biomedical Informatics Research Network (BIRN). 
  • Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. 
  • Localization of age-associated white matter hyperintensities in late-life depression. 
  • Locus of Control and Symptoms of Psychological Distress Among Chinese﷓Americans. 
  • Locus of control and vasomotor response to sensory processing. 
  • Logistical and Methodological Challenges in Conducting a Mental Health Survey of Mount Pinatubo Disaster Victims 
  • Loneliness in young adulthood: Findings from an epidemiological cohort study 
  • Lonely young adults in modern Britain: findings from an epidemiological cohort study. 
  • Long-acting risperidone vs. placebo in the treatment of hospital inpatients with schizophrenia. 
  • Long-term (2-year) effectiveness of collaborative care for late-life depression 
  • Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD. 
  • Long-term course of substance use disorders among patients with severe mental illness. 
  • Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits? 
  • Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. 
  • Long-term issues in the treatment of sleep disorders 
  • Long-term issues in the treatment of sleep disorders. 
  • Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis. 
  • Long-term outcome of major psychoses. I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. 
  • Long-term psychosocial effects of childhood exposure to parental problem drinking. 
  • Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. 
  • Long-term treatment and prevention of posttraumatic stress disorder. 
  • Long-term treatment gains of a brief exposure-based treatment for PTSD. 
  • Long-term treatment of social phobia with clonazepam. 
  • Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. 
  • Longitudinal classification in schizophrenia: The relationship between kraepelinian and deficit syndrome subtypologies 
  • Longitudinal cohort study of depression, post-traumatic stress, and alcohol use in South African women who attend alcohol serving venues. 
  • Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study. 
  • Longitudinal study of low serum LDL cholesterol and depressive symptom onset in postmenopause. 
  • Longitudinal study of neuropsychological functioning in patients on chronic hemodialysis: a preliminary report. 
  • Looking to the future of research in pediatric anxiety disorders. 
  • Loss of appetite and weight associated with the monoamine oxidase inhibitor isocarboxazid. 
  • Low Seizure Threshold with Ultra-Brief Pulse Right Unilateral ECT in the Elderly: Preliminary Data from Phase I of the PRIDE Study 
  • Low educational attainment, John Henryism, and cardiovascular reactivity to and recovery from personally relevant stress. 
  • Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. 
  • Low yield of thyroid-stimulating hormone testing in elderly patients with depression. 
  • Low-Frequency Right Repetitive Transcranial Magnetic Stimulation for the Treatment of Depression After Traumatic Brain Injury: A Randomized Sham-Controlled Pilot Study. 
  • Low-dimensional chaos in bipolar disorder? 
  • Lower SES and increased illness risk: A role for gene-environment interactions? 
  • Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. 
  • Loxapine in psychogeriatrics: A placebo- and standard-controlled clinical investigation 
  • Lying for patients: physician deception of third-party payers. 
  • Lymphocyte numbers in endogenous depression. 
  • MAO inhibition and control of anxiety following amitriptyline therapy. A pilot study. 
  • MAO inhibitor therapy in trichotillomania associated with depression: case report. 
  • MAOA genotype, childhood maltreatment, and their interaction in the etiology of adult antisocial behaviors. 
  • MAOA, early adversity, and gene-environment interaction predicting children's mental health: New evidence and a meta-analysis 
  • MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. 
  • MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. 
  • MET BDNF protects against morphological S allele effects of 5-HTTLPR 
  • METHODOLOGY IN PSYCHOSOMATIC RESEARCH 
  • MICROVASCULAR FUNCTION AND COGNITIVE PERFORMANCE AMONG INDIVIDUALS WITH MAJOR DEPRESSION 
  • MODELING THE IMPACT OF CHRONIC ILLNESS, RELIGION, AND SOCIAL SUPPORT ON DEPRESSIVE SYMPTOMS 
  • MR signal intensity of gray matter/white matter contrast and intracranial fat: effects of age and sex. 
  • MRI changes in schizophrenia in late life: a preliminary controlled study. 
  • MRI correlates of suicide attempt history in unipolar depression. 
  • MRI of corpus callosum and septum pellucidum in depression. 
  • MRI scans in patients with tardive dyskinesia. 
  • MRI signal hyperintensities in geriatric depression. 
  • MRI-defined vascular depression. 
  • Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: preliminary findings. 
  • Magnetic resonance findings in patients with early-onset Alzheimer's disease. 
  • Magnetic resonance imaging abnormalities and psychiatric illness. 
  • Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. 
  • Magnetic resonance imaging changes in putamen nuclei iron content and distribution in normal subjects. 
  • Magnetic resonance imaging correlates of depression in early- and late-onset Alzheimer's disease. 
  • Magnetic resonance imaging in biological psychiatry. 
  • Magnetic resonance imaging in social phobia. 
  • Magnetic resonance imaging of Alzheimer's disease. 
  • Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. 
  • Magnetic resonance imaging signal hypointensity and iron content of putamen nuclei in elderly depressed patients. 
  • Magnetic resonance imaging using deoxyhemoglobin contrast versus positron emission tomography in the assessment of brain function. 
  • Magnetic resonance in patients with affective illness. 
  • Magnetic resonance spectroscopy in social phobia: preliminary findings. 
  • Magnetic seizure therapy and other convulsive therapies 
  • Magnetic seizure therapy improves mood in refractory major depression. 
  • Magnetic seizure therapy of major depression. 
  • Magnetic seizure therapy: Development of a novel intervention for treatment resistant depression 
  • Magnetic source imaging evidence of sex differences in cerebral lateralization in schizophrenia. 
  • Magnetic-resonance morphometry in patients with major depression. 
  • Magnitude of placebo response and drug-placebo differences across psychiatric disorders. 
  • Maintenance ECT in schizophrenia: A systematic review. 
  • Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study. 
  • Major depression and personality disorder. 
  • Major depression and physical illness trajectories in heart failure and pulmonary disease. 
  • Major depression and the NIMH Diagnostic Interview Schedule: validation in medically ill hospitalized patients. 
  • Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards. 
  • Major depressive disorder treatment guidelines in America and Europe. 
  • Major depressive disorder treatment guidelines in America and Europe. 
  • Major depressive disorder with psychotic features may lead to misdiagnosis of dementia: a case report and review of the literature. 
  • Maladaptive coping mediates the influence of childhood trauma on depression and PTSD among pregnant women in South Africa. 
  • Male Body Image in Taiwan Versus the West:Yanggang ZhiqiMeets the Adonis Complex 
  • Male-female differences in the setting and construction of violence among people with severe mental illness. 
  • Managed depression care reduces mortality in older adults with major depression. 
  • Management of fibromyalgia. 
  • Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs. 
  • Management of late-life depression in the nursing home 
  • Management of posttraumatic stress disorder: diagnostic and therapeutic issues. 
  • Managing Stigma Effectively: What Social Psychology and Social Neuroscience Can Teach Us. 
  • Managing depression in countries with low and middle incomes: an imperative for human immunodeficiency virus/acquired immune deficiency syndrome care and treatment and general public health. 
  • Managing depression in geriatric populations. 
  • Managing patients with vascular disease and depression 
  • Managing the risks of repetitive transcranial stimulation. 
  • Mandated community treatment: beyond outpatient commitment. 
  • Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism and mood disorders: a preliminary study. 
  • Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia. 
  • Mania in Alzheimer's disease. 
  • Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders. 
  • Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. 
  • Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. 
  • Marketing off-label uses: Shady practices within a gray market 
  • Masked depression in a combined medical-psychiatric unit. 
  • Massage therapy effects on depression and somatic symptoms in chronic fatigue syndrome 
  • Maternal childhood trauma, postpartum depression, and infant outcomes: Avoidant affective processing as a potential mechanism. 
  • Maternal depression and children's antisocial behavior: nature and nurture effects. 
  • Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model. 
  • Maternal mental health priorities, help-seeking behaviors, and resources in post-conflict settings: a qualitative study in eastern Uganda. 
  • Maternal prenatal pregnancy-related anxiety and spontaneous preterm birth in Baltimore, Maryland. 
  • Maternal psychological distress, prenatal cortisol, and fetal weight. 
  • Maternal separation in neonatal rats elicits activation of the hypothalamic-pituitary-adrenocortical axis: a putative role for corticotropin-releasing factor. 
  • Maternal smoking during pregnancy and risk to boys' conduct disturbance: an examination of the causal hypothesis. 
  • Measurement of depression treatment among patients receiving HIV primary care: Whither the truth? 
  • Measurement of intracerebral electric field induced by electroconvulsive therapy 
  • Measurement of the process of coping with sexual trauma 
  • Measurement reliability of cardiovascular reactivity change scores: a comparison of intermittent and continuous methods of assessment. 
  • Measures and predictors of community-based employment and earnings of persons with schizophrenia in a multisite study. 
  • Measures of attention and hyperactivity symptoms in a high-risk sample of children of bipolar parents. 
  • Measures of cognitive change in schizophrenia clinical trials 
  • Measuring Depressive Symptomatology in China. 
  • Measuring childhood maltreatment to predict early-adult psychopathology: Comparison of prospective informant-reports and retrospective self-reports. 
  • Measuring outcome priorities and preferences in people with schizophrenia. 
  • Measuring results of treatment of PTSD. 
  • Measuring the Quality of VA Care. 
  • Measuring the role of psychological inflexibility in Trichotillomania. 
  • Mecamylamine increases cigarette smoking in psychiatric patients. 
  • Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy. 
  • Mechanistic classification of neural circuit dysfunctions: insights from neuroeconomics research in animals. 
  • Meclizine enhancement of sensorimotor gating in healthy male subjects with high startle responses and low prepulse inhibition. 
  • Medial orbital frontal lesions in late-onset depression. 
  • Mediation of employment discrimination disputes involving persons with psychiatric disabilities. 
  • Medical comorbidity and alcohol dependence. 
  • Medical comorbidity in a bipolar outpatient clinical population. 
  • Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. 
  • Medical diplomacy and global mental health: from community and national institutions to regional centers of excellence. 
  • Medical management of levodopa-associated motor complications in patients with Parkinson's disease. 
  • Medical service utilization by veterans seeking help for posttraumatic stress disorder. 
  • Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. 
  • Medication compliance. 
  • Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. 
  • Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. 
  • Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes. 
  • Medico-legal risk associated with pediatric mental health telephone consultation programs. 
  • Meet our editorial board member 
  • Meeting of minds in psychiatry and homeopathy: an example in social phobia. 
  • Meeting the needs of primary care physicians: a guide to content for programs on depression. 
  • Memory performance by mild hypertensives following beta-adrenergic blockade. 
  • Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele. 
  • Mental Disorders and Violence in a Total,::Birth Cohorts Results from the Dunedin Study 
  • Mental Health Courts: Does Treatment Make a Difference? 
  • Mental Health and Functional Outcomes in Young Adulthood of Children With Psychotic Symptoms: A Longitudinal Cohort Study. 
  • Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. 
  • Mental disorder and violence in a total birth cohort 
  • Mental disorders and violence in a total birth cohort: results from the Dunedin Study. 
  • Mental disorders in primary care: epidemiologic, diagnostic, and treatment research directions. 
  • Mental health and reoffending outcomes of jail diversion participants with a brief incarceration after arraignment. 
  • Mental health and substance abuse services to parents of children involved with child welfare: a study of racial and ethnic differences for American Indian parents. 
  • Mental health first aid training of the public in a rural area: a cluster randomized trial [ISRCTN53887541]. 
  • Mental health impact of the Iraq and Afghanistan conflicts: a review of US research, service provision, and programmatic responses. 
  • Mental health issues among female clients of domestic violence programs in North Carolina. 
  • Mental health paraprofessional training for filipina foreign domestic workers in Singapore: Feasibility and effects on knowledge about depression and cognitive behavioral therapy skills 
  • Mental health screenings for couples at churches in Nigeria: a strategy for enhancing community-based maternal mental health services in low-resource settings. 
  • Mental health service utilization in the U.S. Army. 
  • Mental health training of primary care residents: a review of recent literature (1974-1981). 
  • Mental illness in U.S. Presidents between 1776 and 1974: a review of biographical sources. 
  • Mental patients' attitudes toward hospitalization: a neglected aspect of hospital tenure 
  • Mental patients' attraction to the hospital: correlates of living preference. 
  • Mental-physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys. 
  • Mesocorticolimbic Predictors of Responses to Psychotherapy in Major Depression 
  • Meta-Analysis of DNA Methylation and PTSD in the Psychiatric Genomics Consortium PTSD Epigenetics Workgroup 
  • Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. 
  • Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. 
  • Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy. 
  • Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders 
  • Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled. 
  • Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. 
  • Metabolomic mapping of atypical antipsychotic effects in schizophrenia. 
  • Metabolomic mapping of schizophrenia and atypical antipsychotic effects 
  • Metabolomic mapping of schizophrenic patients treated with atypical antipsychotics discloses drug-specific differences in global lipid changes 
  • Metabolomics and lipidomics of neuropsychiatric disorders: Emerging data 
  • Metabolomics: A Global Biochemical Approach to the Study of Neuropsychiatric Disorders 
  • Metabolomics: a global biochemical approach to the study of central nervous system diseases. 
  • Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. 
  • Methadone dose for cocaine abuse. 
  • Methodologic issues in maintenance therapy clinical trials. 
  • Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders. 
  • Methodological considerations for the quantification of self-reported caffeine use. 
  • Methodological issues in negative symptom trials. 
  • Metoclopramide-induced tardive respiratory dyskinesia. 
  • Mianserin: Determination of therapeutic dose range 
  • Microvascular abnormality in schizophrenia as shown by retinal imaging. 
  • Midbrain Modulation of Hippocampus Dependent Learning in Singaporeans at Ultra High Risk for the Development of Schizophrenia 
  • Middle cerebral artery velocity during upright posture after marijuana smoking. 
  • Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation. 
  • Mifepristone in psychotic depression? 
  • Mild ventriculomegaly detected in utero with ultrasound: clinical associations and implications for schizophrenia. 
  • Mindfulness, Self-Compassion, Posttraumatic Stress Disorder Symptoms, and Functional Disability in U.S. Iraq and Afghanistan War Veterans. 
  • Mindfulness-based stress reduction and health-related quality of life in a heterogeneous patient population. 
  • Mindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice. 
  • Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity. 
  • Mini-SPIN: A brief screening assessment for generalized social anxiety disorder. 
  • Minimal maintenance medication: Effects of three dose schedules on relapse rates and symptoms in chronic schizophrenic outpatients 
  • Minimum Electric Field Exposure for Seizure Induction with Electroconvulsive Therapy and Magnetic Seizure Therapy. 
  • Minor depression and physical outcome trajectories in heart failure and pulmonary disease. 
  • Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes. 
  • Minor depression: a review of the literature. 
  • Minor self-harm and psychiatric disorder: a population-based study. 
  • Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial. 
  • Mismatch in Spouses' Anger-Coping Response Styles and Risk of Early Mortality: A 32-Year Follow-Up Study. 
  • Mismatch of posttraumatic stress disorder (PTSD) symptoms and DSM-IV symptom clusters in a cancer sample: exploratory factor analysis of the PTSD Checklist-Civilian Version. 
  • Missing the sweet spot disengagement in schizophrenia. 
  • Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. 
  • Mixed depression: a study of its phenomenology and relation to treatment response. 
  • Moclobemide in social phobia: a controlled dose-response trial. 
  • Modafinil for atypical depression: Effects of open-label and double-blind discontinuation treatment (vol 26, pg 373, 2006) 
  • Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. 
  • Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. 
  • Model utility in postpartum psychosis 
  • Modeling Health Disparities and Outcomes in Disenfranchised Populations. 
  • Models of dopaminergic and serotonergic signaling. 
  • Models of mental health training for primary care physicians: a validation study. 
  • Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. 
  • Modification effects of coping on post-traumatic morbidity among earthquake rescuers. 
  • Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine. 
  • Modulation Effect of Rumination Trait and Low Tryptophan on Default-Mode Network Connectivity 
  • Modulation of motor cortex excitability in obsessive-compulsive disorder: an exploratory study on the relations of neurophysiology measures with clinical outcome. 
  • Molecular biology, II: A dopamine transporter mouse knockout 
  • Molecular cloning, pharmacological characterization and genetic studies of the human dopamine transporter 
  • Molecular genetic and family studies in affective disorders: state of the art. 
  • Molecular genetics of successful smoking cessation: convergent genome-wide association study results. 
  • Money management, mental health, and psychiatric disability: a recovery-oriented model for improving financial skills. 
  • Monitoring lithium dose levels: estimation of lithium in blood and other body fluids. 
  • Monitoring of clozapine blood levels in the real world [10] 
  • Monoamine oxidase inhibitors in patients with chronic pain. 
  • Mood alters amygdala activation to sad distractors during an attentional task. 
  • Mood and suicidality outcomes 3-11 years following pediatric anxiety disorder treatment. 
  • Mood disorders and chronic obstructive pulmonary disease: current research and future needs. 
  • Mood disorders in the medically ill: scientific review and recommendations. 
  • Mood variability in adolescents: a study of depressed, nondepressed and comorbid patients. 
  • Mood, major depression, and fluoxetine response in cigarette smokers. 
  • Moral Injury and Religiosity in US Veterans With Posttraumatic Stress Disorder Symptoms. 
  • Moral engagement, combat trauma, and the lure of psychiatric dualism: why psychiatry is more than a technical discipline. 
  • Moral injury, posttraumatic stress disorder, and religious involvement among U.S. veterans. 
  • More data on speed of remission with ECT in geriatric depression. 
  • More than the loss of a parent: potentially traumatic events among orphaned and abandoned children. 
  • Morphine inhibits cortisol and stimulates prolactin secretion in man. 
  • Morphological differences associated with a serotonin transporter polymorphism (5-HTTLPR) in rhesus macaques 
  • Mortality in patients with schizophrenia, mania, depression and surgical conditions. A comparison with general population mortality. 
  • Motivated behavior and the estrous cycle in rats. 
  • Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. 
  • Motor cortex excitability after vagus nerve stimulation in major depression. 
  • Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression. 
  • Moving assertive community treatment into standard practice. 
  • Much ado about small differences. 
  • Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. 
  • Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans. 
  • Multidimensional effects of sertraline in social anxiety disorder. 
  • Multidisciplinary training in the College Mental Health Service. 
  • Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. 
  • Multifamily group treatment for veterans with traumatic brain injury: what is the value to participants? 
  • Multilevel regression analyses to investigate the relationship between two variables over time: examining the longitudinal association between intrusion and avoidance. 
  • Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. 
  • Multimodal treatment of a case of obsessive-compulsive neurosis. 
  • Multiple embolic phenomenon in the brain associated with parenteral buprenorphine abuse. 
  • Multiple rare SAPAP3 missense variants in trichotillomania and OCD. 
  • N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. 
  • N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. 
  • NATURALISTIC STRESSORS ARE ASSOCIATED WITH REDUCED 24-HOUR HRV IN ACUTE POST-MI PATIENTS 
  • NCAM1 and neurocognition in schizophrenia. 
  • NEUROENDOCRINE EFFECTS OF CAFFEINE AT WORK 
  • NEUROENDOCRINE FACTORS IN PREMENSTRUAL DYSPHORIC DISORDER 
  • NEUROENDOCRINE RESPONSES ARE ASSOCIATED WITH LIPIDS IN HOSTILE WOMEN 
  • NEUROSTEROIDS AS NOVEL THERAPEUTIC AGENTS IN SCHIZOPHRENIA AND PTSD 
  • NORMATIVE DATA FOR RUSSIAN POPULATION AND STANDARDIZATION OF THE SCALE "BRIEF ASSESSMENT OF COGNITION IN SCHIZOPHRENIA" 
  • Naltrexone blockade of nicotine effects in cigarette smokers. 
  • Naltrexone potentiates glycemic responses during stress and epinephrine challenge in genetically obese mice. 
  • Narcissism and the development of chronic pain. 
  • Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. 
  • National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. 
  • National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. 
  • National trends in antidepressant medication treatment among publicly insured pregnant women. 
  • Navigating diagnoses: understanding mind-body relations, mental health, and stigma in Nepal. 
  • Nefazodone in post-traumatic stress disorder: results from six open-label trials. 
  • Negative affect and chemical intolerance as risk factors for building-related symptoms: a controlled exposure study. 
  • Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence. 
  • Negative life stress and longitudinal hippocampal volume changes in older adults with and without depression. 
  • Neighborhood characteristics moderate effects of caregiving on glucose functioning. 
  • Neighbourhood Adversity, Crime Victimisation and Adolescent Psychotic Experiences: Findings from a Longitudinal Cohort Study 
  • Neocortical modulation of the amygdala response to fearful stimuli. 
  • Neonatal bacterial infection alters fever to live and simulated infections in adulthood. 
  • Neonatal cerebral ventricle volume: A comparison of 3D ultrasound and MRI 
  • Nepali concepts of psychological trauma: the role of idioms of distress, ethnopsychology and ethnophysiology in alleviating suffering and preventing stigma. 
  • Network Analysis of Intrinsic Functional Organization of the Brain in Mild Traumatic Brain Injury 
  • Neural Effects of rTMS: Single Neuron Recordings From a Rhesus Macaque 
  • Neural Mechanisms and Psychophysiology of Emotion Regulation Impairments in Autism 
  • Neural Mechanisms of Emotion Regulation in Major Depression and Implications for Psychotherapy Effectiveness 
  • Neural Mechanisms of Uncertainty Processing in Children with Autism Spectrum Disorders 
  • Neural Response to Loss Is Associated with Rumination in Remitted Major Depression 
  • Neural bases of different cognitive strategies for facial affect processing in schizophrenia. 
  • Neural correlates of automatic and controlled auditory processing in schizophrenia. 
  • Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. 
  • Neural correlates of food addiction. 
  • Neural mechanisms of cognitive reappraisal in remitted major depressive disorder. 
  • Neural mechanisms of subclinical depressive symptoms in women: a pilot functional brain imaging study. 
  • Neural mechanisms underlying 5-HTTLPR-related sensitivity to acute stress. 
  • Neural substrates for processing task-irrelevant emotional distracters in maltreated adolescents with depressive disorders: a pilot study. 
  • Neural substrates of orthographic lexical access as demonstrated by functional brain imaging. 
  • Neural systems for executive and emotional processing are modulated by level of posttraumatic stress disorder symptoms in Iraq war veterans 
  • Neural systems for executive and emotional processing are modulated by symptoms of posttraumatic stress disorder in Iraq War veterans. 
  • Neuroactive Steroids Enhance Activation of Emotion Regulation Brain Circuits 
  • Neuroactive steroid alterations in posterior cingulate and parietal cortex in subjects with schizophrenia and bipolar disorder: Potential gender specificity 
  • Neuroactive steroid alterations in schizophrenia and bipolar disorder: A negative ion chemical ionization gas chromatography/mass spectrometry investigation in posterior cingulate 
  • Neuroactive steroid alterations in schizophrenia and bipolar disorder: Negative ion chemical ionization gas chromatography/mass spectrometry investigations in posterior cingulate and parietal cortex 
  • Neuroactive steroids and neurodegenerative disorders: Investigations in subjects with Alzheimer's and relevance to neuropathological disease stage 
  • Neuroactive steroids and suicidality in posttraumatic stress disorder. 
  • Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. 
  • Neuroactive steroids are related to psychiatric symptoms in veterans returning from iraq and Afghanistan 
  • Neuroactive steroids in Alzheimer's disease: Investigations in prefrontal cortex 
  • Neuroactive steroids in schizophrenia, PTSD, and Alzheimer's disease: Relevance to pathophysiology and treatment 
  • Neuroactive steroids in schizophrenia: Relevance to symptoms and therapeutics 
  • Neuroactive steroids, mood stabilizers, and neuroplasticity: Alterations following lithium and changes in Bcl-2 knockout mice 
  • Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice. 
  • Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. 
  • Neuroanatomical and neurochemical substrates of timing. 
  • Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities. 
  • Neuroanatomical substrates of depression in the elderly. 
  • Neurobehavioral functioning in a nonconfounded group of asymptomatic HIV-seropositive homosexual men. 
  • Neurobiochemical changes in tardive dyskinesia. 
  • Neurobiological mechanisms in generalized anxiety disorder. 
  • Neurobiological pathways that link gene and environment: early life stress disorder. 
  • Neurobiology of chronic fatigue syndrome. 
  • Neurobiology, cellular and molecular biology, and psychosomatic medicine. 
  • Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale. 
  • Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. 
  • Neurocognitive disorders in DSM-5. 
  • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. 
  • Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial 
  • Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder 
  • Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis 
  • Neurocognitive effects of olanzapine and low-dose haloperidol: A two-year treatment study in first episode psychosis 
  • Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression. 
  • Neuroendocrine evaluation of depression in borderline patients. 
  • Neuroendocrine identification of depressed patients. 
  • Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. 
  • Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. 
  • Neuroendocrine responses to caffeine in the work environment. 
  • Neuroendocrine, cardiovascular, and emotional responses of hostile men: the role of interpersonal challenge. 
  • Neuroimaging in late-life depression. 
  • Neuroimaging of Nicotine Dependence: Key Findings and Application to the Study of Smoking-Mental Illness Comorbidity. 
  • Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease 
  • Neuroleptic dose and the need for prophylactic anticholinergic drugs. 
  • Neuroleptic effects on CPT and eye tracking in schizophrenia 
  • Neuron-specific Sumo1-3 knockdown in mice impairs episodic and fear memories. 
  • Neuropathologic examination after 91 ECT treatments in a 92-year-old woman with late-onset depression. 
  • Neuropathology in affective illness. 
  • Neuropeptide Y and alcohol: Brain levels following chronic ethanol exposure and in alcohol-preferring and non-preferring rats 
  • Neurophysiological characterization of high-dose magnetic seizure therapy: comparisons with electroconvulsive shock and cognitive outcomes. 
  • Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. 
  • Neuropsychiatric considerations in the use of electroconvulsive therapy. 
  • Neuropsychiatric manifestations of porphyria. 
  • Neuropsychiatric problems after traumatic brain injury: unraveling the silent epidemic. 
  • Neuropsychiatry--an emerging field. 
  • Neuropsychological aspects of eating disorders 
  • Neuropsychological characterization of dementia patients 
  • Neuropsychological characterization of dementia patients 
  • Neuropsychological characterization of dementia patients. 
  • Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. 
  • Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study. 
  • Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. 
  • Neuropsychological deficits at age 13 and later schizophreniform disorder: A longitudinal birth cohort study 
  • Neuropsychological function at age 13 and later schizophreniform disorder in a longitudinal birth cohort 
  • Neuropsychological function before and after subcallosal cingulate deep brain stimulation in patients with treatment-resistant depression. 
  • Neuropsychological function in children with maltreatment-related posttraumatic stress disorder. 
  • Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. 
  • Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. 
  • Neuropsychological functions of prefrontal cortex are selectively impaired early in the course of schizophrenia 
  • Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. 
  • Neuropsychological performance at the age of 13 years and adult schizophreniform disorder: prospective birth cohort study. 
  • Neuropsychological profile in adult schizophrenia measured with the CMINDS. 
  • Neuropsychological status of subjects at high risk for a first episode of psychosis. 
  • Neuropsychological test scores at age 13 and later schizophreniform disorder: a prospective longitudinal birth cohort study 
  • Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. 
  • Neuroserpin Protects Parvalbumin Interneurons Against Perineuronal Net Degradation for Cortical Stability 
  • Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders. 
  • Neurosteroid modulation of GABAergic neurotransmission in the central amygdala 
  • Neurosteroids and pharmacological treatment strategies in schizophrenia, depression, and anxiety disorders 
  • Neurosteroids as Novel Therapeutics and Biomarker Candidates in Schizophrenia and PTSD 
  • Neurosteroids as candidate modulators of pathophysiology in Alzheimer's disease and nicotine dependence 
  • Neurosyphilis occurring in a patient with schizophrenia: a cautionary tale. 
  • Neuroticism and personality disorder in depression. 
  • Neurotransmitter studies of neuroendocrine pathology in depression 
  • Neurotransmitter studies of neuroendocrine pathology in depression. 
  • Neurotrophic factor-α1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone. 
  • Neurotrophin-3 levels in the cerebrospinal fluid of patients with schizophrenia or medical illness 
  • Neurovegetative symptoms in chronic pain and depression. 
  • Neutrality, autonomy and mental health: a closer look. 
  • New Challenges for Anxiety Disorders: Where Treatment, Resilience, and Economic Priority Converge 
  • New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy. 
  • New Developments in Insomnia Medications of Relevance to Mental Health Disorders. 
  • New developments in dosing strategies for ECT 
  • New developments in electroconvulsive therapy and magnetic seizure therapy. 
  • New directions in research on involuntary outpatient commitment. 
  • New directions in the rational design of electrical and magnetic seizure therapies: individualized Low Amplitude Seizure Therapy (iLAST) and Magnetic Seizure Therapy (MST). 
  • New frontiers in psychiatric neuroimaging. 
  • New onset and remission of suicidal ideation among a depressed adult sample. 
  • New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. 
  • New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging. 
  • New strategies for the treatment of posttraumatic stress disorder 
  • New treatment options to improve clinical outcomes 
  • Newer pharmacotherapies for depression in primary care: A literature synthesis 
  • Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade. 
  • Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats. 
  • Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling. 
  • Nicotine and nonnicotine factors in cigarette addiction. 
  • Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia. 
  • Nicotine deprivation influences P300 markers of cognitive control. 
  • Nicotine effects on adults with attention-deficit/hyperactivity disorder. 
  • Nicotine effects on learning in zebrafish: the role of dopaminergic systems. 
  • Nicotine increases anterior insula activation to expected and unexpected outcomes among nonsmokers. 
  • Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. 
  • Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior. 
  • Nicotine psychopharmacology 
  • Nicotine self-administration in animals and humans: similarities and differences. 
  • Nicotine skin patch treatment and adverse reactions: skin irritation, skin sensitization, and nicotine as a hapten. 
  • Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. 
  • Nicotine therapy in adulthood reverses the synaptic and behavioral deficits elicited by prenatal exposure to phenobarbital. 
  • Nicotine withdrawal modulates frontal brain function during an affective Stroop task 
  • Nicotine withdrawal modulates frontal brain function during an affective Stroop task. 
  • Nicotine-antipsychotic drugs interaction and sustained attention in rats 
  • Nicotine-haloperidol interactions and cognitive performance in schizophrenics. 
  • Nicotinic acetylcholine involvement in cognitive function in animals. 
  • Nicotinic attention-deficit/hyperactivity disorder treatment. 
  • Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. 
  • Nicotinic receptor modulation of attention: An endophenotype for therapeutic drug development 
  • Nicotinic systems and cognitive function. 
  • Nicotinic-serotonergic drug interactions and attentional performance in rats. 
  • Nighttime heart rate and survival in depressed patients post acute myocardial infarction. 
  • No association between RORA polymorphisms and PTSD in two independent samples. 
  • No association between alleles or genotypes at the dopamine transporter gene and schizophrenia. 
  • No association between polymorphisms in the serotonin transporter gene and susceptibility to cocaine dependence among African-American individuals. 
  • No influence of SLC6A3 40 base VNTR polymorphism on the response to risperidone. 
  • Nocturnal and early morning secretion of ACTH and cortisol in humans. 
  • Non-REM sleep EEG spectral analysis in insomnia 
  • Non-cholinergic strategies for treating and preventing Alzheimer's disease. 
  • Non-pharmacological treatment modalities in children and adolescents: A review of electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, magnetic seizure therapy, and deep brain stimulation 
  • Non-suicidal self-injury as a predictor of active and passive suicidal ideation among Iraq/Afghanistan war veterans. 
  • Non-suicidal self-injury with and without borderline personality disorder: differences in self-injury and diagnostic comorbidity. 
  • Nondaily Cigarette Smoking Is Increasing Among People With Common Mental Health and Substance Use Problems in the United States: Data From Representative Samples of US Adults, 2005-2014. 
  • Nonmedical stimulant use among young Asian-Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals aged 12-34 years in the United States. 
  • Nonpharmacologic treatments for depression in patients with coronary heart disease. 
  • Nonsuicidal Self-Injury and Borderline Personality Features as Risk Factors for Suicidal Ideation Among Male Veterans With Posttraumatic Stress Disorder. 
  • Nonsuicidal self-injury and interpersonal violence in U.S. veterans seeking help for posttraumatic stress disorder. 
  • Nonsuicidal self-injury and suicide attempts in Iraq/Afghanistan war veterans. 
  • Nonsuicidal self-injury in men: a serious problem that has been overlooked for too long. 
  • Normal CSF oxytocin and NPY levels in OCD. 
  • Normal female and male adolescent psychological development: an overview of theory and research. 
  • Normal smooth pursuit eye movements in volunteer subjects meeting schizotypal personality disorder criteria. 
  • Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. 
  • Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). 
  • Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study. 
  • Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. 
  • Nuclear magnetic resonance spectroscopy: a review of neuropsychiatric applications. 
  • Numbing of Positive, Negative, and General Emotions: Associations With Trauma Exposure, Posttraumatic Stress, and Depressive Symptoms Among Justice-Involved Youth. 
  • Nutrition and Bipolar Depression. 
  • OBESITY IS ASSOCIATED WITH POORER NEUROCOGNITIVE PERFORMANCE AMONG ADULTS WITH HIGH BLOOD PRESSURE 
  • ON SIMULATING POSTTRAUMATIC-STRESS-DISORDER - REPLY 
  • Obesity: a public health approach. 
  • Obesity: overview of an epidemic. 
  • Objective assessment of peritraumatic dissociation: psychophysiological indicators. 
  • Objective evidence of sleep disturbance in women with posttraumatic stress disorder. 
  • Observable Social Cognition--A Rating Scale: an interview-based assessment for schizophrenia. 
  • Observations on pain and suffering. 
  • Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. 
  • Obsessions and compulsions in women with postpartum depression. 
  • Obsessive-compulsive disorder in callers to the Anxiety Disorders Association of America. 
  • Occurrence of cancer among people with mental health claims in an insured population. 
  • Occurrence of subcortical hyperintensities in elderly subjects with mania. 
  • Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. 
  • Olanzapine and fluoxetine effects on hippocampal pregnenolone and peripheral deoxycorticosterone: Relevance to therapeutic efficacy 
  • Olanzapine and haloperidol in first episode psychosis: two-year data. 
  • Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study. 
  • Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. 
  • Olanzapine increases allopregnanolone in the rat cerebral cortex. 
  • Olanzapine induced reductions in frontal lobe lactate levels correlate with treatment response in first episode psychosis 
  • Olanzapine on trial. 
  • Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose. 
  • Omission of bupropion as a recommended treatment for PTSD. 
  • On Thoughts, Threats, and Throwing the Spear. 
  • On chronic fatigue syndrome. 
  • On the Concurrent Use of Self-System Therapy and Functional Magnetic Resonance Imaging-Guided Transcranial Magnetic Stimulation as Treatment for Depression. 
  • On the new clinical case conferences. 
  • Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo. 
  • Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration. 
  • One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area study. 
  • One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. 
  • One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. 
  • Ongoing life stressors and suicidal ideation among HIV-infected adults with depression. 
  • Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis. 
  • Ontogenetic studies of tolerance development: effects of chronic morphine on the hypothalamic-pituitary-adrenal axis. 
  • Ontogeny of the behavioral response to dopamine agonists after chronic cocaine. 
  • Open trial of nefazodone for combat-related posttraumatic stress disorder. 
  • Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. 
  • Operant conditioning: a new theoretical approach in psychosomatic medicine. 
  • Ophthalmology issues in schizophrenia. 
  • Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose. 
  • Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats. 
  • Opioid dysfunction and risk for hypertension: naloxone and blood pressure responses during different types of stress. 
  • Opioid regulation of hypothalamic-pituitary-adrenal function in depression. 
  • Opioid use affects antioxidant activity and purine metabolism: preliminary results. 
  • Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. 
  • Optimization of a multinomial model for investigating hallucinations and delusions with source monitoring. 
  • Optimizing Stimulus Pulse Characteristics for Transcranial Magnetic Stimulation and Electroconvulsive Therapy via Device Development, Computational Modeling, and Biophysically-motivated Dosing Paradigms 
  • Optimizing a Positive Psychology Intervention to Promote Health Behaviors After an Acute Coronary Syndrome: The Positive Emotions After Acute Coronary Events III (PEACE-III) Randomized Factorial Trial. 
  • Optimizing outcome with antipsychotic treatment in first-episode schizophrenia: balancing efficacy and side effects. 
  • Orbitofrontal cortex volume and intrinsic religiosity in non-clinical psychosis. 
  • Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. 
  • Organic affective disorder in a patient with congenital adrenal hyperplasia. 
  • Organic anxiety disorder. Iatrogenic hyperthyroidism. 
  • Organic brain syndromes in DSM-III. 
  • Organizational effects of gonadal steroids on sexually dimorphic spatial ability 
  • Organizing and conducting clinical trials 
  • Origins of depression in later life. 
  • Oscillations of attachment in borderline personality disorder. 
  • Outcome in children with fetal isolated mild ventriculomegaly: A case study 
  • Outcome in children with fetal mild ventriculomegaly: a case series. 
  • Outcomes of Mental Health Screening for United Kingdom Nationals Affected by the 2015-2016 Terrorist Attacks in Tunisia, Paris, and Brussels. 
  • Outcomes of early pubertal timing in young women: a prospective population-based study. 
  • Outpatient Mental Health Services in Mozambique: Use and Treatments. 
  • Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. 
  • Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD. 
  • Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study. 
  • Overriding psychiatric advance directives: factors associated with psychiatrists' decisions to preempt patients' advance refusal of hospitalization and medication. 
  • Overt Aggression and Psychotic Symptoms in Patients with Schizophrenia Treated with Clozapine, Olanzapine, Risperidone, or Haloperidol 
  • Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants. 
  • P.1.027 The role of FKBP5 in mechanisms linking stress and aging 
  • P.1.a.003 Epigenetic regulation at the FKBP5 genetic locus by age and depressive phenotypes: implications for age-related disease 
  • P.1.a.006 CACNA1C gene and schizophrenia: A case-control and pharmacogenetic study 
  • P.1.a.015 Brain-Derived Neurotrophic Factor (BDNF) genetic pathway and bipolar disorder 
  • P.1.a.031 Lifetime stress accelerates epigenetic aging 
  • P.2.137 Can the PANSS cognitive factor be a validsurrogate for neurocognon in schizophrenia? 
  • P.2.a.017 Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels 
  • P.2.c.012 Predictors of response and remission during an open-label, 10-week trial with selegiline transdermal system 
  • P.2.c.013 Efficacy and safety of selegiline transdermal system for atypical depression: pooled analysis of short-term placebo-controlled trials 
  • P.2.f.013 Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine 
  • P.3.037 A randomized, double-blind, placebo-controlled trial: Paroxetine controlled release in fibromyalgia 
  • P.T. Barnum and the borderline personality disorder muddle (I: Reply) 
  • P1.a.023 Impact of a SNP in SIGMAR1 on major depression, bipolar disorder and treatment response 
  • PDE7B, NMBR and EPM2A Variants and Schizophrenia: A Case-Control and Pharmacogenetics Study. 
  • PERCEIVED SOCIAL SUPPORT IS RELEVANT IN THE MANAGEMENT OF PAIN AND DEPRESSION AMONG ADULTS WITH SICKLE CELL DISEASE (SCD) 
  • PERCEPTION OF COGNITIVE IMPAIRMENT IN OLDER ADULTS UNDERGOING CARDIAC SURGERY 
  • PERFORMANCE ON TESTS SENSITIVE TO FRONTAL-LOBE DYSFUNCTION AND DEFICIT-LIKE SYMPTOMS IN SCHIZOTYPAL PERSONALITY-DISORDER 
  • PERSONALITY PREDICTION OF EXERCISE IN THE UNC ALUMNI HEART-STUDY 
  • PET imaging of prefrontal dopamine D1 receptors in chronic ketamine human abusers: A model for schizophrenia 
  • PET studies of the influences of nicotine on neural systems in cigarette smokers. 
  • PIP syndrome. 
  • PL.05.01 The future of molecular pharmacology and drug discovery in psychiatry 
  • PLASMA OXYTOCIN CONCENTRATION AND DEPRESSIVE SYMPTOMS: A REVIEW OF CURRENT EVIDENCE AND DIRECTIONS FOR FUTURE RESEARCH. 
  • POPULATION DIFFERENCES IN ASSOCIATIONS OF SEROTONIN TRANSPORTER PROMOTER POLYMORPHISM (5HTTLPR) DI- AND TRIALLELIC GENOTYPES WITH BLOOD PRESSURE AND HYPERTENSION PREVALENCE 
  • POSITIVE FAMILY HISTORY AFFECTS NEUROPSYCHOLOGICAL PERFORMANCE IN HYPERTENSIVE PATIENTS 
  • PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin. 
  • PROPERTIES OF THE TELEPHONE INTERVIEW FOR COGNITIVE STATUS - APPLICATION IN EPIDEMIOLOGIC AND LONGITUDINAL-STUDIES 
  • PROTECTIVE FACTORS FOR PSYCHOTIC EXPERIENCES AMONGST ADOLESCENTS EXPOSED TO MULTIPLE FORMS OF VICTIMIZATION 
  • PSYCHOLOGICAL CORRELATES OF CHRONIC BLOOD-GLUCOSE CONTROL IN DIABETIC CHILDREN AND ADOLESCENTS 
  • PSYCHOLOGICAL EFFECTS OF LIPID-LOWERING DRUGS 
  • PTSD and substance abuse. 
  • PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. 
  • PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma. 
  • PTSD symptom clusters associated with physical health and health care utilization in rural primary care patients exposed to natural disaster. 
  • Pain catastrophizing in patients with noncardiac chest pain: relationships with pain, anxiety, and disability. 
  • Pain in depression: STAR*D study findings. 
  • Palinacousis after closed-head injury in a patient with schizophrenia [13] 
  • Panel discussion: changing how we think about insomnia. 
  • Panic attacks and suicide attempts in mid-adolescence. 
  • Panic disorder: making clinical sense of the latest research. 
  • Paradoxical response to dopamine agonists in tardive dyskinesia. 
  • Parental history of hypertension and cardiovascular responses to behavioral stress in young black women. 
  • Parental loss by death in childhood as an etiological factor among schizophrenic and alcoholic patients compared with a non-patient community sample. 
  • Parents' and teachers' concordance with children's self-ratings of suicidality: findings from a high-risk sample. 
  • Parotid gland swelling with clozapine. 
  • Paroxetine CR (paxil CR) in the treatment of patients with fibromyalgia: A randomized, double blind, parallel group, flexible dose, placebo-controlled trial 
  • Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. 
  • Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. 
  • Paroxetine for somatic pain associated with physical illness: a review. 
  • Paroxetine: current status in psychiatry. 
  • Part 2. Adult ADHD: Clinical Criteria for Diagnosis and Management 
  • Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling. 
  • Partial REM sleep deprivation, schizophrenia and field articulation. 
  • Participant reactions to a pretreatment research assessment during a treatment outcome study for PTSD. 
  • Participation in trauma research: is there evidence of harm? 
  • Partnering in support of war zone veterans and their families 
  • Partners' ratings of combat veterans' anger. 
  • Parvalbumin Interneurons of the Mouse Nucleus Accumbens are Required For Amphetamine-Induced Locomotor Sensitization and Conditioned Place Preference. 
  • Past loss as a symptom formation factor in depression. 
  • Pastoral care use among post-9/11 veterans who screen positive for mental health problems. 
  • Paternal history of mental illness associated with posttraumatic stress disorder among veterans. 
  • Pathogenic variants in E3 ubiquitin ligase RLIM/RNF12 lead to a syndromic X-linked intellectual disability and behavior disorder. 
  • Pathophysiology of depression - Bipolar illness and melancholia: The role of dopamine? 
  • Pathophysiology of depression: The emerging role of substance P 
  • Pathophysiology of hypercortisolism in depression. 
  • Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback. 
  • Pathways into and through mental health services for children and adolescents. 
  • Pathways to PTSD, part II: Sexually abused children. 
  • Patient Health Questionnaire-9 score and adverse cardiac outcomes in patients hospitalized for acute cardiac disease. 
  • Patient compliance with MAO inhibitor therapy. 
  • Patient, Therapist, and System Factors Influencing the Effectiveness of Prolonged Exposure for Veterans With Comorbid Posttraumatic Stress Disorder and Traumatic Brain Injury. 
  • Patient-centered mental health care for female veterans. 
  • Patients of psychiatrists and psychologists in office-based practice: 1980. 
  • Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia Treatment. 
  • Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain. 
  • Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and women. 
  • Patterns and predictors of pain following lung transplantation. 
  • Patterns of change in hostility from college to midlife in the UNC Alumni Heart Study predict high-risk status. 
  • Patterns of cocaine abuse and indications for treatment 
  • Patterns of justice involvement among adults with schizophrenia and bipolar disorder: key risk factors. 
  • Patterns of physical symptoms and relationships with psychosocial factors in adolescents. 
  • Patterns of professional activities of psychiatrists: a follow-up of 100 psychiatric residents. 
  • Perceived Feasibility, Acceptability, and Cultural Adaptation for a Mental Health Intervention in Rural Haiti. 
  • Perceived Social Support among Depressed Elderly, Middle-Aged, and Young Adult Samples 
  • Perceived cannabis use norms and cannabis use among adolescents in the United States. 
  • Perceived coercion among jail diversion participants in a multisite study. 
  • Perceived mental health and disablement of primary care and end-stage renal disease patients. 
  • Perceived social support among depressed elderly, middle-aged, and young-adult samples: cross-sectional and longitudinal analyses. 
  • Perceived social support as a predictor of mortality in coronary patients: effects of smoking, sedentary behavior, and depressive symptoms. 
  • Perceived stress in anxiety disorders and the general population: a study of the Sheehan stress vulnerability scale. 
  • Perception of early parenting in panic and agoraphobia. 
  • Perceptual learning with right unilateral versus bilateral electroconvulsive therapy. 
  • Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. 
  • Performance feedback deficit in geriatric depression. 
  • Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. 
  • Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay. 
  • Perfusion abnormalities and decision making in cocaine dependence. 
  • Perinatal depression in HIV-infected African women: a systematic review. 
  • Perioperative pain management. 
  • Peritraumatic dissociation and posttraumatic stress in male Vietnam theater veterans. 
  • Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at 6 months of age. 
  • Peroneal palsy in depressed patients. Weight loss, psychomotor retardation predispose patients to this complication. 
  • Peroneal palsy in depression. 
  • Perseverative behaviour after amphetamine; dissociation of response tendency from reward association. 
  • Persistence of combat-related posttraumatic stress symptoms for 75 years. 
  • Persistent Depressive Symptoms in a Population With High Levels of Occupational Stress: Trajectories Offer Insights Into Both Chronicity and Resilience. 
  • Persistent cardiovascular effects with repeated caffeine administration. 
  • Persistent infection with neurotropic herpes viruses and cognitive impairment. 
  • Persistent pain and depression: a biopsychosocial perspective. 
  • Personal genomes in progress: From the human genome project to the Personal Genome Project 
  • Personal genomes in progress: From the human genome project to the Personal Genome Project 
  • Personal genomes in progress: from the human genome project to the personal genome project. 
  • Personality Traits Are Associated with Academic Achievement in Medical School: A Nationally Representative Study. 
  • Personality and problem gambling: a prospective study of a birth cohort of young adults. 
  • Personality disorders at the interface of psychiatry and the law: legal use and clinical classification. 
  • Personality facets and all-cause mortality among Medicare patients aged 66 to 102 years: a follow-on study of Weiss and Costa (2005). 
  • Personality--life event congruence effects in late-life depression. 
  • Perspectives on depression, mild cognitive impairment, and cognitive decline. 
  • Perspectives on the Management of Vascular Depression. 
  • Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. 
  • Pharmacogenctic of DTNBP1 variations in the bipolar acute treatment with mood stabilizers 
  • Pharmacologic and behavioral interventions to improve cardiovascular risk factors in adults with serious mental illness: a systematic review and meta-analysis. 
  • Pharmacologic treatment of acute and chronic stress following trauma: 2006. 
  • Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use. 
  • Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine review 
  • Pharmacotherapy for post-traumatic stress disorder. 
  • Pharmacotherapy of chronic hospitalized schizophrenics: Prescription practices 
  • Pharmacotherapy of depression in pregnancy. 
  • Pharmacotherapy of generalized anxiety disorder. 
  • Pharmacotherapy of impaired affect in recovering schizophrenic patients. 
  • Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. 
  • Pharmacotherapy of social anxiety disorder. 
  • Pharmacotherapy of social anxiety disorder: what does the evidence tell us? 
  • Pharmacotherapy of social phobia. 
  • Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia. 
  • Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism 
  • Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder. 
  • Phobia: prevalence and risk factors. 
  • Phobic anxiety and increased risk of mortality in coronary heart disease. 
  • Phobic anxiety, depression, and risk of ventricular arrhythmias in patients with coronary heart disease. 
  • Phosphorylation of MeCP2 in Reward-Related Circuits is Required for Amphetamine-Induced Conditioned Place Preference in Mice 
  • Photoperiod affects the expression of sex and species differences in leukocyte number and leukocyte trafficking in congeneric hamsters. 
  • Physical activity and depressive symptoms among pregnant women: the PIN3 study. 
  • Physical activity and psychosocial function following cardiac rehabilitation: One-year follow-up of the ENHANCED study. 
  • Physician Beliefs about Physical and Mental Competency of Patients Applying for Concealed Weapon Permits. 
  • Physician race and treatment preferences for depression, anxiety, and medically unexplained symptoms. 
  • Physicians' Beliefs about the nature of addiction: a survey of primary care physicians and psychiatrists. 
  • Physicians' beliefs about faith-based treatments for alcoholism. 
  • Physiologic impairment of olfactory stimulus processing in schizophrenia. 
  • Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. 
  • Physiological predictors of posttraumatic stress disorder. 
  • Physiology and pathophysiology of cortico-basal ganglia-thalamocortical loops: theoretical and practical aspects. 
  • Pilot Study of Sustained Oxytocin Treatment in Children and Adolescents with Autistic Disorder 
  • Pituitary abnormalities in eating disorders: further evidence from MRI studies. 
  • Pituitary volumes in pediatric maltreatment-related posttraumatic stress disorder. 
  • Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. 
  • Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. 
  • Plasma HVA correlates of attentional performance in unmedicated schizophrenics 
  • Plasma amyloid beta 1-42 levels in geriatric depression: A pilot study 
  • Plasma cortisol determination for the dexamethasone suppression test. Comparison of competitive protein-binding and commercial radioimmunoassay methods. 
  • Plasma dexamethasone concentration and cortisol response during manic episodes. 
  • Plasma dexamethasone concentrations and the dexamethasone suppression test. 
  • Plasma haloperidol levels drawn at neuroleptic threshold doses: A pilot study 
  • Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging. 
  • Plasma prolactin and severe premenstrual tension. 
  • Platelet MAO activity in posttraumatic stress disorder. 
  • Platelet MAO inhibition following tricyclic antidepressant therapy. 
  • Platelet [3H]-imipramine binding and leukoencephalopathy in geriatric depression. 
  • Platelet alpha 2-adrenergic receptors in schizophrenic patients before and after phenothiazine treatment. 
  • Platelet alpha-2-adrenergic dysfunction in negative symptom schizophrenia: a preliminary study. 
  • Platelet gamma-aminobutyrate-alpha-ketoglutarate transaminase (GABA-T) in schizophrenia. 
  • Platelet monoamine oxidase activity and the classification of depression. 
  • Platelet monoamine oxidase activity in schizophrenia. 
  • Political violence and mental health in Nepal: prospective study. 
  • Poly-victimisation and Adolescent Psychotic Symptoms in a Nationally-Representative Prospective Cohort Study of Twins 
  • Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia. 
  • Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls. 
  • Polypharmacy in pregnant women with major psychiatric illness: a pilot study. 
  • Polypharmacy in schizophrenia. 
  • Poor executive function at age 13 predicts later schizophreniform disorder: A longitudinal birth cohort study 
  • Portuguese version of Duke Religious Index - DUREL 
  • Position statement on school-based health clinics 
  • Positive Association Between Nightmares and Heart Rate Response to Loud Tones: Relationship to Parasympathetic Dysfunction in PTSD Nightmares. 
  • Positive Correlation Between Nightmares and Heart Rate Response to Loud Tones Supports Parasympathetic Dysfunction in Posttraumatic Stress Disorder 
  • Possibilities within acceptance and commitment therapy for approaching moral injury 
  • Possible lack of anticholinergic effects with mianserin: A pilot study 
  • Post traumatic stress disorder: Guidelines for investigating efficacy of pharmacological intervention 
  • Post-Katrina stabilization of the LSU/Ochsner Psychiatry Residency Program: caveats for disaster preparedness. 
  • Post-partum mood change in Jamaican women: a description and discussion on its significance. 
  • Post-traumatic stress after terrorist attack: psychological reactions following the US embassy bombing in Nairobi: Naturalistic study. 
  • Post-traumatic stress disorder in Vietnam veterans: An experimental validation of the DSM-III diagnostic criteria 
  • Post-traumatic stress disorder in the community: an epidemiological study. 
  • Post-traumatic stress disorder in women: current concepts and treatments. 
  • Post-traumatic stress disorder. 
  • Postdexamethasone Cortisol Levels and Subgroups of Affective Illness-Reply 
  • Poster #143 AT RISK FOR PSYCHOSIS: THE ROLE OF COGNITION 
  • Poster #199 CLINICAL TRIALS OF POTENTIAL COGNITIVE-ENHANCING DRUGS IN SCHIZOPHRENIA: WHAT HAVE WE LEARNED SO FAR? 
  • Poster Abstracts 
  • Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study. 
  • Postpartum depression: a randomized trial of sertraline versus nortriptyline. 
  • Postpartum psychiatric syndromes. 
  • Postsynaptic Mechanisms Render Syn I/II/III Mice Highly Responsive to Psychostimulants. 
  • Posttraumatic Stress Disorder and Common Genetic Variants Affect Subcortical Brain Volumes in Recent Military Veterans 
  • Posttraumatic Stress Disorder in the Elderly. 
  • Posttraumatic distress and coping strategies among rescue workers after an earthquake. 
  • Posttraumatic growth in treatment-seeking female assault victims. 
  • Posttraumatic mental and physical health correlates of forgiveness and religious coping in military veterans. 
  • Posttraumatic stress among young children after the death of a friend or acquaintance in a terrorist bombing. 
  • Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing. 
  • Posttraumatic stress disorder and interpersonal process in homeless veterans participating in a peer mentoring intervention: Associations with program benefit. 
  • Posttraumatic stress disorder and self-reported physical health status among U.S. Military personnel serving during the Gulf War period: a population-based study. 
  • Posttraumatic stress disorder and smoking cessation in veteran smokers 
  • Posttraumatic stress disorder and smoking relapse: A theoretical model. 
  • Posttraumatic stress disorder and traumatic brain Injury: Sex differences in veterans. 
  • Posttraumatic stress disorder in Iraeli combat veterans 
  • Posttraumatic stress disorder in callers to the Anxiety Disorders Association of America. 
  • Posttraumatic stress disorder subtypes invalid 
  • Posttraumatic stress disorder: Recent advances in basic science and clinical research 
  • Posttraumatic stress disorder: acquisition, recognition, course, and treatment. 
  • Posttraumatic stress disorder: anxiety or traumatic stress disorder? 
  • Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. 
  • Posttraumatic stress disorder: epidemiology and health-related considerations. 
  • Posttraumatic stress without trauma in children. 
  • Posttraumatic stress, heart rate variability, and the mediating role of behavioral health risks. 
  • Posttraumatic stress, mental health professionals, and the clergy: a need for collaboration, training, and research. 
  • Postural effects on blood pressure reactivity: implications for studies of laboratory-field generalization. 
  • Potential interactions between GABAb and cholinergic systems: baclofen augments scopolamine-induced performance deficits in the eight-arm radial maze. 
  • Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. 
  • Potential role of pregabalin in the treatment of lithium-induced tremor: a case report. 
  • Potential utility of optogenetics in the study of depression. 
  • Potentiation of L-DOPA induced motor activity by an inhibitor of phenylethanolamine-N-methyltransferase. 
  • Practical aspects of MAO inhibitor therapy. 
  • Practical assessment and evaluation of mental health problems following a mass disaster. 
  • Practical clinical trials in psychiatry: studies of schizophrenia from the CATIE network 
  • Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. 
  • Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association. 
  • Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association. 
  • Practice patterns in the diagnosis and treatment of anxiety and depression in the medically ill. A survey of psychiatrists. 
  • Pre-existing major depression predicts in-hospital cardiac complications after acute myocardial infarction. 
  • Preclinical atherosclerosis covaries with individual differences in reactivity and functional connectivity of the amygdala. 
  • Preclinical perspectives on posttraumatic stress disorder criteria in DSM-5. 
  • Predict Resident Exam Performance (PREP) study. 
  • Predicting fatigue and depression in HIV-positive gay men. 
  • Predicting persistent alcohol problems: a prospective analysis from the Great Smoky Mountain Study. 
  • Predicting personality in adulthood from college MMPI scores: implications for follow-up studies in psychosomatic medicine. 
  • Predicting response to amitriptyline in posttraumatic stress disorder. 
  • Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. 
  • Predicting three types of dissociation in female survivors of intimate partner violence. 
  • Prediction from low birth weight to female adolescent depression: a test of competing hypotheses. 
  • Prediction in drug abuse: Cocaine interactions with alcohol and buprenorphine 
  • Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine. 
  • Prediction of differential adult health burden by conduct problem subtypes in males. 
  • Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. 
  • Prediction of numbing and effortful avoidance in female rape survivors with chronic PTSD. 
  • Prediction of smoking cessation with treatment: the emerging contribution of brain imaging research. 
  • Prediction of the utility of a switch from unilateral to bilateral ECT in the elderly using treatment 2 ictal EEG indices. 
  • Prediction of treatment outcome with lithium. 
  • Predictive relationships between chronic pain and negative emotions: a 4-month daily process study using Therapeutic Interactive Voice Response (TIVR). 
  • Predictive value of family history on severity of illness: the case for depression, anxiety, alcohol dependence, and drug dependence. 
  • Predictors and patterns of participant adherence to a cortisol collection protocol. 
  • Predictors of acute and posttraumatic stress symptoms in parents following their child's cancer diagnosis. 
  • Predictors of antidepressant use among older adults: have they changed over time? 
  • Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. 
  • Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. 
  • Predictors of children's involvement in parents' treatment among homeless veterans in community residential care. 
  • Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics. 
  • Predictors of emotional numbing in posttraumatic stress disorder. 
  • Predictors of high and low levels of HIV risk behavior among adults with chronic mental illness. 
  • Predictors of intimate partner violence revictimization: the relative impact of distinct PTSD symptoms, dissociation, and coping strategies. 
  • Predictors of mental health care use among male and female veterans deployed in support of the wars in Afghanistan and Iraq. 
  • Predictors of nonresponse to treatment in primary care patients with dysthymia. 
  • Predictors of posttraumatic outcomes following the 1999 Taiwan earthquake. 
  • Predictors of primary care physicians' self-reported intention to conduct suicide risk assessments. 
  • Predictors of recurrence in remitted late-life depression. 
  • Predictors of relapse in patients with major depressive disorder in a 52-week, fixed dose, double blind, randomized trial of selegiline transdermal system (STS). 
  • Predictors of response to monoamine oxidase inhibitors: do they exist? 
  • Predictors of response to ziprasidone: results from a 6-week randomized double-blind, placebo-controlled trial for acute depressive mixed state. 
  • Predictors of suicidal ideation in a gender-stratified sample of OEF/OIF veterans. 
  • Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. 
  • Predictors of treatment engagement in ethnically diverse, urban children receiving treatment for trauma exposure. 
  • Predictors of treatment response in patients with posttraumatic stress disorder. 
  • Predictors of workforce turnover in a transported treatment program. 
  • Preferences for psychiatric advance directives among Latinos: views on advance care planning for mental health. 
  • Preferential amygdala reactivity to the negative assessment of neutral faces. 
  • Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans. 
  • Preferred intensity exercise for adolescents receiving treatment for depression: a pragmatic randomised controlled trial. 
  • Prefrontal Cortex-amygdalar Circuit Dynamics Predict Stress Susceptibility 
  • Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. 
  • Prefrontal neuropsychological predictors of treatment remission in late-life depression. 
  • Prefrontal white matter lesions and prefrontal task impersistence in depressed and nondepressed elders. 
  • Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. 
  • Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study. 
  • Pregabalin in generalized anxiety disorder: a placebo-controlled trial. 
  • Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate. 
  • Pregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice 
  • Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia 
  • Pregnenolone reductions in parietal cortex are associated with suicide in patients with schizophrenia 
  • Preliminary studies of 6 beta-hydroxydexamethasone and its importance in the DST. 
  • Preliminary study of carbamazepine in post-traumatic stress disorder. 
  • Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival. 
  • Premenstrual mood changes: A [feminist] guide to evaluation and treatment 
  • Premenstrual symptom changes and plasma beta-endorphin/beta-lipotropin throughout the menstrual cycle. 
  • Premenstrual symptoms in black and white community samples. 
  • Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. 
  • Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs. 
  • Premorbid sociosexual functioning and long-term outcome in schizophrenia. 
  • Prenatal dysthymia versus major depression effects on maternal cortisol and fetal growth. 
  • Prenatal mild ventriculomegaly predicts abnormal development of the neonatal brain. 
  • Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. 
  • Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: Serotonin receptors and cell signaling. 
  • Prenatal smoking and early childhood conduct problems: testing genetic and environmental explanations of the association. 
  • Prenatal smoking and young children’s antisocial behavior: Testing genetic and environmental explanations of the association 
  • Preparing Psychiatrists for Leadership Roles in Healthcare 
  • Preserved working memory and altered brain activation in persons at risk for psychosis. 
  • Pressor hyperreactivity is a predictor of the future development of essential hypertension. 
  • Pretreatment brain connectivity during positive emotion upregulation predicts decreased anhedonia following behavioral activation therapy for depression. 
  • Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. 
  • Prevalence and development of psychiatric disorders in childhood and adolescence. 
  • Prevalence and diagnostic reliability of methadone maintenance detoxification fear. 
  • Prevalence and factors associated with antenatal depressive symptoms among women enrolled in Option B+ antenatal HIV care in Malawi: a cross-sectional analysis. 
  • Prevalence and incidence of probable perinatal depression among women enrolled in Option B+ antenatal HIV care in Malawi. 
  • Prevalence and psychosocial correlates of food addiction in persons with obesity seeking weight reduction. 
  • Prevalence of HIV infection in a general psychiatric outpatient population. 
  • Prevalence of antithyroid antibodies in mood disorders 
  • Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study. 
  • Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. 
  • Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal. 
  • Prevalence of depression and its treatment in an elderly population: the Cache County study. 
  • Prevalence of health-related behaviors among physicians and medical trainees. 
  • Prevalence of obstructive sleep apnea in suicidal patients with major depressive disorder. 
  • Prevalence of psychiatric disorders among incarcerated women. II. Convicted felons entering prison. 
  • Prevalence of psychiatric morbidity in United States military spouses: The Millennium Cohort Family Study. 
  • Prevalence of seasonal affective disorder. 
  • Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. 
  • Prevalence of traumatic brain injury in incarcerated groups compared to the general population: a meta-analysis. 
  • Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. 
  • Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. 
  • Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. 
  • Prevalence, factorial structure, and clinical correlates of first rank symptoms in urban, African-American patients with first-episode nonaffective psychosis 
  • Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. 
  • Preventing suicide in primary care patients: the primary care physician's role. 
  • Preventing the unpredicted: managing violence risk in mental health care. 
  • Prevention of postpartum depression: a pilot randomized clinical trial. 
  • Prevention of postpartum episodes in women with bipolar disorder. 
  • Prevention of recurrent postpartum depression: A randomized clinical trial 
  • Prevention of recurrent postpartum depression: a randomized clinical trial. 
  • Primary care physicians' and psychiatrists' approaches to treating mild depression. 
  • Primary care physicians' and psychiatrists' willingness to refer to religious mental health providers. 
  • Priming deficits in patients with dementia of the Alzheimer type. 
  • Primum non nocere (first do no harm): symptom worsening and improvement in female assault victims after prolonged exposure for PTSD. 
  • Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects. 
  • Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. 
  • Private health insurance coverage for substance abuse and mental health services, 1995 to 1998. 
  • Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews. 
  • Probing reward function in post-traumatic stress disorder with beautiful facial images. 
  • Problem-solving therapy for the treatment of depression in primary care (PST-PC): A brief and practical treatment approach 
  • Problematic internet use: proposed classification and diagnostic criteria. 
  • Problems in psychotherapy with suicidal patients. 
  • Problems of Southeast Asian children in a refugee camp. 
  • Problems with diagnostic criteria for depression. 
  • Producing Guanxi: Sentiment, Self and Subculture in a North China Village 
  • Profiling posttraumatic functional impairment. 
  • Prognosis for psychophysiologic disorders in the naval service. 
  • Prognostic validity of self-report and interview measures of personality disorder in depressed inpatients. 
  • Progression of subcortical ischemic disease from vascular depression to vascular dementia. 
  • Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. 
  • Progression to AIDS: the effects of stress, depressive symptoms, and social support. 
  • Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study. 
  • Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors 
  • Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods. 
  • Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. 
  • Prolactin response to TRH in depression. 
  • Prolactin response to electroconvulsive therapy. 
  • Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. 
  • Prolactin response to morphine in depression. 
  • Prolactin-related and metabolic adverse effects of atypical antipsychotic agents. 
  • Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. 
  • Prolonged Exposure Therapy With Veterans and Active Duty Personnel Diagnosed With PTSD and Traumatic Brain Injury. 
  • Prolonged confusional state and EEG seizure activity following concurrent ECT and lithium use. 
  • Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. 
  • Promoting mental health recovery and improving clinical assessment using video technology. 
  • Promoting trauma-informed parenting of children in out-of-home care: An effectiveness study of the resource parent curriculum. 
  • Proof-of-Concept Randomized Controlled Trial with Pregnenolone in Mild Traumatic Brain Injury 
  • Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia. 
  • Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. 
  • Proof-of-concept trial with the neurosterold pregnenolone targeting neurocognitive and negative symptoms in schizophrenia 
  • Properties of the telephone interview for cognitive status: Application in epidemiological and longitudinal studies 
  • Propranolol in the treatment of anxiety neurosis. 
  • Propranolol treatment of an ECT-related ventricular arrythmia. 
  • Prospective Study of Major Loss Life Events and Risk for Suicidal Thoughts and Behaviors Among Adolescents and Young Adults. 
  • Prospective study of externalizing and internalizing subtypes of posttraumatic stress disorder and their relationship to mortality among Vietnam veterans. 
  • Prospective, observational cohort study of JAKE (TM), an autism knowledge 
  • Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. 
  • Protective effect of pregnancy in women with lithium-responsive bipolar disorder. 
  • Protective factors and risk modification of violence in Iraq and Afghanistan War veterans. 
  • Protective factors for psychotic experiences amongst adolescents exposed to multiple forms of victimization. 
  • Protective mechanisms and prevention of violence and aggression in veterans. 
  • Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. 
  • Protein kinase a in major depression: the link between hypothalamic-pituitary-adrenal axis hyperactivity and neurogenesis. 
  • Proton spectroscopy of human brain: effects of age and sex. 
  • Providers' Behaviors and Beliefs on Prescribing Antipsychotic Medication to Children: A Qualitative Study. 
  • Providers' perceptions of barriers to the treatment of emotional disorders in non-urban primary care clinics 
  • Proximal Risk Factors for Short-Term Community Violence Among Adults With Mental Illnesses. 
  • Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. 
  • Pseudoseizures: recognition and treatment. 
  • Psychiatric Care of the Post-September 11 Combat Veteran: A Review. 
  • Psychiatric Disorders in Individuals with Alcoholic Parents: An Epidemiologic Enquiry 
  • Psychiatric advance directives among public mental health consumers in five U.S. cities: prevalence, demand, and correlates. 
  • Psychiatric advance directives and reduction of coercive crisis interventions. 
  • Psychiatric advance directives and social workers: an integrative review. 
  • Psychiatric advance directives: a tool for consumer empowerment and recovery. 
  • Psychiatric advance directives: an alternative to coercive treatment? 
  • Psychiatric and medical comorbidities of bipolar disorder. 
  • Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. 
  • Psychiatric co-morbidities and patients with head and spinal cord trauma. Effects on acute hospital care. 
  • Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. 
  • Psychiatric consequences of the 1998 US Embassy bombing in Nairobi, Kenya 
  • Psychiatric consultation in a Vietnamese refugee camp. 
  • Psychiatric disease in the genomic era: rational approach. 
  • Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression. 
  • Psychiatric disorder, impairment, and service use in rural African American and white youth. 
  • Psychiatric disorders after terrorist bombings among rescue workers and bombing survivors in Nairobi and rescue workers in Oklahoma City. 
  • Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. 
  • Psychiatric disorders in adult children of alcoholics: data from the Epidemiologic Catchment Area project. 
  • Psychiatric disorders in pediatric primary care. Prevalence and risk factors. 
  • Psychiatric disorders in primary care patients receiving complementary medical treatments. 
  • Psychiatric disorders. A rural/urban comparison. 
  • Psychiatric education in the State Hospital: A current approach 
  • Psychiatric education in the emergency room: must teaching stop at 5 p.m.? 
  • Psychiatric education of the internist: a teaching conference approach. 
  • Psychiatric episodes in women with young children. 
  • Psychiatric health service areas in the southeast. 
  • Psychiatric impairment, social contact, and violent behavior: evidence from a study of outpatient-committed persons with severe mental disorder. 
  • Psychiatric manifestations in Churg-Strauss syndrome. 
  • Psychiatric morbidity during the early phase of coronary care for myocardial infarction: association with cardiac diagnosis and outcome. 
  • Psychiatric outcomes of bullying victimization: a study of discordant monozygotic twins. 
  • Psychiatric sequelae of traumatic brain injury: a case report. 
  • Psychiatric syncope: a new look at an old disease. 
  • Psychiatric training in primary care medicine residency programs. A national survey. 
  • Psychiatric violence risk assessment 
  • Psychiatrists' and primary care physicians' beliefs about overtreatment of depression and anxiety. 
  • Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment. 
  • Psychiatrists' transition from training to career: stress and mastery. 
  • Psychiatry Takes to the Streets 
  • Psychiatry and social values: the American Psychiatric Association and immigration restriction, 1880-1930. 
  • Psychiatry and the oldest old. 
  • Psychodynamic perspectives of collaborative treatment. 
  • Psychodynamic psychotherapy for PTSD. 
  • Psychodynamic understanding and the therapeutic alliance in the psychiatric emergency room. 
  • Psychogenomics and psychiatric practice, a new paradigm 
  • Psychological Inflexibility Predicts of Suicidal Ideation Over Time in Veterans of the Conflicts in Iraq and Afghanistan. 
  • Psychological and physiological effects of physical conditioning on the elderly. 
  • Psychological aspects of hypertension. II. The differential influence of interview variables on blood pressure. 
  • Psychological changes accompany aerobic exercise in healthy middle-aged adults. 
  • Psychological distress is associated with tobacco smoking and quitting behaviour in the Australian population: evidence from national cross-sectional surveys. 
  • Psychological treatments delivered by community health workers in low-resource government health systems: effectiveness of group interpersonal psychotherapy for caregivers of children affected by nodding syndrome in Uganda. 
  • Psychological variables in hypertension: relationship to casual or ambulatory blood pressure in men. 
  • Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients. 
  • Psychometric detection of fabricated symptoms of posttraumatic stress disorder. 
  • Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. 
  • Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. 
  • Psychometric properties of the UCLA PTSD reaction index. part II: investigating factor structure findings in a national clinic-referred youth sample. 
  • Psychometric properties of the UCLA PTSD reaction index: part I. 
  • Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam. 
  • Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. 
  • Psychoneuroendocrinology and brain imaging in depression. 
  • Psychoneuroendocrinology of schizophrenia. 
  • Psychopharmacological investigations of a lead-induced long-term cognitive deficit in monkeys. 
  • Psychopharmacology curriculum field test. 
  • Psychoses associated with propranolol withdrawal. 
  • Psychosis in Parkinson's disease: diagnosis and treatment. 
  • Psychosis related to ropinirole [2] 
  • Psychosis related to ropinirole. 
  • Psychosocial and physical correlates of chronic depression. 
  • Psychosocial and physical predictors of anginal pain relief with medical management. 
  • Psychosocial aspects of substance abuse by clients with severe mental illness. 
  • Psychosocial benefits of three formats of a standardized behavioral stress management program. 
  • Psychosocial correlates of job strain in a sample of working women. 
  • Psychosocial protective factors and suicidal ideation: Results from a national longitudinal study of veterans. 
  • Psychosocial risk factors and urban/rural differences in the prevalence of major depression. 
  • Psychosocial risk factors for CHD and biobehavioral mechanisms: The role of CNS serotonin and serotonin-related genes 
  • Psychosocial self-prognosis in relation to mortality and morbidity in hemophiliacs with HIV infection. 
  • Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. 
  • Psychosocial work environment and depressive symptoms among US workers: comparing working poor and working non-poor. 
  • Psychotherapeutic Treatment of Bipolar Depression. 
  • Psychotherapy in the Third Reich: Goering Institute by Geoffrey Cocks, 
  • Psychotherapy in the Third Reich: The Göring Institute 
  • Psychotherapy in the overall management strategy for social anxiety disorder: Comments 
  • Psychotic disorders cause the greatest mortality disparity among mental disorders, though more deaths are attributable overall to mood and anxiety disorders. 
  • Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area study. 
  • Psychotic symptoms in patients with medical disorders. 
  • Psychotropic drugs on general medical and surgical wards of a teaching hospital. 
  • Psychotropic medication claims among religious clergy. 
  • Pubertal changes in hormone levels and depression in girls. 
  • Puberty and depression: the roles of age, pubertal status and pubertal timing. 
  • Puberty onset of gender differences in rates of depression: a developmental, epidemiologic and neuroendocrine perspective. 
  • Public anti-stigma programmes might impove help-seeking. 
  • Public attitudes towards the acceptability of using drugs to treat depression and ADHD. 
  • Public policy and obesity: the need to marry science with advocacy. 
  • Pure and mixed manic subtypes: a review of diagnostic classification and validation. 
  • QTc prolongation, torsades de pointes, and psychotropic medications. 
  • Quality assessment and improvement in group psychotherapy. 
  • Quality of Life in Geriatric Depression Preliminary Data From Phase I of the PRIDE Study 
  • Quality of life and cost factors in panic disorder 
  • Quality of life and cost factors in panic disorder. 
  • Quality of life and physical activity associated to lower prevalence of depression in community-dwelling elderly subjects from Sao Paulo. 
  • Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine. 
  • Quality of life and recovery after cardiac surgery. 
  • Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. 
  • Quality of medical care and excess mortality in older patients with mental disorders. 
  • Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses. 
  • Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. II. Topographic analyses. 
  • Quantitative analysis of T2 signal intensities in Alzheimer's disease. 
  • Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. 
  • Quetiapine XR: current status for the treatment of major depressive disorder. 
  • Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study. 
  • Quetiapine augmentation for depression: dosing pattern in routine practice. 
  • Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. 
  • Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. 
  • Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. 
  • Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders. 
  • RACE DIFFERENCES IN RESTING AND STRESS-RELATED HEART RATE VARIABILITY IN PATIENTS WITH HEART FAILURE 
  • RACE, PARENTAL HISTORY OF HYPERTENSION, AND PATTERNS OF CARDIOVASCULAR REACTIVITY IN WOMEN 
  • REDUCED ADRENAL MEDULLARY ACTIVITY MAY BE IMPORTANT FOR THE MAINTENANCE OF NORMAL GLUCOSE REGULATION IN THE OBESE STATE 
  • REDUCED VAGALLY MEDIATED HEART RATE VARIABILITY PREDICTS HYPERTENSION 
  • REMOVED: Investigating misophonia: A review of the literature, clinical implications and research agenda reflecting current neuroscience and emotion research perspectives. 
  • RU486 in depression. 
  • Race and sex differences in cutaneous pain perception. 
  • Racial Disparities in the Administration of ECT in Texas, 1998-2013. 
  • Racial differences in antidepressant treatment preceding suicide in a Medicaid population. 
  • Racial differences in blood pressure and forearm vascular responses to the cold face stimulus. 
  • Racial/ethnic differences in parent-reported barriers to accessing children's health services. 
  • Racial/ethnic variations in substance-related disorders among adolescents in the United States. 
  • Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs. 
  • Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions. 
  • Randomized Trial of the Effect of Four Second-Generation Antipsychotics and One First-Generation Antipsychotic on Cigarette Smoking, Alcohol, and Drug Use in Chronic Schizophrenia. 
  • Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. 
  • Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). 
  • Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. 
  • Randomized sham controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area (SMA) for the treatment of medication resistant obsessive-compulsive disorder (OCD) 
  • Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive-compulsive disorder. 
  • Randomized trial of sertraline versus venlafaxine XR in major depression: Efficacy and discontinuation symptoms 
  • Randomized, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study of GSK239512 for Cognitive Impairment in Stable Schizophrenia Subjects on Background Antipsychotic Therapy 
  • Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia. 
  • Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. 
  • Randomized, placebo-controlled, double-blind trial of paroxetine controlled release in irritable bowel syndrome 
  • Randomized, placebo-controlled, double-blind trial of paroxetine controlled release in irritable bowel syndrome 
  • Rape: The misunderstood crime. By Julie A. Allison & Lawrence S. Wrightsman. Newbury Park, CA: Sage Publications, 1993, 307 pages. Hardcover: $45.00, softcover: $21.95 
  • Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. 
  • Rapid selection for serotonin-1A sensitivity in rats. 
  • Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial. 
  • Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans. 
  • Rash associated with st. John’s wort treatment in premenstrual dysphoric disorder 
  • Rate Sensitive Immediate Feedback Inhibition of ACTH Secretionby Endogenous Cortisol in Human CRH Test 
  • Rate of head growth decelerates and symptoms worsen in the second year of life in autism. 
  • Rates and predictors of rehospitalization among formerly hospitalized adolescents. 
  • Rationale for Spiritually Oriented Cognitive Processing Therapy for Moral Injury in Active Duty Military and Veterans With Posttraumatic Stress Disorder. 
  • Re-evaluating the Electroconvulsive Therapy Stimulus: Frequency and Directionality 
  • Re-evaluating the Electroconvulsive Therapy Stimulus: Train Duration 
  • Re: Community treatment orders for psychiatric patients: the emperor with no clothes. 
  • Reactivity to sensations in borderline personality disorder: a preliminary study. 
  • Realizing the dream. 
  • Recent advances in poststroke depression. 
  • Recent advances in the pharmacologic treatment of bipolar illness 
  • Recent victimization in women and men with severe mental illness: prevalence and correlates. 
  • Recognition and Prevention of Major Mental and Substance Use Disorders 
  • Recognition and assessment of shift work disorder. 
  • Recognition of depression in medical patients with heart failure. 
  • Recognizing and managing insomnia in primary care and specialty settings. 
  • Reconsideration of the training of psychiatrists and mental health professionals: helping to make soup. 
  • Reconsidering somatic presentation of generalized anxiety disorder in Nepal. 
  • Recovery and recurrence following treatment for adolescent major depression. 
  • Recovery of orientation after electroconvulsive therapy. 
  • Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: a candidate for psychiatric illnesses. 
  • Red blood cell catechol O-methyl transferase and response to imipramine in unipolar depressive women. 
  • Redirecting the Mental Health and Gun Violence Conversation From Mass Shootings to Suicide. 
  • Reduced Amygdala and Hippocampal Volumes Associated with PTSD in Recent Military Veterans from Iraq and Afghanistan 
  • Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression. 
  • Reduced amygdala response in youths with disruptive behavior disorders and psychopathic traits: decreased emotional response versus increased top-down attention to nonemotional features. 
  • Reduced amygdala-orbitofrontal connectivity during moral judgments in youths with disruptive behavior disorders and psychopathic traits. 
  • Reduced blue cone electroretinogram in cocaine-withdrawn patients. 
  • Reduced cannabis use after low-dose naltrexone addition to opioid detoxification. 
  • Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. 
  • Reduced hippocampal and amygdala activity predicts memory distortions for trauma reminders in combat-related PTSD. 
  • Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression. 
  • Reduced neural habituation in the amygdala and social impairments in autism spectrum disorders. 
  • Reduced tolerance and cardiovascular response to ischemic pain in minor depression. 
  • Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study. 
  • Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial. 
  • Reducing barriers to completing psychiatric advance directives. 
  • Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone. 
  • Reduction in risk behavior among adults with severe mental illness who learned to advocate for HIV prevention. 
  • Reduction of dorsolateral prefrontal cortex gray matter in late-life depression. 
  • Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats. 
  • Reduction of orbital frontal cortex volume in geriatric depression. 
  • Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia. 
  • Reductions in arrest under assisted outpatient treatment in New York. 
  • Referrals to psychiatrists. Assessing the communication interface between psychiatry and primary care. 
  • Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder 
  • Refining the latent structure of neuropsychological performance in schizophrenia. 
  • Reflechi twòp--thinking too much: description of a cultural syndrome in Haiti's Central Plateau. 
  • Refractory calculation-induced idiopathic generalized epilepsy. A case report and review of the literature 
  • Refractory calculation-induced idiopathic generalized epilepsy: A case report and review of the literature 
  • Regarding "The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands". 
  • Regional brain activity correlates of nicotine dependence. 
  • Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. 
  • Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy. 
  • Regional cerebral blood flow correlates of a dichotic listening task. 
  • Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. 
  • Regional heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the ventral tegmental area of alcohol-preferring (P) rats: Involvement of dopamine and serotonin 
  • Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study. 
  • Regular sources of medical care among persons with severe mental illness at risk of hepatitis C infection. 
  • Regulation and function of MeCP2 Ser421 phosphorylation in U50488-induced conditioned place aversion in mice. 
  • Regulation of appetite and cholecystokinin secretion in anorexia nervosa. 
  • Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking. 
  • Regulation of dopamine release and metabolism in rat striatum in vivo: effects of dopamine receptor antagonists. 
  • Regulatory Focus and Reward Sensitivity: Integrating Social-Cognitive and Affective Neuroscience Perspectives 
  • Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). 
  • Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. 
  • Relapse Following Combined Treatment Discontinuation in a Placebo-Controlled Trial for Panic Disorder 
  • Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report. 
  • Relating Intrinsic Low-Frequency BOLD Cortical Oscillations to Cognition in Schizophrenia. 
  • Relation between informant-rated personality and clinician-rated depression in patients with memory disorders. 
  • Relation of lifetime trauma and depressive symptoms to mortality in HIV. 
  • Relation of subjective and received social support to clinical and self-report assessments of depressive symptoms in an elderly population. 
  • Relations of trait depression and anxiety to low lipid and lipoprotein concentrations in healthy young adult women. 
  • Relationship between abdominal pain subgroups in the community and psychiatric diagnosis and personality. A birth cohort study. 
  • Relationship between all-cause mortality and cumulative working life course psychosocial and physical exposures in the United States labor market from 1968 to 1992. 
  • Relationship between change in in-vivo exposure distress and PTSD symptoms during exposure therapy for active duty soldiers. 
  • Relationship between depression and pancreatic cancer in the general population. 
  • Relationship between pain sensitivity and resting arterial blood pressure in patients with painful temporomandibular disorders. 
  • Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. 
  • Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo. 
  • Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers. 
  • Relationship between tobacco smoking and positive and negative symptoms in schizophrenia 
  • Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. 
  • Relationship between traumatic brain injury history and recent suicidal ideation in Iraq/Afghanistan-era veterans. 
  • Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women. 
  • Relationship of clinic, ambulatory, and laboratory stress blood pressure to left ventricular mass in overweight men and women with high blood pressure. 
  • Relationship of cognition and psychopathology to functional impairment in schizophrenia. 
  • Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients. 
  • Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. 
  • Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. 
  • Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia. 
  • Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia. 
  • Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study. 
  • Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence. 
  • Relationship of psychiatric illness to childbearing status: a hospital-based epidemiologic study. 
  • Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence. 
  • Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence. 
  • Relationship of trauma symptoms to amygdala-based functional brain changes in adolescents. 
  • Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. 
  • Relationships between maternal and adolescent weight-related behaviors and concerns: the role of perception. 
  • Relationships of Shared Decision Making with Parental Perceptions of Child Mental Health Functioning and Care. 
  • Relationships of maternal folate and vitamin B12 status during pregnancy with perinatal depression: The GUSTO study. 
  • Relationships of mental health problems with stress among civil servants in Guangzhou, China. 
  • Relative accuracy and reproducibility of regional MRI brain volumes for point-counting methods. 
  • Relative impact of maternal depression and associated risk factors on offspring psychopathology. 
  • Relevance of religion and spirituality in German patients with chronic diseases. 
  • Reliabilities and intercorrelations of reported and objective measures of smoking in patients with schizophrenia. 
  • Reliability and validity of SAFTEE: Preliminary analyses 
  • Reliability of reports of violent victimization and posttraumatic stress disorder among men and women with serious mental illness. 
  • Reliability of the services assessment for children and adolescents. 
  • Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. 
  • Relief of expressed suicidal intent by ECT: a consortium for research in ECT study. 
  • Religion and beliefs about treating medically unexplained symptoms: a survey of primary care physicians and psychiatrists. 
  • Religion and medicine I: historical background and reasons for separation. 
  • Religion and medicine II: religion, mental health, and related behaviors. 
  • Religion and medicine III: developing a theoretical model. 
  • Religion and medicine IV: religion, physical health, and clinical implications. 
  • Religion and mental health: Evidence for an association 
  • Religion and mental health: What should psychiatrists do? 
  • Religion and psychotic experiences. 
  • Religion and remission of depression in medical inpatients with heart failure/pulmonary disease. 
  • Religion index for psychiatric research. 
  • Religion, Culture and Mental Health. By K. Loewenthal. (Pp. 169; $85.00; ISBN 13-978-0-521-85023-0 hb.) Cambridge University Press: New York. 2007. 
  • Religion, sense of calling, and the practice of medicine: findings from a national survey of primary care physicians and psychiatrists. 
  • Religion, spirituality and depression in prospective studies: A systematic review. 
  • Religion, spirituality and psychiatry: A new era in mental health care 
  • Religion, spirituality and psychotic disorders 
  • Religion, spirituality, and depression in adolescent psychiatric outpatients. 
  • Religion, spirituality, and health: a review and update. 
  • Religion, spirituality, and medicine: a rebuttal to skeptics. 
  • Religion, spirituality, and medicine: psychiatrists' and other physicians' differing observations, interpretations, and clinical approaches. 
  • Religion, spirituality, and mental health of U.S. military veterans: Results from the National Health and Resilience in Veterans Study. 
  • Religion, spirituality, and mental health: current controversies and future directions. 
  • Religion, spirituality, and mental health: what we know and why this is a tough topic to research. 
  • Religion, spirituality, and mysticism. 
  • Religion/spirituality and depression: what can we learn from empirical studies? 
  • Religiosity and decreased risk of substance use disorders: is the effect mediated by social support or mental health status? 
  • Religiosity and remission of depression in medically ill older patients. 
  • Religiosity and self-rated health among Latin American and Caribbean elders. 
  • Religiosity as a protective factor in depressive disorder. 
  • Religiosity enhances cardiovascular reactivity among black males with low education 
  • Religiosity may help preserve the cortisol rhythm in women with stress-related illness. 
  • Religiosity, depression and telomere length in Chinese older adults. 
  • Religiosity, depression, and quality of life in bipolar disorder: a two-year prospective study. 
  • Religiosity/spirituality and pain in patients with sickle cell disease. 
  • Religious Involvement and Telomere Length in Women Family Caregivers. 
  • Religious activities as predictors of health and survival 
  • Religious affiliations in mental health research samples as compared with national samples. 
  • Religious and spiritual factors and the consequences of trauma: a review and model of the interrelationship. 
  • Religious beliefs and alcohol control policies: a Brazilian nationwide study. 
  • Religious content in the DSM-III-R glossary of technical terms. 
  • Religious coping and ambulatory blood pressure: The moderating effects of ethnicity 
  • Religious coping and cognitive symptoms of depression in elderly medical patients. 
  • Religious coping and depression among elderly, hospitalized medically ill men. 
  • Religious coping and health status in medically ill hospitalized older adults. 
  • Religious coping and quality of life among individuals living with schizophrenia. 
  • Religious coping and quality of life among individuals living with schizophrenia. 
  • Religious coping in the nursing home: a biopsychosocial model. 
  • Religious coping, ethnicity, and ambulatory blood pressure 
  • Religious coping, ethnicity, and ambulatory blood pressure. 
  • Religious involvement is associated with greater purpose, optimism, generosity and gratitude in persons with major depression and chronic medical illness. 
  • Religious involvement, suicidal ideation and behavior in mainland China. 
  • Religious vs. conventional cognitive behavioral therapy for major depression in persons with chronic medical illness: a pilot randomized trial. 
  • Religious, spiritual, and traditional beliefs and practices and the ethics of mental health research in less wealthy countries. 
  • Religiousness and mental health: a review. 
  • Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale. 
  • Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR. 
  • Remitted major depression is characterized by reduced prefrontal cortex reactivity to reward loss. 
  • Remitted major depression is characterized by reward network hyperactivation during reward anticipation and hypoactivation during reward outcomes. 
  • Repairing the shattered self: recovering from trauma. 
  • Repeated measures, interventions, and time series analysis. 
  • Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. 
  • Repetitive Transcranial Magnetic Stimulation (rTMS) of the Superior Frontal Gyrus Modulates Craving for Cigarettes 
  • Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). 
  • Repetitive transcranial magnetic stimulation (rTMS): A noninvasive neuromodulation probe and intervention (Journal of ECT (2011) 27, (2)) 
  • Repetitive transcranial magnetic stimulation (rTMS): a noninvasive neuromodulation probe and intervention. 
  • Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. 
  • Replication analysis for composition of the Delirium Motor Subtype Scale (DMSS) in a referral cohort from Northern India. 
  • Replication in Imaging Genetics: The Case of Threat-Related Amygdala Reactivity. 
  • Reply 
  • Reply to Dr Ng's comments on "A Randomized, Double-Blind, Placebo-Controlled Trial of Augmentation with An Extended Release Formulation of Methylphenidate in Outpatients with Treatment-Resistant Depression" [11] 
  • Reply to Kocsis letter 
  • Reply to Mushtaq et al. 
  • Reply to: Declining use of electroconvulsive therapy in U.S. general hospitals is not restricted to unipolar depression. 
  • Report card on the National Plan for Research on Child and Adolescent Mental Disorders. The midway point. 
  • Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia. 
  • Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia. 
  • Research design features and patient characteristics associated with the outcome of antidepressant clinical trials. 
  • Research funding: The view from NIH 
  • Research issues in psychological studies of chronic dialysis. 
  • Research on field-based services: models for reform in the delivery of mental health care to populations with complex clinical problems. 
  • Research on religion, spirituality, and mental health: a review. 
  • Research priorities in adolescent psychiatry: report of the committee on research of the American Society for Adolescent Psychiatry. 
  • Research priorities in mental health, Part 2: an evaluationof the current research effort against stakeholders' priorities. 
  • Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. 
  • Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo. 
  • Resilience as a translational endpoint in the treatment of PTSD. 
  • Resilience in the face of chronic illness and family caregiving in middle and later life 
  • Resilience: Determinants, measurement, and treatment responsiveness 
  • Resiliency among individuals with childhood sexual abuse and HIV: perspectives on addressing sexual trauma. 
  • Resolution of trauma-related guilt following treatment of PTSD in female rape victims: a result of cognitive processing therapy targeting comorbid depression? 
  • Resolved: psychosocial interventions can improve clinical outcomes in organic disease (pro). 
  • Resolved: psychosocial interventions can improve clinical outcomes in organic disease--rebuttals and closing arguments. 
  • Response 
  • Response 
  • Response 
  • Response characteristics to antidepressants and placebo in post-traumatic stress disorder. 
  • Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges 
  • Response of the norepinephrine system to antidepressant drugs 
  • Response to Baandrup letter 
  • Response to Bora. 
  • Response to Burns. 
  • Response to Fred W. Becker's 'The politics of closing state mental hospitals' 
  • Response to Gorelick. 
  • Response to Kahn and Kahn, "group treatment assignment for outpatients with schizophrenia" 
  • Response to effect of the first ECT in a series by C. Kellner, MD [5] 
  • Response to letters to the editor [3] 
  • Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. 
  • Responses to hypercarbia induced by acetazolamide in panic disorder patients. 
  • Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy. 
  • Resting State Connectivity Between Amygdalar Subregions and the Prefrontal Cortex is Disrupted in PTSD 
  • Resting state cortical connectivity reflected in EEG coherence in individuals with autism. 
  • Resting-state brain fluctuation and functional connectivity dissociate moral injury from posttraumatic stress disorder. 
  • Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives. 
  • Resting-state connectivity predictors of response to psychotherapy in major depressive disorder. 
  • Resting-state mapping of neural signatures of vulnerability to depression relapse. 
  • Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms. 
  • Restored WAVE1 Levels in a Model of NMDA Receptor Hypofunction Attenuates Working Memory Deficits 
  • Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder. 
  • Results of phase 3 of the CATIE schizophrenia trial. 
  • Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls. 
  • Retrograde amnesia with electroconvulsive therapy: characteristics and implications. 
  • Reversal of Consolidated Behavioral Sensitization and Associated Neurochemical Changes by Local Infusion of PKC Zeta (zeta) Inhibitory Pseudosubstrate (ZIP) Peptide in Nucleus Accumbens Core 
  • Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions. 
  • Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors. 
  • Review of literature on aftercare services among children and adolescents. 
  • Review: More RCTs on early intensive behavioural intervention for young children with autism spectrum disorders needed 
  • Review: Nicotine replacement treatments achieve smoking abstinence at 6-12 months: Commentary 
  • Review: Pharmacotherapy increases response and reduces symptom severity in paediatric anxiety disorders 
  • Review: Self help interventions alone minimally increase smoking cessation: Commentary 
  • Review: antidepressants are effective for the treatment of major depressive disorder in individuals aged 55 years or older. 
  • Review: clozapine shows some improved clinical efficacy over risperidone and zotepine in treatment of schizophrenia, but robust evidence is lacking. 
  • Revised PORT recommendations. 
  • Revisiting cycloid psychosis: a case of an acute, transient and recurring psychotic disorder. 
  • Revisiting monoamine oxidase inhibitors. 
  • Revisiting the backward masking deficit in schizophrenia: individual differences in performance and modeling with transcranial magnetic stimulation. 
  • Reward-related learning via multiple memory systems. 
  • Richard Dadd and the Fairy Feller's Master-Stroke. 
  • Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study. 
  • Right amygdala volume in adolescent and young adult offspring from families at high risk for developing alcoholism. 
  • Risk Factors for New-Onset Depression After First-Time Traumatic Brain Injury. 
  • Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. 
  • Risk factors of attempted suicide in bipolar disorder. 
  • Risk factors prospectively associated with adult obsessive-compulsive symptom dimensions and obsessive-compulsive disorder. 
  • Risk of smoking and receipt of cessation services among veterans with mental disorders. 
  • Risk reconsidered: targets of violence in the social networks of people with serious psychiatric disorders. 
  • Risks versus benefits of different types of long-acting injectable antipsychotics. 
  • Risks, Benefits, and Recommendations for Pastoral Care on Inpatient Psychiatric Units: A Systematic Review. 
  • Risperidone and cognitive function in children with disruptive behavior disorders. 
  • Risperidone and pituitary tumors: a pharmacovigilance study 
  • Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. 
  • Robbing Peter to pay Paul: did New York State's outpatient commitment program crowd out voluntary service recipients? 
  • Role of GABRA2 in trajectories of externalizing behavior across development and evidence of moderation by parental monitoring. 
  • Role of individual and developmental differences in voluntary cocaine intake in rats. 
  • Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats. 
  • Role of serotonin in hypothalamo pituitary adrenal axis escape from dexamethasone suppression. 
  • Role of stress in the etiology and treatment of diabetes mellitus. 
  • Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms. 
  • Roles of mental health professionals in multidisciplinary medically supervised treatment programs for obesity. 
  • Roth and batson reply to "creative balance" commentary 
  • Rudolf Steiner (1861-1925). 
  • Rurality and mental health treatment. 
  • S.03.02 Gene-environment interaction in depression 
  • S.14.04 CATIE trial results 
  • S80. Individual Differences of Spontaneous Angular Gyrus Brain Activity in Dissociating Moral Injury and Posttraumatic Stress Disorder 
  • SLEEP PATTERNS OF INDIVIDUALS WITH SCHIZOPHRENIA 
  • SLITRK1 mutations in trichotillomania 
  • SLITRK1 mutations in trichotillomania. 
  • SNARE proteins and the timing of neurotransmitter release. 
  • SPRINT: a brief global assessment of post-traumatic stress disorder. 
  • SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept. 
  • STABILITY OF PSYCHIATRIC-DIAGNOSIS 
  • STATIC AND DYNAMIC COGNITIVE DEFICITS IN CHILDHOOD PRECEDE ADULT SCHIZOPHRENIA: A 30-YEAR STUDY 
  • SYNERGISTIC IMPACT OF PERCEIVED DISCRIMINATION AND HOSTILITY ON ADRENERGIC RESPONSIVITY 
  • Safety Considerations in Pharmacotherapy of Bipolar Disorder 
  • Safety and antipsychotic efficacy of "forced" intramuscular olanzapine over five days: a case report. 
  • Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder. 
  • Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. 
  • Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients. 
  • Safety considerations in pharmacotherapy of bipolar disorder 
  • Safety considerations in pharmacotherapy of bipolar disorder. 
  • Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index. 
  • Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures. 
  • Salivary testosterone and a trinucleotide (CAG) length polymorphism in the androgen receptor gene predict amygdala reactivity in men. 
  • Sampling in difficult to access refugee and immigrant communities. 
  • Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats. 
  • Schedule for affective disorders and schizophrenia for school-age children (K-SADS-PL) for the assessment of preschool children--a preliminary psychometric study. 
  • Schirophrenia, substance misuse, and smoking 
  • Schizophrenia, narrative, and neurocognition: The utility of life-stories in understanding social problem-solving skills. 
  • Schizophrenic-like deficits in nonpsychotic children and adolescents with 22Q11 deletion syndrome 
  • Science and recovery in schizophrenia. 
  • Scope of agency control: assertive community treatment teams' supervision of consumers. 
  • Scoring Nonresponse on the Mini Mental State Examination 
  • Scoring nonresponse on the Mini-Mental State Examination. 
  • Screening for Early Alzheimer's Disease: Is There Still a Role for the Mini-Mental State Examination? 
  • Screening for major depression in post-myocardial infarction patients: operating characteristics of the Beck Depression Inventory-II. 
  • Screening for trauma history on an inpatient affective-disorders unit: a pilot study. 
  • Screening for violence risk in military veterans: predictive validity of a brief clinical tool. 
  • Seasonal variation of mixed and pure episodes of bipolar disorder. 
  • Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers. 
  • Seclusion. 
  • Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II. 
  • Segmented hippocampal volume in children and adolescents with posttraumatic stress disorder. 
  • Seizure Induction With Low-Amplitude-Current Electroconvulsive Therapy: A Case Series 
  • Seizure induction with low-amplitude-current (0.5 A) electroconvulsive therapy. 
  • Seizure length and clinical outcome in electroconvulsive therapy using methohexital or thiopental. 
  • Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT. 
  • Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold. 
  • Seizures and bupropion: a review. 
  • Seizures associated with clozapine treatment in a state hospital 
  • Seizures terminable and interminable with ECT. 
  • Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission. 
  • Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? 
  • Selective serotonin reuptake inhibitors in post-traumatic stress disorder. 
  • Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial. 
  • Selegiline transdermal system: current awareness and promise. 
  • Self- and parent-reported depressive symptoms rated by the mood and feelings questionnaire. 
  • Self-Compassion as a prospective predictor of PTSD symptom severity among trauma-exposed U.S. Iraq and Afghanistan war veterans. 
  • Self-Regulation and Psychopathology: Toward an Integrative Translational Research Paradigm. 
  • Self-monitoring deficits in schizophrenia: Autonoetic agnosia 
  • Self-mutilative behaviors in male veterans with posttraumatic stress disorder. 
  • Self-punishment as a regulation strategy in borderline personality disorder. 
  • Self-rated depressive symptoms in medical inpatients: age and racial differences. 
  • Self-ratings of type A (coronary prone) adults: do type A's know they are type A's? 
  • Self-report and longitudinal predictors of violence in Iraq and Afghanistan war era veterans. 
  • Self-reported diurnal mood changes, early morning awakening and the dexamethasone suppression test in endogenous depression. 
  • Self-reported health and physician diagnosed illnesses in women with posttraumatic stress disorder and major depressive disorder. 
  • Self-reported medication nonadherence predicts cholesterol levels over time. 
  • Self-reported sleep disturbances associated with procedural learning impairment in adolescents at ultra-high risk for psychosis. 
  • Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans. 
  • Sensory acuity and reasoning in delusional disorder. 
  • Separating hope from hype: some ethical implications of the development of deep brain stimulation in psychiatric research and treatment. 
  • Separating mood disturbance from mild cognitive impairment in geriatric depression. 
  • Separation of subtypes of depression using discriminant analysis. I. Separation of unipolar endogenous depression from non-endogenous depression. 
  • Separation of subtypes of depression using discriminant analysis. Separation of bipolar endogenous depression from nonendogenous ("Neurotic") depression. 
  • Serial dexamethasone suppression tests among rapidly cycling bipolar patients. 
  • Serious physical illness as a stressor: effects on family use of medical services. 
  • Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats. 
  • Serotonin deficiency alters susceptibility to the long-term consequences of adverse early life experience. 
  • Serotonin syndrome after a massive overdose of controlled-release paroxetine. 
  • Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine. 
  • Serotonin syndrome produced by a combination of fluoxetine and lithium. 
  • Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. 
  • Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. 
  • Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. 
  • Serotonin transporter gene polymorphisms and brain function during emotional distraction from cognitive processing in posttraumatic stress disorder. 
  • Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. 
  • Serotonin transporter genotype and function in relation to antidepressant response in Koreans. 
  • Serotonin transporter polymorphism influences the prolactin response to tryptophan and stress 
  • Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals. 
  • Serotonin transporter promoter genotypes, CNS serotonin turnover, and cardiovascular reactivity to stress 
  • Serotonin-related gene polymorphisms and central nervous system serotonin function. 
  • Serotonin. 
  • Sertraline and the Cheshire cat in geriatric depression. 
  • Sertraline and the Cheshire cat in geriatric depression. 
  • Serum bupropion levels in 2 breastfeeding mother-infant pairs. 
  • Serum dopamine-beta-hydroxylase (DBH) activity and blood pressure response of rat strains to shock-induced fighting. 
  • Serum fluvoxamine levels in breastfed infants. 
  • Serum lipid changes following the onset of depressive symptoms in postmenopausal women. 
  • Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease. 
  • Serum valproate levels in 6 breastfeeding mother-infant Pairs 
  • Serum valproate levels in 6 breastfeeding mother-infant pairs. 
  • Service Utilization Patterns as Predictors of Response to Trauma-Informed Integrated Treatment for Women With Co-occurring Disorders. 
  • Service costs of caring for adolescents with mental illness in a rural community, 1993-2000. 
  • Service system involvement and delinquent offending at system of care entry. 
  • Service use and health status of persons with severe mental illness in full-risk and no-risk medicaid programs. 
  • Service use patterns for adolescents with ADHD and comorbid conduct disorder. 
  • Services for adolescents with psychiatric disorders: 12-month data from the National Comorbidity Survey-Adolescent. 
  • Severe episode of depression in late life: the long road to recovery. 
  • Severe hyperglycemia associated with high doses of clozapine. 
  • Severe life stress as a predictor of early disease progression in HIV infection. 
  • Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol. 
  • Severe premenstrual tension: delineation of the syndrome. 
  • Severe stress and adjustment disorder diagnoses in the population of Denmark. 
  • Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder. 
  • Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. 
  • Severity of depressive symptoms and hostility jointly predict interleukin-6 levels in healthy men 
  • Severity of posttraumatic stress disorder and involvement with the criminal justice system 
  • Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. 
  • Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. 
  • Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. 
  • Sex and depression in the National Comorbidity Survey. II: Cohort effects. 
  • Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy. 
  • Sex differences in neurochemical effects of dopaminergic drugs in rat striatum. 
  • Sex differences in novelty- and psychostimulant-induced behaviors of C57BL/6 mice. 
  • Sex differences in response to chronic mild stress and congenital serotonin deficiency. 
  • Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats. 
  • Sex roles and regional cerebral blood flow. 
  • Sex-dependent neurobiological features of prenatal immune activation via TLR7. 
  • Sex-differentiated changes in C-reactive protein from ages 9 to 21: the contributions of BMI and physical/sexual maturation. 
  • Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior. 
  • Sexual Assault and Psychiatric Disorders Among Women in a Community Population 
  • Sexual assault and psychiatric disorders among a community sample of women. 
  • Sexual harassment in the Marines, posttraumatic stress symptoms, and perceived health: evidence for sex differences. 
  • Sexual revictimization among Iraq and Afghanistan war era veterans. 
  • Sexuality in middle and late life. The effects of age, cohort, and gender. 
  • Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. 
  • Shame as a mediator between posttraumatic stress disorder symptoms and suicidal ideation among veterans. 
  • Shared features of neuroleptic malignant syndrome and alcohol abuse complications. 
  • Shift work disorder case studies: applying management principles in clinical practice. 
  • Short stature, growth hormone deficiency, and social anxiety. 
  • Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds. 
  • Short-term and long-term treatment for bipolar patients: beyond the guidelines. 
  • Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. 
  • Short-term variability of mood ratings in unipolar and bipolar depressed patients. 
  • Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4. 
  • Should cognitive impairment be included in the diagnostic criteria for schizophrenia? 
  • Should physicians screen for depression in elderly medical inpatients?: Results of a decision analysis. 
  • Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease? 
  • Should we be anxious when assessing anxiety using the Beck Anxiety Inventory in clinical insomnia patients? 
  • Sickness absence indicating depressive symptoms of working population in South Korea. 
  • Significance of monoclonal antibodies in diagnosis and therapy of tumors of the central nervous system 
  • Signs and symptoms of mania in pure and mixed episodes. 
  • Silent cerebrovascular events and Alzheimer's disease: an overlooked opportunity for prevention? 
  • Simultaneous major depression and panic disorder: treatment with electroconvulsive therapy. 
  • Simultaneous monitoring of dopamine, its metabolites and trans-isomer of atypical neuroleptic drug carbidine concentrations in striatal dialysates of conscious rats. 
  • Single case study. Complementary effects of phenelzine and psychotherapy in long term treatment of depression. 
  • Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome. 
  • Single-session psychotherapy. 
  • Single-trials analyses demonstrate that increases in clock speed contribute to the methamphetamine-induced horizontal shifts in peak-interval timing functions. 
  • Situational determinants of cardiovascular and emotional reactivity in high and low hostile men. 
  • Six-month outcomes for MRI-related vascular depression. 
  • Six-year outcome for children with ODD or CD treated with the coping power program. 
  • Sleep Disturbance After Traumatic Brain Injury 
  • Sleep Disturbances in the Elderly. 
  • Sleep EEG, depression rating scales, and diagnosis. 
  • Sleep and Eating Disorders. 
  • Sleep and Mood: Chicken or Egg? 
  • Sleep and psychiatric disorders: future directions. 
  • Sleep difficulties and alcohol use motives in female rape victims with posttraumatic stress disorder. 
  • Sleep disturbance and PTSD. 
  • Sleep disturbance and baroreceptor sensitivity in women with posttraumatic stress disorder. 
  • Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504. 
  • Sleep disturbance in euthymic bipolar patients. 
  • Sleep disturbance in euthymic bipolar patients: a STEP-BD study 
  • Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. 
  • Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis. 
  • Sleep impairment, mood symptoms, and psychosocial functioning in adolescent bipolar disorder. 
  • Sleep quality varies as a function of 5-HTTLPR genotype and stress. 
  • Sleep therapeutics and neuropsychiatric illness. 
  • Sleeping with one eye open: loneliness and sleep quality in young adults. 
  • Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept. 
  • Small for gestational age boys at increased risk of later psychiatric hospitalisation. 
  • Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study: Subcortical Volumetry Results From Posttraumatic Stress Disorder Consortia. 
  • Smaller hippocampal CA1 subfield volume in posttraumatic stress disorder. 
  • Smaller orbital frontal cortex volumes associated with functional disability in depressed elders. 
  • Smoking Abstinence-Induced Changes in Resting State Functional Connectivity with Ventral Striatum Predict Lapse During a Quit Attempt. 
  • Smoking and mental health in young women – challenges in interpretation : a reply. 
  • Smoking and psychosis in patients with bipolar I disorder. 
  • Smoking and therapeutic response to clozapine in patients with schizophrenia. 
  • Smoking automaticity and tolerance moderate brain activation during explore-exploit behavior. 
  • Smoking cessation delivered by medical students is helpful to homeless population. 
  • Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program. 
  • Smoking in Vietnam combat veterans with post-traumatic stress disorder. 
  • Smoking in first-episode patients with schizophrenia [12] 
  • Smoking intensity and severity of specific symptom clusters in posttraumatic stress disorder. 
  • Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances 
  • Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. 
  • Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation: a preliminary study. 
  • Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control. 
  • Social Functioning Deficits in Young People at Risk for Schizophrenia 
  • Social Inequality and Alcohol Consumption-Abuse in Bahia, Brazil: Interactions of Gender, Ethnicity, and Social Class 
  • Social Support Scales: A Methodological Note. 
  • Social and personal resources and the prevalence of phobic disorder in a community population. 
  • Social anxiety disorder in callers to the Anxiety Disorders Association of America. 
  • Social anxiety disorder in review: two decades of progress. 
  • Social anxiety disorder under scrutiny 
  • Social anxiety disorder under scrutiny. 
  • Social anxiey disorder: Etiology and early clinical presentation: Comments 
  • Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis. 
  • Social dominance and 22-year all-cause mortality in men. 
  • Social ecology interventions for post-traumatic stress disorder: what can we learn from child soldiers? 
  • Social ecology of child soldiers: child, family, and community determinants of mental health, psychosocial well-being, and reintegration in Nepal. 
  • Social functioning in urban, predominantly African American, socially disadvantaged patients with first-episode nonaffective psychosis. 
  • Social inequality and alcohol consumption-abuse in Bahia, Brazil-- interactions of gender, ethnicity and social class. 
  • Social isolation, loneliness and depression in young adulthood: a behavioural genetic analysis. 
  • Social learning and systems family therapy for childhood oppositional disorder: comparative treatment outcome. 
  • Social phobia in review 
  • Social phobia: biological aspects and pharmacotherapy. 
  • Social phobia: outlook for the '90s. 
  • Social skills training in unipolar nonpsychotic depression. 
  • Social support and coronary heart disease: epidemiologic evidence and implications for treatment. 
  • Social support and experimental pain. 
  • Social support and hostility as predictors of depressive symptoms in cardiac patients one month after hospitalization: a prospective study. 
  • Social support and the development of immune function in human immunodeficiency virus infection. 
  • Social support and the outcome of major depression. 
  • Social support as a predictor of the natural history of major depression 
  • Social support in elderly patients with bipolar disorder. 
  • Social support in social interaction: a moderator of cardiovascular reactivity. 
  • Social support, type A behavior, and coronary artery disease. 
  • Sociodemographic and clinical correlates of number of previous depressive episodes in the depressed elderly. 
  • Socioeconomic indices as independent correlates of C-reactive protein in the National Longitudinal Study of Adolescent Health. 
  • Socioeconomic status moderates associations between CNS serotonin and expression of beta2-integrins CD11b and CD11c. 
  • Socioeconomic status moderates the association between John Henryism and NEO PI-R personality domains. 
  • Sociopsychiatric treatment of alcoholism in an urban ghetto. 
  • Sociotropy, autonomy, and personality disorder criteria in psychiatric patients. 
  • Sodium oxybate for the treatment of fibromyalgia: A double-blind, placebo-controlled trial 
  • Sodium transfer from plasma to CSF in severe depressive illness. 
  • Somatic treatments for mood disorders. 
  • Somatic, positive and negative domains of the Center for Epidemiological Studies Depression (CES-D) scale: a meta-analysis of genome-wide association studies. 
  • Somatization Disorder in a Southern Community 
  • Somatization disorder in a US southern community: use of a new procedure for analysis of medical classification. 
  • Somatization disorder in a community population. 
  • Somatization disorder in the community. A study of diagnostic concordance among three diagnostic systems. 
  • Somatization symptoms in the community: a rural/urban comparison. 
  • Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis. 
  • Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications. 
  • Source-monitoring deficits for self-generated stimuli in schizophrenia: multinomial modeling of data from three sources. 
  • Sources of differentiation of cocaine withdrawal symptomatology 
  • Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls. 
  • Special section on assertive community treatment: an introduction. 
  • Special section on involuntary outpatient commitment: introduction. 
  • Special symposium on remoxipride: Closing remarks 
  • Specialist/generalist division of responsibility for patients with mental disorders. 
  • Specific psychotherapies for childhood and adolescent depression. 
  • Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. 
  • Specificity of symptoms in RDC endogenous depression. 
  • Spectral and topographic analysis of EEG in schizophrenic patients. 
  • Speech pause time: a marker of psychomotor retardation among endogenous depressives. 
  • Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. 
  • Speed of response to electroconvulsive therapy compared with ketamine. 
  • Spillover Effects of Massachusetts Health Reform on Mental Health Use by VA and Medicare Dual Enrollees. 
  • Spiritual Transformation and Healing 
  • Spirituality and depressive symptoms in a racially diverse US sample of community-dwelling adults. 
  • Spirituality and religion in outpatients with schizophrenia: a multi-site comparative study of Switzerland, Canada, and the United States. 
  • Spirituality and religion in psychiatry practice: parameters and implications. 
  • Spirituality in geriatric psychiatry. 
  • Spirituality in medical school curricula: findings from a national survey. 
  • Spirituality or religiosity: is there any difference? 
  • Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction (Psychosomatic Medicine (2007) 69, (501-508)) 
  • Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction (vol 69, pg 501, 2007) 
  • Spirituality, religion, and clinical outcomes in patients recovering from an acute myocardial infarction. 
  • Spirituality, resilience, and anger in survivors of violent trauma: a community survey. 
  • St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological, and clinical literature. 
  • St. John's wort in generalized anxiety disorder: three case reports. 
  • Stability of cardiovascular reactivity to laboratory stressors: a 2 1/2 yr follow-up. 
  • Stability of cardiovascular reactivity to psychological stressors: A two and a half year follow-up 
  • Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period. 
  • Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: A randomized, double-blind, fixed-dose study 
  • Standardizing the use of the Continuous Performance Test in schizophrenia research: a validation study. 
  • State Laws on Emergency Holds for Mental Health Stabilization. 
  • Static and Dynamic Cognitive Deficits in Childhood Precede Adult Schizophrenia: A 30-Year Study 
  • Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. 
  • Statins and cognition: what can we learn from existing randomized trials? 
  • Statistical guidelines for Psychosomatic Medicine 
  • Statistical procedures for analyzing mental health services data. 
  • Status of minor depression or dysthymia in primary care following a randomized controlled treatment. 
  • Stelazine advertisement "dismays" readers. 
  • Stigma and treatment delay in first-episode psychosis: a grounded theory study. 
  • Stimulant prescription cautions: addressing misuse, diversion and malingering. 
  • Stimulation strength in hippocampus for various ECT electrode configurations computed in a realistic head model 
  • Stoltzman, R., McEvoy, L., & Nestadt, G. The Exclusion Criteria of DSM-III: A Study of the Co-occurrence of Hierarchy-free Syndromes 
  • Storm clouds over the public mental health safety net. 
  • Strategies for assessing mental health in Haiti: local instrument development and transcultural translation. 
  • Strategy for investigating interactions between measured genes and measured environments. 
  • Stress Vulnerability Moderates the Association between White Matter Lesions and Late-Life Depression 
  • Stress alleviation and reward enhancement: two promising targets for relapse prevention. 
  • Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. 
  • Stress and telomere biology: a lifespan perspective. 
  • Stress and the heart 
  • Stress in employed women: impact of marital status and children at home on neurohormone output and home strain. 
  • Stress invalidates reported effects of sodium valproate on brain CRF systems. 
  • Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. 
  • Stress-related anhedonia is associated with ventral striatum reactivity to reward and transdiagnostic psychiatric symptomatology. 
  • Stress-system genes and life stress predict cortisol levels and amygdala and hippocampal volumes in children. 
  • Stressful life events and the onset of a generalized anxiety syndrome. 
  • Stressful politics: voters' cortisol responses to the outcome of the 2008 United States Presidential election. 
  • Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. 
  • Striatal abnormalities and spontaneous dyskinesias in non-clinical psychosis. 
  • Striatal dopamine D2/D3 receptor availability in male smokers. 
  • Structural MRI in bipolar disorder: An international collaborative mega-analysis of individual patient data 
  • Structural alterations within cerebellar circuitry are associated with general liability for common mental disorders. 
  • Structural brain changes revealed by MRI. 
  • Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature. 
  • Structural covariance network centrality in maltreated youth with posttraumatic stress disorder. 
  • Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. 
  • Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. 
  • Structural neuroimaging of geriatric depression. 
  • Structured interview for PTSD (SIP): psychometric validation for DSM-IV criteria. 
  • Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. 
  • Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results. 
  • Subcortical brain anatomy in anorexia and bulimia. 
  • Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects. 
  • Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. 
  • Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression. 
  • Subcortical white matter lesions and functional impairment in geriatric depression. 
  • Subjective effects and changes in steroid hormone concentrations in humans following acute consumption of alcohol. 
  • Subjective social support and depressive symptoms in major depression: separate phenomena or epiphenomena. 
  • Substance abuse (including nicotine) in schizophrenic patients 
  • Substance abuse and cerebral blood flow. 
  • Substance abuse and the transmission of hepatitis C among persons with severe mental illness. 
  • Substance abuse in bipolar disorder. 
  • Substance use after bariatric surgery: A review. 
  • Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa 
  • Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study. 
  • Substance use and schizophrenia: adverse correlates in the CATIE study sample. 
  • Substance use disorders and co-morbidities among Asian Americans and Native Hawaiians/Pacific Islanders 
  • Substance use disorders and co-morbidities among Asian Americans and Native Hawaiians/Pacific Islanders. 
  • Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database. 
  • Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. 
  • Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study. 
  • Subtypes of mania determined by grade of membership analysis. 
  • Successful coping styles in professional women. 
  • Successful recruitment strategies for women in postpartum mental health trials. 
  • Successful treatment of self-monitoring deficits predicts psychotic symptom decrease 
  • Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia. 
  • Suicidal Behavior and Problems with Emotion Regulation. 
  • Suicidal events in the Treatment for Adolescents With Depression Study (TADS). 
  • Suicidal ideation and sex differences in relation to 18 major psychiatric disorders in college and university students: anonymous web-based assessment. 
  • Suicidality as a Possible Side Effect of Antidepressant Treatment. 
  • Suicidality as a possible side effect of antidepressant treatment. 
  • Suicidality, aggression, and other treatment considerations among pregnant, substance-dependent women with posttraumatic stress disorder. 
  • Suicide Behaviors in Bipolar Disorder: A Review and Update for the Clinician. 
  • Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. 
  • Suicide in Nepal: Qualitative Findings from a Modified Case-Series Psychological Autopsy Investigation of Suicide Deaths. 
  • Suicide in Nepal: a modified psychological autopsy investigation from randomly selected police cases between 2013 and 2015. 
  • Suicide risk protocols: addressing the needs of high risk youths identified through suicide prevention efforts and in clinical settings. 
  • Superior temporal gyrus volumes in maltreated children and adolescents with PTSD. 
  • Superior temporal gyrus volumes in pediatric generalized anxiety disorder. 
  • Supernatural Explanations of Neurological and Psychiatric Disorders Among Health Care Professionals at an Academic Tertiary Care Hospital in Saudi Arabia. 
  • Supplemental Material for Actuarial Prediction of Psychotherapy Retention Among Iraq–Afghanistan Veterans With Posttraumatic Stress Disorder 
  • Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. 
  • Suppression of alcohol and saccharin preference in rats by a novel Ca2+ channel inhibitor, Goe 5438. 
  • Survey analysis of combat-related stress disorders in Viet Nam veterans. 
  • Survey evaluates: Complex trauma exposure outcome, and intervention among children and adolescents 
  • Surveying treatment preferences in U.S. Iraq-Afghanistan Veterans with PTSD symptoms: a step toward veteran-centered care. 
  • Surviving disaster: what comes after the trauma? 
  • Suspiciousness, health, and mortality: a follow-up study of 500 older adults. 
  • Sustained anterior cingulate cortex activation during reward processing predicts response to psychotherapy in major depressive disorder. 
  • Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials. 
  • Swedish Register Analysis of Divorce and Alcohol Use Disorder Highlights Social Relationships as a Target for Preventive Psychiatry and Genetic Research. 
  • Swim test immobility co-segregates with serotonergic but not cholinergic sensitivity in cross-breeds of Flinders Line rats. 
  • Symposium on atropine toxicity therapy; experience of use in private practice. 
  • Symptom and comorbidity patterns in World War II and Vietnam veterans with posttraumatic stress disorder. 
  • Symptom exacerbation in psychotically depressed adolescents due to high desipramine plasma concentrations. 
  • Symptom factors and clinical subtypes in mania. 
  • Symptom profile consistency in recurrent manic episodes. 
  • Symptom profiles of psychiatric disorders based on graded disease classes: an illustration using data from the WHO International Pilot Study of Schizophrenia. 
  • Symptom-specific effects of fluoxetine in post-traumatic stress disorder. 
  • Symptomatic and functional assessment of social anxiety disorder in adults. 
  • Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy. 
  • Symptomatology of affective and psychotic illnesses related to childbearing. 
  • Symptoms do not helpfully distinguish unipolar and bipolar depression. 
  • Symptoms of depression among community-dwelling elderly African-American and white older adults. 
  • Symptoms of interpersonal sensitivity in depression. 
  • Symptoms of neurasthenia following earthquake trauma: re-examination of a discarded syndrome. 
  • Syndrome of inappropriate antidiuretic hormone secretion. 
  • Systematic analysis of research on religious variables in four major psychiatric journals, 1978-1982. 
  • Systematic review of multifaceted interventions to improve depression care. 
  • Systematic studies with amoxapine, a new antidepressant 
  • T-lymphocyte CREB as a potential biomarker of response to antidepressant drugs. 
  • T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram Treatment 
  • T176. Controllability of Structural Brain Networks in Depressed Patients Receiving Repetitive Transcranial Magnetic Stimulation 
  • T184. Effects of Pregnenolone Administration on Emotion Regulation Neurocircuits in Trauma Brain Injury 
  • TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: an open label study. 
  • TAAR6 variations possibly associated with antidepressant response and suicidal behavior. 
  • TASKS FROM MONKEY CORTEX STUDIES AND SPECIFIC PREFRONTAL DYSFUNCTION IN SCHIZOPHRENIA 
  • TELEMEDICINE VERSUS IN-PERSON DELIVERY OF COGNITIVE PROCESSING THERAPY FOR WOMEN WITH POSTTRAUMATIC STRESS DISORDER: A RANDOMIZED NONINFERIORITY TRIAL. 
  • THE EFFECTS OF EXERCISE TRAINING ON CARDIOVASCULAR AND PSYCHOLOGICAL FUNCTIONING IN THE ELDERLY 
  • THE EFFECTS OF RELAXATION ON GLUCOSE-TOLERANCE 
  • THE EXTENT OF WORKING-MEMORY DEMANDS PREDICTS RESPONSE TO NEUROLEPTIC MEDICATION ON CONTINUOUS PERFORMANCE TESTS 
  • THE JOINT EFFECT OF SOCIAL SUPPORT AND HOSTILITY ON BETA2-ADRENOCEPTOR FUNCTION 
  • THE TREATMENT OF PRIMARY INSOMNIA 
  • TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. 
  • TYPE-A BEHAVIOR AND CHOLESTEROL LEVELS PREDICT NEURO-ENDOCRINE REACTIVITY TO MENTAL ARITHMETIC STRESS 
  • TYPE-A BEHAVIOR PATTERN AND NEUROENDOCRINE RESPONSE DURING MENTAL WORK 
  • Taking issue 
  • Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. 
  • Tardive dyskinesia: 21st century may bring new treatments to a forgotten disorder. 
  • Teacher-led relaxation response curriculum in an urban high school: impact on student behavioral health and classroom environment. 
  • Teaching evidence-based approaches to suicide risk assessment and prevention that enhance psychiatric training. 
  • Teaching scholarly activity in psychiatric training: years 6 and 7. 
  • Telephone adaptation of the Modified Mini-Mental State Exam (3MS). The Cache County Study. 
  • Temozolomide 
  • Temporal disintegration and its psychological and physiological correlates: Changes in the experience of time after marijuana smoking 
  • Temporal lobe volume in bipolar disorder: relationship with diagnosis and antipsychotic medication use. 
  • Temporal stability of individual differences in amygdala reactivity. 
  • Temporo-Parietal Junction Stimulation in the Treatment of Depersonalization Disorder 
  • Temporo-parietal junction stimulation in the treatment of depersonalization disorder. 
  • Ten rules of academic life: reflections on the career of an affective disorders researcher. 
  • Test-retest reliability of the dot test of visuospatial working memory in patients with schizophrenia and controls. 
  • Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. 
  • Testosterone Rapidly Increases Neural Reactivity to Threat in Healthy Men: A Novel Two-Step Pharmacological Challenge Paradigm 
  • Testosterone rapidly increases neural reactivity to threat in healthy men: a novel two-step pharmacological challenge paradigm. 
  • Testosterone responses to competition predict decreased trust ratings of emotionally neutral faces. 
  • Testosterone, antisocial behavior, and social dominance in boys: pubertal development and biosocial interaction. 
  • Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats. 
  • Textbook of psychyosomatic medicine 
  • The 'offset effect' of mental health treatment on ambulatory medical care utilization and charges. Month-by-month and grouped-month analyses of a five-year study. 
  • The 13- and 20-item Hopkins Symptom Checklist Depression Scale: psychometric properties in primary care patients with minor depression or dysthymia. 
  • The 2-week duration criterion and severity and course of early childhood depression: implications for nosology. 
  • The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support. 
  • The AMDP-system in chronic hospitalized schizophrenics 
  • The Alzheimer's Disease Assessment Scale: Predictors of baseline cognitive performance in clinical trials 
  • The Alzheimer's disease assessment scale .6. Noncognitive signs and symptoms in outpatients with Alzheimer's disease 
  • The American Psychiatric Press Textbook of Psychopharmacology (Second Edition) 
  • The Association Between a Sense of Calling and Physician Well-Being: A National Study of Primary Care Physicians and Psychiatrists. 
  • The BENEFIT through spirituality/religiosity scale--a 6-item measure for use in health outcome studies. 
  • The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. 
  • The Biological Bases of Nicotine and Alcohol Co-Addiction 
  • The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls. 
  • The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. 
  • The Brief Social Phobia Scale. 
  • The Brief Social Phobia Scale: a psychometric evaluation. 
  • The COMT Val158Met polymorphism and temporal lobe morphometry in healthy adults. 
  • The Carroll rating scale for depression. I. Development, reliability and validation. 
  • The Carroll rating scale for depression. II. Factor analyses of the feature profiles. 
  • The Carroll rating scale for depression. III. Comparison with other rating instruments. 
  • The Challenge of Bipolar Depression in the 21st Century. 
  • The Charles Bonnet syndrome (pseudohallucinations) in an AIDS patient with cytomegalovirus retinitis. 
  • The Child and Adolescent Psychiatric Assessment (CAPA). 
  • The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. 
  • The Clinical Significance of Bilateral Basal Ganglia Calcification Presenting With Mania and Delusions 
  • The Clinical Significance of Posterior Insular Volume in Adolescent Anorexia Nervosa. 
  • The Clinical Specialty Unit: the use of the psychiatry inpatient unit to treat chronic pain syndromes. 
  • The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition. 
  • The Cognitive Assessment Interview (CAI): reliability and validity of a brief interview-based measure of cognition. 
  • The Concept of "Concept Mapping" Is Useful in Teaching Residents to Teach. 
  • The Cook-Medley hostility scale: item content and ability to predict survival. 
  • The DST and posttraumatic stress disorder. 
  • The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. 
  • The Design of the Epidemiologic Catchment Area Surveys: The Control and Measurement of Error 
  • The Dunedin Multidisciplinary Health and Development Study: overview of the first 40 years, with an eye to the future. 
  • The Dunedin Multidisciplinary Health and Development Study: overview of the first 40 years, with an eye to the future 
  • The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions. 
  • The Effect of Patient Education on Chinese Adolescent and Parental Beliefs About Counselors' Breaches of Confidentiality. 
  • The Effect of Support and Training for Family Members on Access to Outpatient Services for Veterans with Posttraumatic Stress Disorder (PTSD). 
  • The Effect of Testosterone Levels on Mood in Men: A Review 
  • The Effects of Posttraumatic Stress Disorder Symptoms on Educational Functioning in Student Veterans 
  • The Effects of Tryptophan Enhancement and Depletion on Plasma Catecholamine Levels in Healthy Individuals. 
  • The Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Verbal Learning and Memory 
  • The FDA and ECT. 
  • The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later? 
  • The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. 
  • The G72/G30 gene complex and cognitive abnormalities in schizophrenia. 
  • The Garrett Lee Smith memorial suicide prevention program. 
  • The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. 
  • The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance. 
  • The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. 
  • The Great Smoky Mountains Study: developmental epidemiology in the southeastern United States. 
  • The Impact of Borderline Personality Disorder on Post-Traumatic Stress in the Community: A Study of Health Status, Health Utilization, and Functioning 
  • The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders. 
  • The Impact of Eszopiclone Insomnia Treatment on Cognition in Schizophrenia: A Double-blind, Randomized, Placebo-controlled Trial 
  • The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia. 
  • The Impact of Military Status on Cognitive Processing Therapy Outcomes in the Community. 
  • The Importance of Scrutinizing Emergent ADHD Symptoms in Adults: Response to Chamberlain and Müller. 
  • The Influence of APOE Genotype on Aging's Effect on Brain Structure and Cognition in Younger Adults with and without Depression 
  • The Inpatient Milieu: Organizational and Functional Principles 
  • The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. 
  • The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. 
  • The Invalidating Childhood Environment Scale (ICES): psychometric properties and relationship to borderline personality symptomatology. 
  • The Iowa structured psychiatric interview. Rationale, reliability, and validity 
  • The Late Positive Potential indicates Heightened Emotion Responses to Restricted Interests in Youth with Autism Spectrum Disorder 
  • The Latino mental health project: a local mental health needs assessment. 
  • The Life History Calendar: A Research and clinical assessment method for collecting retrospective event-history data 
  • The Life Trajectory Interview for Youth (LTI-Y): method development and psychometric properties of an instrument to assess life-course models and achievement. 
  • The Lives and Legends of Jacques Lacan 
  • The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR perspective. 
  • The MARIGOLD study: Feasibility and enhancement of an online intervention to improve emotion regulation in people with elevated depressive symptoms. 
  • The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. 
  • The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. 
  • The MATRICS consensus cognitive battery in patients with bipolar I disorder. 
  • The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. 
  • The Many Channels of Screen Media Technology in ADHD: a Paradigm for Quantifying Distinct Risks and Potential Benefits. 
  • The Millennium Cohort Family Study: a prospective evaluation of the health and well-being of military service members and their families. 
  • The Mini Mental State Exam as a predictor of neuropsychological functioning after cardiac surgery. 
  • The Monoamine Oxidase Inhibitors: Relics Reconsidered 
  • The Montgomery-Asberg Depression Scale: reliability and validity. 
  • The Morbidity of Insomnia 
  • The NIMH Child Emotional Faces Picture Set (NIMH-ChEFS): a new set of children's facial emotion stimuli. 
  • The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. 
  • The NIMH epidemiologic catchment area program 
  • The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. 
  • The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants. 
  • The Newcastle Endogenous Depression Diagnostic Index: validity and reliability. 
  • The Origins of Cognitive Deficits in Victimized Children: Implications for Neuroscientists and Clinicians. 
  • The Post-Deployment Mental Health (PDMH) study and repository: A multi-site study of US Afghanistan and Iraq era veterans. 
  • The Psychiatric Genomics Consortium Posttraumatic Stress Disorder Workgroup: Posttraumatic Stress Disorder Enters the Age of Large-Scale Genomic Collaboration. 
  • The Relationship Between Posttraumatic Stress Symptoms and Physical Health in a Survey of U.S. Veterans of the Iraq and Afghanistan Era. 
  • The Rise and Fall of the Biopsychosocial Model Reconciling Art and Science in Psychiatry 
  • The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms. 
  • The Role of Serotonin (5-HT) in Behavioral Control: Findings from Animal Research and Clinical Implications. 
  • The Role of Serotonin in Posttraumatic Stress Disorder: Neurobiology and Pharmacotherapy 
  • The Role of the Caregiver in the Drug Treatment of Dementia 
  • The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. 
  • The Schizophrenia Cognition Rating Scale: validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia. 
  • The Singapore flagship programme in translational and clinical research in psychosis. 
  • The Stress﷓Buffering Role of Social Support. 
  • The Systems SOAP Note: A Systems Learning Tool. 
  • The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes. 
  • The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. 
  • The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. 
  • The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. 
  • The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. 
  • The accumulative effect of trauma exposure on short-term and delayed verbal memory in a treatment-seeking sample of female rape victims. 
  • The adrenal gland and depression [1] 
  • The age at onset of attention deficit hyperactivity disorder. 
  • The age-of onset of attention-deficit hyperactivity disorder. 
  • The assertive community treatment team as a complex dynamic system of care. 
  • The assessment and management of insomnia: an update. 
  • The association between cognitive function and subsequent depression: a systematic review and meta-analysis. 
  • The association between early parental loss and diagnosis in the Iowa 500. 
  • The association between spiritual and religious involvement and depressive symptoms in a Canadian population. 
  • The association between weight change and symptom reduction in the CATIE schizophrenia trial. 
  • The association of alcohol consumption patterns with self-rated physical health and psychiatric distress among Afghanistan- and Iraq-era U.S. veterans. 
  • The association of dehydroepiandrosterone and dehydroepiandrosterone sulfate with anxiety sensitivity and electronic diary negative affect among smokers with and without posttraumatic stress disorder. 
  • The association of sexual assault and attempted suicide within the community. 
  • The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 
  • The benzodiazepine inverse agonist RO19-4603 exerts prolonged and selective suppression of ethanol intake in alcohol-preferring (P) rats 
  • The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. 
  • The boundaries of schizophrenia. 
  • The boundary of social phobia. Exploring the threshold. 
  • The brief assessment of cognition in schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery 
  • The caregiving environments provided to children by depressed mothers with or without an antisocial history. 
  • The case for practical clinical trials in psychiatry. 
  • The changing perspective on chronic insomnia management. 
  • The characteristics of poor outcome, 'Kraepelinian' schizophrenia 
  • The child and adolescent burden assessment (CABA): Measuring the family impact of emotional and behavioral problems 
  • The choice of stimulus intensity with ECT 
  • The chronically mentally ill in primary care. 
  • The clinical epidemiology of pure and mixed manic episodes. 
  • The clinical future of repetitive transcranial magnetic stimulation and depression: Separating hope from hype 
  • The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs 
  • The clinical utility of ictal EEG seizure adequacy models 
  • The clinician as the agent of change or terminator under managed care: Hasta la vista baby, au revoir, or good-bye? 
  • The combined medical specialties unit: an innovative approach to patient care. 
  • The complex relationship between depressive symptoms and functional limitations in community-dwelling older adults: the impact of subthreshold depression. 
  • The construct validity of the ischemic score of Hachinski for the detection of dementias. 
  • The continuous performance test, identical pairs: norms, reliability and performance in healthy controls and patients with schizophrenia in Singapore. 
  • The contribution of neuropsychology to psychiatry. 
  • The control group dilemma in clinical research: applications for psychosocial and behavioral medicine trials. 
  • The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. 
  • The cost of assisted outpatient treatment: can it save states money? 
  • The costs of schizophrenia. 
  • The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. 
  • The course of cognitive functioning over six months in individuals at clinical high risk for psychosis. 
  • The course of postdisaster psychiatric disorders in directly exposed civilians after the US Embassy bombing in Nairobi, Kenya: a follow-up study. 
  • The course of psychological distress following threatened and actual conjugal bereavement. 
  • The creative balance: The therapeutic relationship and thematic issues in trauma resolution 
  • The critical warzone experiences (CWE) scale: initial psychometric properties and association with PTSD, anxiety, and depression. 
  • The danger of reducing reimbursement for psychiatric disorders in late life. 
  • The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference 
  • The depression treatment cascade in primary care: a public health perspective. 
  • The development and modelling of devices and paradigms for transcranial magnetic stimulation. 
  • The development and retrospective testing of an electroencephalographic seizure quality-based stimulus dosing paradigm with ECT. 
  • The development of a patient-centered program based on the relaxation response: the Relaxation Response Resiliency Program (3RP). 
  • The dexamethasone suppression test and quantitative cerebral anatomy in depression. 
  • The dexamethasone suppression test as a diagnostic aid in catatonia. 
  • The dexamethasone suppression test for melancholia. 
  • The dexamethasone suppression test in borderline personality disorder. 
  • The dexamethasone suppression test in prepubertal depressed children. 
  • The dexamethasone suppression test in repeated hospitalizations. 
  • The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry. 
  • The dissociative subtype of PTSD: a replication and extension. 
  • The doctrine of the two depressions in historic perspective 
  • The dopamine D4 receptor and the hyperactivity phenotype: a developmental-epidemiological study. 
  • The dose-response relationship for memory impairment by anticholinergic drugs 
  • The double-blind in danger: untoward consequences of informed consent. 
  • The economic burden of anxiety disorders in the 1990s. 
  • The economic burden of depression. 
  • The effect of amphetamine on plasma cortisol in patients with endogenous and non-endogenous depression. 
  • The effect of cognitive processing therapy on cognitions: impact statement coding. 
  • The effect of context processing on different aspects of social cognition in schizophrenia. 
  • The effect of dexamethasone on sleep: preliminary results in eleven patients. 
  • The effect of draft DSM-V criteria on posttraumatic stress disorder prevalence. 
  • The effect of emotional context on facial emotion ratings in schizophrenia. 
  • The effect of isocarboxazid on platelet MAO activity. 
  • The effect of nicotine and trauma context on acoustic startle in smokers with and without posttraumatic stress disorder. 
  • The effect of nonsedating doses of diazepam on regional cerebral blood flow 
  • The effect of prayer on depression and anxiety: maintenance of positive influence one year after prayer intervention. 
  • The effect of surgery on intraocular pressure fluctuations with electroconvulsive therapy in a patient with severe glaucoma. 
  • The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study. 
  • The effectiveness of mental health consultation and referral in ambulatory primary care: a research lacuna. 
  • The effects of Brief Behavioral Activation Therapy for Depression on cognitive control in affective contexts: An fMRI investigation. 
  • The effects of ECT modifications on autobiographical and verbal memory. 
  • The effects of ECT stimulus dose and electrode placement on the ictal electroencephalogram: an intraindividual crossover study. 
  • The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study. 
  • The effects of aerobic exercise on premenstrual symptoms in middle-aged women: a preliminary study. 
  • The effects of aggression on symptom severity and treatment response in a trial of cognitive behavioral therapy for panic disorder 
  • The effects of amantadine vs. trihexyphenidyl on memory in elderly normal volunteers 
  • The effects of amoxapine and ethanol on psychomotor skills related to driving: A placebo and standard controlled study 
  • The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial. 
  • The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression. 
  • The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. 
  • The effects of brain serotonin deficiency on behavioural disinhibition and anxiety-like behaviour following mild early life stress. 
  • The effects of childhood parental death and divorce on six-month history of anxiety disorders. 
  • The effects of electroconvulsive therapy on memory of autobiographical and public events. 
  • The effects of exercise on the Type A behavior pattern 
  • The effects of isocarboxazid on blood pressure and pulse. 
  • The effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis: A double-blind, 52-week comparison 
  • The effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis: A double-blind, 52-week comparison 
  • The effects of optimism and gratitude on adherence, functioning and mental health following an acute coronary syndrome. 
  • The effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans 
  • The effects of psychotherapy on neural responses to rewards in major depression. 
  • The effects of race and criminal justice involvement on access to atypical antipsychotic medications among persons with schizophrenia. 
  • The effects of state psychiatric hospital waitlist policies on length of stay and time to readmission. 
  • The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. 
  • The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. 
  • The efficacy of acute electroconvulsive therapy in atypical depression. 
  • The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. 
  • The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. 
  • The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. 
  • The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health. 
  • The epidemiology of major depression and ethnicity in the United States. 
  • The epidemiology of religious coping: A review of recent literature 
  • The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. 
  • The estimated rate of depressed mood in US adults: recent evidence for a peak in later life. 
  • The evidence-based pharmacological treatment of paediatric ADHD. 
  • The evolution of witchcraft and the meaning of healing in colonial Andean society. 
  • The experience of sexual trauma 
  • The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. 
  • The extent and impact of mental health problems after disaster. 
  • The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults. 
  • The factor structure of psychiatric comorbidity among Iraq/Afghanistan-era veterans and its relationship to violence, incarceration, suicide attempts, and suicidality. 
  • The fifth psychoactive drug usage guide [1] 
  • The five-site health and risk study of blood-borne infections among persons with severe mental illness. 
  • The functional hurdle: Connecting through cognition 
  • The generalizability of cardiovascular responses across settings. 
  • The genetics of dementia in late life. 
  • The global cognitive impairment in schizophrenia: Consistent over decades and around the world 
  • The great debate editorial, revisited [1] 
  • The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. 
  • The highs and lows of amygdala reactivity in bipolar disorders. 
  • The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. 
  • The impact of Tourette Syndrome in adults: results from the Tourette Syndrome impact survey. 
  • The impact of borderline personality disorder on post-traumatic stress in the community: a study of health status, health utilization, and functioning. 
  • The impact of childhood abuse among women with assault-related PTSD receiving short-term cognitive-behavioral therapy. 
  • The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. 
  • The impact of dissociation on PTSD treatment with cognitive processing therapy. 
  • The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial. 
  • The impact of evidence-based education on prescribing in a psychiatry residency. 
  • The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder. 
  • The impact of obesity on health care costs among persons with schizophrenia. 
  • The impact of posttraumatic stress disorder on quality of life and health service utilization among veterans who have schizophrenia. 
  • The impact of prolonged exposure therapy on social support and PTSD symptoms. 
  • The impact of social support on psychological distress for U.S. Afghanistan/Iraq era veterans with PTSD and other psychiatric diagnoses. 
  • The impact of sudden gains in cognitive behavioral therapy for posttraumatic stress disorder. 
  • The impact of terrorism on children: Considerations for a new era 
  • The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. 
  • The impairment of Presidents Pierce and Coolidge after traumatic bereavement. 
  • The implications of DSM-III personality disorders for patients with major depression. 
  • The implications of genetics studies of major mood disorders for clinical practice. 
  • The importance of dose in isocarboxazid therapy. 
  • The importance of early treatment of schizophrenia. 
  • The incidence of mental and behavioral disturbances in dementia: the cache county study. 
  • The influence of depressive symptoms on suicidal ideation among U.S. Vietnam-era and Afghanistan/Iraq-era veterans with posttraumatic stress disorder. 
  • The influence of emotional distraction on verbal working memory: an fMRI investigation comparing individuals with schizophrenia and healthy adults. 
  • The influence of interpersonal interaction on diastolic blood pressure. 
  • The influence of problems with concentration and memory on emotional distress and daily activities in chronic pain patients. 
  • The influence of resting blood pressure and gender on pain responses. 
  • The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia. 
  • The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse. 
  • The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. 
  • The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. 
  • The iowa structured psychiatric interview. Rationale, reliability, and validity. 
  • The joint impact of cognitive performance in adolescence and familial cognitive aptitude on risk for major psychiatric disorders: a delineation of four potential pathways to illness. 
  • The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies. 
  • The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18. 
  • The long-term treatment of panic disorder. 
  • The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness. 
  • The management of resistant depression. 
  • The manipulative patient. 
  • The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety. 
  • The medical-psychiatric unit and psychosocial education of internists. 
  • The menstrual cycle in context, I: Affective syndromes associated with reproductive hormonal changes. 
  • The menstrual cycle in context, II: Human gonadal steroid hormone variability. 
  • The monitoring and management of electrically induced seizures. 
  • The multi-dimensional nature of active coping: differential effects of effort and enhanced control on cardiovascular reactivity. 
  • The nature and effectiveness of general hospital psychiatric services. 
  • The nature of social anxiety disorder: Comments 
  • The need for a psychosocial classification system in primary-care settings 
  • The neural circuitry mediating shifts in behavioral response and cognitive set in autism. 
  • The neuroactive steroid dehydroepiandrosterone sulfate (DHEAS) predicts nicotine dependence severity 
  • The neurobiology of social phobia. 
  • The neuroleptic threshold as a marker of minimum effective neuroleptic dose 
  • The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. 
  • The neurostructural/neurofunctional basis of depression/mania 
  • The organizational effects of gonadal steroids on sexually dimorphic spatial ability. 
  • The origins of late-life depression 
  • The other side of the stethoscope. 
  • The performance of DSM-III-R major depression criteria in the diagnosis of bipolar mixed states. 
  • The period of untreated psychosis before treatment initiation: a qualitative study of family members' perspectives. 
  • The persistence of electroconvulsive therapy-induced changes in the electroencephalogram. 
  • The potential role of atypical antipsychotics for the treatment of posttraumatic stress disorder. 
  • The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. 
  • The prevalence of abnormal involuntary movements among chronic schizophrenics. 
  • The prevalence of lifetime and partial post-traumatic stress disorder in Vietnam theater veterans 
  • The prevalence of lifetime and partial post-traumatic stress disorder in vietnam theater veterans 
  • The prevalence of periodic limb movements during sleep in men with erectile dysfunction. 
  • The prevalence of post-traumatic stress disorder in the Vietnam generation: A multimethod, multisource assessment of psychiatric disorder 
  • The prevalence of post-traumatic stress disorder in the Vietnam generation: A multimethod, multisource assessment of psychiatric disorder 
  • The prevalence of posttraumatic stress disorder among American Indian Vietnam veterans: disparities and context. 
  • The prevalence of potentially traumatic events in childhood and adolescence. 
  • The prevention of conduct problems. 
  • The primary care physician and the psychiatric epidemiologist: a symbiotic service research partnership. 
  • The process of coping with sexual trauma 
  • The psychiatric chief residency: a preliminary training experience in administrative process. 
  • The psychiatric use of electrically induced seizures. 
  • The psychobiology of premenstrual dysphoria: review of theories and treatments. 
  • The psychobiology of premenstrual dysphoria: the role of prolactin. 
  • The psychological risks of Vietnam: the NVVRS perspective. 
  • The psychological well-being of people living with HIV/AIDS and the role of religious coping and social support. 
  • The public health approach to reducing suicide: opportunities for curriculum development in psychiatry residency training programs. 
  • The relation between physical assault and psychological functioning in a sample of university women, and the relative effects of physical and sexual assault 
  • The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. 
  • The relation of stress and family environment to atopic dermatitis symptoms in children. 
  • The relationship between age and post-dexamethasone cortisol: a test of three hypotheses. 
  • The relationship between depressive symptoms and climacteric symptoms in women at mid-life 
  • The relationship between hostility and beta-adrenergic receptor physiology in health young males. 
  • The relationship between insurance coverage and psychiatric disorder in predicting use of mental health services. 
  • The relationship between level of training and accuracy of violence risk assessment. 
  • The relationship between negative symptom subdomains and cognition. 
  • The relationship between posttraumatic stress disorder and smoking outcome expectancies among U.S. military veterans who served since September 11, 2001. 
  • The relationship between psychiatry and religion among U.S. physicians. 
  • The relationship between religious activities and blood pressure in older adults. 
  • The relationship between religious attendance and blood pressure: the HUNT Study, Norway. 
  • The relationship between spirituality and depressive symptoms: testing psychosocial mechanisms. 
  • The relationship between working memory deficits and other measures sensitive to prefrontal dysfunction 
  • The relationship of age to dysthymia in primary care 
  • The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. 
  • The relationship of cognition changes and other symptoms following antipsychotic treatment 
  • The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: A literature review. 
  • The relationships between dimensions of hostility and cardiovascular reactivity as a function of task characteristics. 
  • The relative diagnostic utility of child and parent reports of oppositional defiant behaviors 
  • The relative efficiency of altering pulse frequency or train duration when determining seizure threshold. 
  • The research diagnostic criteria for endogenous depression and the dexamethasone suppression test: a discriminant function analysis. 
  • The response of an assertive community treatment program following a natural disaster. 
  • The response of depressed inpatients to isocarboxazid. 
  • The role of couples' interacting world assumptions and relationship adjustment in women's postdisaster PTSD symptoms. 
  • The role of insight in the treatment and outcome of bipolar disorder 
  • The role of neuroimaging in geriatric psychiatry 
  • The role of non-pharmacologic approaches in the management of fibromyalgia. 
  • The role of nuclear magnetic resonance imaging in psychiatric research. 
  • The role of psychiatric and behavioral factors in the practice of medicine. 
  • The role of the ictal EEG in ECT stimulus dosing. 
  • The role of the manuscript reviewer 
  • The role of trauma-related distractors on neural systems for working memory and emotion processing in posttraumatic stress disorder. 
  • The roles of emotion dysregulation and dissociation in the association between sexual abuse and self-injury among juvenile justice-involved youth. 
  • The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. 
  • The self-assessment of resilience and anxiety: psychometric properties. 
  • The severely mentally ill in general hospital psychiatric units. 
  • The six most essential questions in psychiatric diagnosis: a pluralogue part 2: Issues of conservatism and pragmatism in psychiatric diagnosis. 
  • The six most essential questions in psychiatric diagnosis: a pluralogue part 3: issues of utility and alternative approaches in psychiatric diagnosis. 
  • The sleep effects of lurasidone: a placebo-controlled cross-over study using a 4-h phase-advance model of transient insomnia. 
  • The sleep effects of tiagabine on the first night of treatment predict post-traumatic stress disorder response at three weeks. 
  • The social brain in clinical practice 
  • The social brain: A unifying foundation for psychiatry [1] 
  • The social neuroendocrinology of human aggression. 
  • The spectrum of clozapine response in refractory schizophrenia: Four case reports 
  • The stress of stigma: exploring the effect of weight stigma on cortisol reactivity. 
  • The sympathetic nervous system as a model for studying drug-induced alterations of nerve development 
  • The theory and practice of psychiatry in the Soviet Union. 
  • The trauma constellation identification scale: A measure of the psychological impact of a stressful life event 
  • The treatment effectiveness project. A comparison of the effectiveness of paroxetine, problem-solving therapy, and placebo in the treatment of minor depression and dysthymia in primary care patients: background and research plan. 
  • The treatment of primary insomnia. 
  • The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? 
  • The undertreatment of dysthymia. 
  • The use of ECT within the Veterans Administration hospital system. 
  • The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials. 
  • The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. 
  • The use of dexmedetomidine in alcohol withdrawal. 
  • The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. 
  • The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. 
  • The use of topical lidocaine to reduce pain during repetitive transcranial magnetic stimulation for the treatment of depression. 
  • The use of valerian in neuropsychiatry. 
  • The utility of the dexamethasone suppression test. 
  • The varied manifestations of anxiety disorder 
  • The vascular depression subtype: evidence of internal validity. 
  • The views and outcomes of consenting and non-consenting patients receiving ECT. 
  • The what, where, and when of catechol-O-methyltransferase. 
  • The working alliance and Clinician-assisted Emotional Disclosure for rheumatoid arthritis. 
  • The α₂-adrenergic antagonist idazoxan counteracts prepulse inhibition deficits caused by amphetamine or dizocilpine in rats. 
  • The δ₂ -opioid receptor antagonist naltriben reduces motivated responding for ethanol 
  • Thematic resolution, PTSD, and complex PTSD: The relationship between meaning and trauma-related diagnoses 
  • Thematic resolution, PTSD, and complex PTSD: the relationship between meaning and trauma-related diagnoses. 
  • Therapeutic and prophylactic utility of the memory-enhancing drug donepezil hydrochloride on cognition of patients undergoing electroconvulsive therapy: a randomized controlled trial. 
  • Thinking Carefully About Marijuana Legalization: Public Health Considerations for State Policy Makers. 
  • Thioridazine retinopathy within the upper dosage limit. 
  • This issue: Posttraumatic stress disorder 
  • Thought suppression mediates the relationship between negative mood and PTSD in sexually assaulted women. 
  • Threat-related amygdala activity is associated with peripheral CRP concentrations in men but not women. 
  • Threatened miscarriage and depressive and anxiety symptoms among women and partners in early pregnancy. 
  • Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder. 
  • Through the looking glass: risk perception. 
  • Thyroid function in mixed and pure manic episodes. 
  • Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment. 
  • Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. 
  • Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. 
  • Time of Day When Type 1 Diabetes Patients With Eating Disorder Symptoms Most Commonly Restrict Insulin. 
  • Time required for initial improvement during clozapine treatment of refractory schizophrenia 
  • Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. 
  • Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release. 
  • Time-dependent recovery from the effects of 6-hydroxydopamine lesions of the rat nucleus accumbens on cocaine self-administration and the levels of dopamine in microdialysates. 
  • Timely access to mental health care among women veterans. 
  • Timing of depression recurrence in the first year after birth. 
  • Timing of nicotine effects on learning in zebrafish. 
  • Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. 
  • Tolerability of fluoxetine in posttraumatic stress disorder. 
  • Topiramate-induced confusion following a single ingestion of 400 mg. 
  • Topographic maps of brain electrical activity--pitfalls and precautions. 
  • Tourette's syndrome and the law. 
  • Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. 
  • Towards a scientific taxonomy of depression. 
  • Towards a standard documentation for behavioral health 
  • Toxic Interaction Between Valproate and Oxcarbazepine 
  • Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. 
  • Trail making test performance in Vietnam combat veterans with and without posttraumatic stress disorder. 
  • Training Psychiatrists for Global Mental Health: Cultural Psychiatry, Collaborative Inquiry, and Ethics of Alterity. 
  • Training directors' self-assessment of forensic education within residency training. 
  • Training in Geriatric Psychiatry 
  • Training in adolescent psychiatry for general psychiatry residents: elements of a model curriculum. 
  • Trajectories of preschool disorders to full DSM depression at school age and early adolescence: continuity of preschool depression. 
  • Trajectory classes of depressive symptoms in a community sample of older adults. 
  • Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. 
  • Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. 
  • Transcranial magnetic stimulation: Effectiveness and safety in a randomized, controlled, multisite clinical trial and an open-label extension study 
  • Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia. 
  • Transcranial magnetic stimulation: applications in basic neuroscience and neuropsychopharmacology. 
  • Transcranial magnetic stimulation: applications in neuropsychiatry. 
  • Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. 
  • Transdermal nicotine effects on attention. 
  • Transdermal selegiline: the new generation of monoamine oxidase inhibitors. 
  • Transient and spontaneously-remitting complex hallucinations in a patient with melanoma and brain metastases. 
  • Transient situational disturbances: course and outcome. 
  • Translational Development of Novel Pharmacotherapeutic Strategies for Psychostimulant Dependence 
  • Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly. 
  • Trauma and Autonomic Dysregulation: Episodic - Versus Systemic - Negative Affect Underlying Cardiovascular Risk in Posttraumatic Stress Disorder. 
  • Trauma and Autonomic Dysregulation: Episodic-Versus Systemic-Negative Affect Underlying Cardiovascular Risk in Posttraumatic Stress Disorder. 
  • Trauma and posttraumatic stress in users of the Anxiety Disorders Association of America Web site. 
  • Trauma re-experiencing symptoms modulate topology of intrinsic functional networks. 
  • Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. 
  • Trauma, proximity, and developmental psychopathology: the effects of war and terrorism on children. 
  • Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder. 
  • Trauma-informed measurement-based care for children: Implementation in diverse treatment settings. 
  • Trauma-related distractors modulate neural systems for working memory in posttraumatic stress disorder 
  • Trauma-related sleep disturbance and self-reported physical health symptoms in treatment-seeking female rape victims. 
  • Trauma: The impact of post-traumatic stress disorder 
  • Trauma: prevalence, impairment, service use, and cost. 
  • Trauma: the impact of post-traumatic stress disorder. 
  • Traumatic Brain Injury in Iraq and Afghanistan Veterans: New Results From a National Random Sample Study. 
  • Traumatic Brain Injury, Sleep Quality, and Suicidal Ideation in Iraq/Afghanistan Era Veterans. 
  • Traumatic brain injury among veterans returning from Afghanistan and Iraq 
  • Traumatic events and health in women with fibromyalgia 
  • Traumatic events and posttraumatic stress in childhood. 
  • Traumatic events and posttraumatic stress in cross-cultural mission assignments. 
  • Traumatic experiences in psychiatric outpatients 
  • Traumatic stress and accelerated DNA methylation age: A meta-analysis. 
  • Treating Chronic and Severe Mental Disorders—A Handbook of Empirically Supported Interventions 
  • Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications. 
  • Treating Psychological Trauma and PTSD 
  • Treating delirium among elderly patients. 
  • Treating maladaptive grief and posttraumatic stress symptoms in orphaned children in Tanzania: group-based trauma-focused cognitive-behavioral therapy. 
  • Treatment boundaries in the case management relationship: a clinical case and discussion. 
  • Treatment considerations for clinicians in applying evidence-based practice to complex presentations in child trauma. 
  • Treatment costs for youths receiving multisystemic therapy or hospitalization after a psychiatric crisis. 
  • Treatment course with antidepressant therapy in late-life depression. 
  • Treatment engagement and violence risk in mental disorders. 
  • Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density. 
  • Treatment improves symptoms shared by PTSD and disordered eating. 
  • Treatment of Anxiety in Patients With Coronary Heart Disease: A Systematic Review. 
  • Treatment of agitation in elderly persons with Dementia: A summary of the expert consensus guidelines 
  • Treatment of cognitive deficits in first episode schizophrenia 
  • Treatment of depression by mental health specialists and primary care physicians. 
  • Treatment of depression in the medically ill. 
  • Treatment of generalized anxiety disorder with citalopram 
  • Treatment of minor depression and dysthymia in primary care: Response to paroxetine and problem solving therapy-PC 
  • Treatment of obsessive-compulsive disorder 
  • Treatment of posttraumatic stress disorder 
  • Treatment of posttraumatic stress disorder reduces suicidal ideation. 
  • Treatment of posttraumatic stress disorder with amitriptyline and placebo. 
  • Treatment of posttraumatic stress disorder with nefazodone. 
  • Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. 
  • Treatment of premenstrual tension with lithium carbonate. A pilot study. 
  • Treatment of social anxiety disorder with citalopram. 
  • Treatment of social phobia with benzodiazepines. 
  • Treatment of social phobia with clonazepam and placebo. 
  • Treatment of social phobia with gabapentin: a placebo-controlled study. 
  • Treatment of spasmodic torticollis with ethyl chloride. 
  • Treatment of the modal patient: does one size fit nearly all? 
  • Treatment outcome variation between depression symptom combinations in the STAR*D study. 
  • Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia. 
  • Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness. 
  • Treatment response in melancholia 
  • Treatments for alcohol dependence: rethinking the role of comorbidity and clinical subtypes. 
  • Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. 
  • Tremorous mouth movements in rats administered chronic neuroleptics. 
  • Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. 
  • Trends in psychiatric nursing graduate education. 
  • Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. 
  • Tribulin in post-traumatic stress disorder. 
  • Trichotillomania--a review. 
  • Tricyclic antidepressant prescribing for nonpsychiatric disorders. An analysis based on data from the 1985 National Ambulatory Medical Care Survey. 
  • Tricyclic antidepressants. 
  • Tricyclic-induced akathisia in patients taking conjugated estrogens. 
  • Tricyclics vs SSRIs for postpartum depression 
  • Tryptophan depletion in recently manic patients treated with lithium. 
  • Twenty-year depressive trajectories among older women. 
  • Twin studies of psychopathology: why do the concordance rates vary? 
  • Two-Year Stability of Borderline Personality Measures 
  • Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. 
  • Type A behavior and angiographically documented coronary atherosclerosis in a sample of 2,289 patients. 
  • Type A behavior pattern and blood glucose control in diabetic children. 
  • Type A behavior, hostility, and coronary atherosclerosis. 
  • US hospitalizations and costs for illicit drug users with soft tissue infections. 
  • Ultrabrief Right Unilateral ECT in Geriatric Depression: Antidepressant and Cognitive Outcomes 
  • Uncertainty, symptoms, and quality of life in persons with chronic hepatitis C. 
  • Understanding borderline personality disorder across sociocultural groups: Findings, issues, and future directions 
  • Understanding confounding and mediation. 
  • Understanding depression and cognitive impairment in the elderly 
  • Understanding symbol coding in schizophrenia. 
  • Understanding the Research on Extreme Risk Protection Orders: Varying Results, Same Message. 
  • Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system. 
  • Understanding therapeutic equivalence in epilepsy. 
  • Unipolar depression does not moderate responses to the Sweet Taste Test. 
  • Unirhinal olfactory function in schizophrenia patients and first-degree relatives. 
  • Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives. 
  • Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia. 
  • Unraveling the relationship between obesity, schizophrenia and cognition. 
  • Untreated depression and hippocampal volume loss. 
  • Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers. 
  • Update on Assisted Outpatient Treatment. 
  • Update on magnetic seizure therapy: a novel form of convulsive therapy. 
  • Update on posttraumatic stress disorder 
  • Uptake of Web-based clinical resources from the MacArthur Initiative on Depression and Primary Care. 
  • Urinary 6-hydroxymelatonin in menstruating women. 
  • Urinary excretion of biopterin and neopterin in psychiatric disorders. 
  • Urinary free cortisol excretion in depression. 
  • Use of Antidepressants by Non-Psychiatrists in the Treatment of Hospitalized Medically Ill Depressed Elderly Patients 
  • Use of ECT in the United States in 1975, 1980, and 1986. 
  • Use of ECT in treatment of depression in patients with diabetes mellitus. 
  • Use of Expert Consultation in a Complex Case of Neuroleptic Malignant Syndrome Requiring Electroconvulsive Therapy. 
  • Use of a brief behavioral skills intervention to prevent HIV infection among chronic mentally ill adults. 
  • Use of alcohol treatment and mental health services among adolescents with alcohol use disorders. 
  • Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients. 
  • Use of antidepressants in medically ill older patients. 
  • Use of aripiprazole in a patient with multiple sclerosis presenting with paranoid psychosis. 
  • Use of benzodiazepines in panic disorder. 
  • Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. 
  • Use of caffeine to lengthen seizures in ECT. 
  • Use of general medical care services by persons with mental disorders. 
  • Use of health care services in seasonal affective disorder. 
  • Use of health services by hospitalized medically ill depressed elderly patients. 
  • Use of lamotrigine in a patient with a clozapine-related seizure. 
  • Use of leverage to improve adherence to psychiatric treatment in the community. 
  • Use of mental health services by community-resident adults with DSM-IV anxiety and mood disorders in a violence-prone area: São Paulo, Brazil. 
  • Use of neostigmine in the management of acute postoperative pain and labour pain: a review. 
  • Use of outpatient commitment or related civil court treatment orders in five U.S. communities. 
  • Use of phenelzine in continuation therapy. 
  • Use of psychiatric and medical health care by veterans with severe mental illness. 
  • Use of psychopathology vignettes by patients with schizophrenia or schizoaffective disorder and by mental health professionals to judge patients' insight 
  • Use of psychotherapy in a representative adult community sample in São Paulo, Brazil. 
  • Use of psychotropic medications by youths in therapeutic foster care and group homes. 
  • Use of sensory descriptors in assessing chronic pain patients. 
  • Use of substance abuse services by young uninsured american adults. 
  • Use of substance abuse treatment services by persons with mental health and substance use problems. 
  • Use of the Patient Health Questionnaire-9 and a detailed suicide evaluation in determining imminent suicidality in distressed patients with cardiac disease. 
  • Use of the breakthrough series collaborative to support broad and sustained use of evidence-based trauma treatment for children in community practice settings. 
  • Use of the dexamethasone suppression test in depression. 
  • Use, persistence, and intensity: patterns of care for children's mental health across one year. 
  • Useful but Different: Resident Physician Perceptions of Interprofessional Feedback. 
  • Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. 
  • Usefulness of the Patient Health Questionnaire-9 for Korean medical students. 
  • Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations. 
  • Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part II. What makes a "real" difference? 
  • Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults. 
  • Using the WHODAS 2.0 to assess functional disability associated with DSM-5 mental disorders. 
  • Utilization of Standardized Mental Health Assessments in Anthropological Research: Possibilities and Pitfalls. 
  • VAGAL ANTAGONISM OF CARDIOVASCULAR AND ELECTROPHYSIOLOGIC RESPONSES TO ISOPROTERENOL (ISO) INFUSION IS WEAKER IN TYPE-A THAN IN TYPE-B MEN 
  • VIOLENCE IN THE MEDIA - EFFECTS OF AFFECTIVE RESPONSE, GENDER AND HOSTILITY OF THE VIEWER UPON NEUROENDOCRINE REACTIVITY 
  • VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. 
  • Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. 
  • Vagus nerve stimulation. A potential therapy for resistant depression? 
  • Vagus nerve stimulation: a new tool for brain research and therapy. 
  • Validation of a Computerized test of Functional Capacity. 
  • Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia. 
  • Validation of cross-cultural child mental health and psychosocial research instruments: adapting the Depression Self-Rating Scale and Child PTSD Symptom Scale in Nepal. 
  • Validation of four definitions of melancholia by the dexamethasone suppression test. 
  • Validation of the Davidson Trauma Scale in a sample of survivors of childhood sexual abuse. 
  • Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients. 
  • Validation of the German version of the brief assessment of cognition in Schizophrenia (BACS) - preliminary results. 
  • Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study. 
  • Validation of the Purdue Post-Traumatic Stress Scale on a sample of Vietnam veterans. 
  • Validation of the phenomenon of autistic regression using home videotapes. 
  • Validation of the tablet-administered Brief Assessment of Cognition (BAC App). 
  • Validity and reliability analysis of the Chinese parent version of the Autism Spectrum Rating Scale (6-18 years). 
  • Validity and reliability of the DSM-III criteria for posttraumatic stress disorder. Experience with a structured interview. 
  • Validity of DSM-IV conduct disorder in 41/2-5-year-old children: a longitudinal epidemiological study. 
  • Validity of an interviewer-administered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. 
  • Validity of an operational definition for neurotic unipolar major depression. 
  • Validity of the Hamilton Endogenous Subscale: an independent replication. 
  • Validity of the Patient Health Questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South Africa. 
  • Varenicline effects on craving, cue reactivity and smoking reward 
  • Varenicline effects on craving, cue reactivity, and smoking reward. 
  • Variation in functioning, psychosocial characteristics, and six-month outcomes among suicidal youth in comprehensive community mental health services. 
  • Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. 
  • Vascular Depression: Is an Old Research Construct Finally Ready for Clinical Prime Time? 
  • Vascular dementia: The end stage of cerebral vascular disease 
  • Vascular depression prevalence and epidemiology in the United States. 
  • Vascular risk factors in late onset mania. 
  • Vectoring for true north: building a research base on family support. 
  • Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. 
  • Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats. 
  • Ventral striatum reactivity to reward and recent life stress interact to predict positive affect. 
  • Ventricular enlargement in poor-outcome schizophrenia. 
  • Verapamil treatment for women with bipolar disorder. 
  • Victimization history and victim-assailant relationship as factors in recovery from sexual assault 
  • Victimization of persons with severe mental illness: a pressing global health problem. 
  • Video-Based Coping Skills to Reduce Health Risk and Improve Psychological and Physical Well-Being in Alzheimer's Disease Family Caregivers (vol 72, pg 897, 2010) 
  • Video-based coping skills to reduce health risk and improve psychological and physical well-being in Alzheimer's disease family caregivers. 
  • Viloxazine HCl in the treatment of endogenous depression: A standard (imipramine) controlled clinical study 
  • Viloxazine in the treatment of depressive neurosis: A placebo and standard (imipramine) controlled clinical study 
  • Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study 
  • Viloxazine in the treatmentof depressive neurosis: A controlled clinical study with doxepin and placebo 
  • Vintage treatments for PTSD: a reconsideration of tricyclic drugs. 
  • Violence and leveraged community treatment for persons with mental disorders. 
  • Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. 
  • Violent behaviour and post-traumatic stress disorder in US Iraq and Afghanistan veterans. 
  • Virtual reality assessment of functional capacity in people with Schizophrenia: Associations with reduced emotional experience and prediction of functional outcomes. 
  • Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning. 
  • Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia. 
  • VisualDecisionLinc: a visual analytics approach for comparative effectiveness-based clinical decision support in psychiatry. 
  • Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking. 
  • Visuospatial working memory in schizotypal personality disorder 
  • Visuospatial working memory in schizotypal personality disorder 
  • Visuospatial working memory in schizotypal personality disorder patients. 
  • Vital exhaustion and retinal microvascular changes in cardiovascular disease: atherosclerosis risk in communities study. 
  • Vitamin E treatment of tardive dyskinesia. 
  • Volumetric brain imaging findings in mood disorders. 
  • Volumetric brain imaging studies in the elderly with mood disorders. 
  • Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis. 
  • Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder. 
  • Voxel-based morphometric multisite collaborative study on schizophrenia. 
  • Vulnerability genes or plasticity genes? 
  • Vulnerability or Consequence: Amygdala Volume Changes with PTSD in a Large Case-Controlled Veteran Group 
  • WORKING-MEMORY DEFICITS IN SCHIZOPHRENICS WITH SEVERE SELF-CARE DYSFUNCTION 
  • Walking Corpse Syndrome Presenting With Catatonia: Case Report and Literature Review 
  • Wall/Object Punching: An Important but Under-Recognized Form of Nonsuicidal Self-Injury. 
  • Web-based acceptance and commitment therapy smoking cessation treatment for smokers with depressive symptoms. 
  • Weight change and the dexamethasone suppression test. 
  • Weight changes in postpartum women with remitted depression. 
  • Weight reduction at the work site: a promise partially fulfilled. 
  • Well-being in Australia--findings from the National Survey of Mental Health and Well-being. 
  • Wernicke-Korsakoff-syndrome: under-recognized and under-treated. 
  • What CATIE found: results from the schizophrenia trial. 
  • What Ought We to Do With "Thick Terms"? A Response to Frankfurt & Coady's "Bringing Philosophy to Bear on Moral Injury and Posttraumatic Stress Disorder Construct Validation". 
  • What are the causes of late-life depression? 
  • What does the dexamethasone suppression test identify? 
  • What have we learned about trial design from NIMH-funded pragmatic trials? 
  • What is generalized anxiety disorder? 
  • What is the role of pharmacogenetics in clinical psychiatry? 
  • What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. 
  • What's in a word? Addiction versus dependence in DSM-V 
  • What's it worth? Public willingness to pay to avoid mental illnesses compared with general medical illnesses. 
  • When "need plus supply" does not equal demand: challenges in uptake of depression treatment in HIV clinical care. 
  • When Something is Better Than Nothing: Response to Tully and Cosh. 
  • When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. 
  • When treating the pain is not enough: a multidisciplinary approach for chronic pelvic pain. 
  • Whether ionizing radiation is a risk factor for schizophrenia spectrum disorders? 
  • Which adolescents develop persistent substance dependence in adulthood? Using population-representative longitudinal data to inform universal risk assessment. 
  • Which dimension of parenting predicts the change of callous unemotional traits in children with disruptive behavior disorder? 
  • Whistle-blowing in Medical School: A National Survey on Peer Accountability and Professional Misconduct in Medical Students. 
  • White matter abnormalities and neurocognitive deficits associated with the passivity phenomenon in schizophrenia: a diffusion tensor imaging study. 
  • White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies. 
  • White matter hyperintensities and their association with suicidality in major affective disorders: a meta-analysis of magnetic resonance imaging studies. 
  • White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. 
  • White matter hyperintensity progression and late-life depression outcomes. 
  • Whither psychiatric diagnosis. 
  • Who are the new users of antipsychotic medications? 
  • Who gets treated? Factors associated with referral in children with psychiatric disorders. 
  • Whole blood serotonin relates to violence in an epidemiological study. 
  • Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. 
  • Whose disorder?: a constructive MacIntyrean critique of psychiatric nosology. 
  • Why Are Children in Urban Neighborhoods at Increased Risk for Psychotic Symptoms? Findings From a UK Longitudinal Cohort Study. 
  • Why John wasn't healed by prayer: perspectives across disciplines. 
  • Why Psychiatry Is the Hardest Specialty 
  • Why are there no approved treatments for cognitive impairment in schizophrenia? 
  • Why do trauma survivors become depressed? Testing the behavioral model of depression in a nationally representative sample. 
  • Why does the worldwide prevalence of childhood ADHD matter? Editorial 
  • Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter? 
  • Why elderly veterans choose VA services. 
  • Why must some schizophrenic patients be involuntarily committed? The role of insight 
  • Why the Hamilton Depression Rating Scale endures. 
  • Why the evidence for outpatient commitment is good enough. 
  • Widespread white matter but focal gray matter alterations in depressed individuals with thoughts of death. 
  • William W.K. Zung, MDiv, MS, MD 
  • Wisconsin Card Sorting Test performance in schizophrenia: the role of working memory. 
  • Women recovering from social rejection: The effect of the person and the situation on a hormonal mechanism of affiliation. 
  • Work expectations, realizations, and depression in older workers. 
  • Work stress precipitates depression and anxiety in young, working women and men 
  • Work stress precipitates depression and anxiety in young, working women and men. 
  • Work-site treatment for obesity. 
  • Working memory and schizophrenia: evidence for slowed encoding. 
  • Working memory dysfunction in Kraepelinian schizophrenics 
  • Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. 
  • Writing projects: lessening undergraduates' unique suicidal bereavement. 
  • Young adult mental health and functional outcomes among individuals with remitted, persistent and late-onset ADHD. 
  • Youth therapeutic alliance in intensive treatment settings. 
  • Ziprasidone-associated mania: a case series and review of the mechanism. 
  • Zolpidem for persistent insomnia in SSRI-treated depressed patients. 
  • Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. 
  • Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats. 
  • [³ H]Imipramine binding in type I and type II alcoholism 
  • [Health services in Canada and Norway. Looked at from the psychiatric point of view]. 
  • [No Title] 
  • [Significance of monoclonal antibodies in diagnosis and therapy of tumors of the central nervous system]. 
  • [The evaluation of cognitive dysfunctions in schizophrenia]. 
  • cTMS: A novel TMS device inducing near rectangular pulses with controllable pulse width 
  • d-Amphetamine-induced "floating limb" syndrome in young rhesus monkeys. 
  • fMRI activity correlated with auditory hallucinations during performance of a working memory task: data from the FBIRN consortium study. 
  • fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence. 
  • fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder. 
  • fMRI- and Computationally-Guided rTMS Enhances Performance in Working Memory Manipulation 
  • fMRI-guided rTMS in the remediation of sleep deprivation-induced performance deficits ina working memory task 
  • rTMS strategies for the study and treatment of schizophrenia: a review. 
  • μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids. 
• 

  Keywords of People

  • Charles, Hal Cecil, Associate Professor of Radiology, Radiology
  • Gazzola, Luiz R.A., Associate Consulting Professor in the Department of Psychiatry & Behavioral Sciences, Psychiatry & Behavioral Sciences, General Psychiatry
  • Kimbrel, Nathan Andrew, Associate Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Behavioral Medicine
  • Thielman, Samuel B., Adjunct Associate Professor in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Social and Community Psychiatry
  • Webb, Jason Allen, Assistant Professor of Medicine, Medicine, General Internal Medicine
  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine